Caspase-activation complex ARCosome –  its regulation and signalling for cell death by Chaisaklert, Wanwisa
 P  
  
 
 
 
 
 
 
 
 
IMPERIAL COLLEGE LONDON 
 
DEPARTMENT OF MEDICINE 
 
 
 
 
 
Caspase-Activation Complex ARCosome –  
Its Regulation and Signalling for Cell Death 
 
 
A thesis submitted by: 
 
 
Wanwisa Chaisaklert 
 
 
for the degree of Doctor of Philosophy. 
 
 
2014 
2 | P a g e  
 
 
  
3 | P a g e  
 
 
 
Declaration of Originality  
 
 
 
I, Wanwisa Chaisaklert, hereby affirm that the work presented in this thesis is my 
own original research work conducted at the Department of Medicine, Imperial 
College London. 
 
Any content in this thesis, including figures, data, ideas and materials obtained 
from other sources are appropriately cited and acknowledged in the text and a full 
list of references is given at the end of this thesis. 
 
I declare that the content of this thesis has not been and will not be submitted in 
any form for a higher degree from any other university or institution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 | P a g e  
 
 
 
Copyright Declaration  
 
 
 
The copyright of this thesis rests with the author and is made available under a 
Creative Commons Attribution Non-Commercial No Derivatives licence. 
Researchers are free to copy, distribute or transmit the thesis on the condition 
that they attribute it, that they do not use it for commercial purposes and that   
they do not alter, transform or build upon it. For any reuse or redistribution, 
researchers must make clear to others the licence terms of this work. 
 
 
 
 
 
 
 
 
 
 
 
6 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 | P a g e  
 
 
 
Abstract  
 
 
Mitochondria and the endoplasmic reticulum (ER) cooperatively orchestrate 
signalling pathways for cell death (apoptosis). My research focused on the 
ARCosome, a novel protein complex that spans the interface between the 
mitochondria and the ER. This complex was discovered in our laboratory and 
was shown to play a role in cell-death regulation. It is composed of Fission1 
homologue (Fis1), a fission protein, and Bap31, an integral ER membrane 
protein. Caspase-8 was shown to be recruited to the complex under cell death 
conditions and to cleave Bap31 into the pro-apoptotic p20Bap31. However, the 
question of how this complex is controlled in healthy and dying cells was 
unknown. In my study, I show that Bcl-XL and Bcl-2 dissociate from the complex 
upon etoposide-induced cell death. I discovered that Bcl-2 and Bcl-XL block the 
recruitment of caspase-8 to the complex and inhibit apoptotic signals activated by 
Fis1 and Bap31. Their rescue effect was demonstrated by inhibiting Bap31 
cleavage into the pro-apoptotic p20Bap31. Hence, our work reveals the changes 
that take place at the ARCosome for apoptosis induction and highlight in 
particular the release of Bcl-XL and Bcl-2 as pivotal factors to control apoptosis in 
this pathway.  
I also investigated the downstream signalling of p20Bap31-inducedcell death for 
which I studied complex II activation and ROS generation. Prohibitin, an 
assembly factor for complex II, and cyclophylin D, an inhibitor of the PT pore, 
were found to inhibit p20Bap31-induced cell death as well as ROS generation. 
Ectopic p20Bap31 expression resulted in the dissociation of respiratory chain 
complex II components SDHB and SDHD, as shown by the decrease of FRET 
efficiency when their GFP-variant fusion proteins were transfected into cells. 
Moreover, I showed that ARCosome activation is not only involved in apoptosis 
pathways, but also in IFN-induced necroptosis and amyloid-β-mediated cell 
death in neuronal cells.  
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HEPES  :  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
Hip  :  Huntingtin-Interacting Protein  
Hippi  :  Hip-Interacting Protein  
HK  :  Hexokinase  
HR domain  :  Heptad Repeat Domain  
HRP  :  Horse Raddish Peroxidase  
IAP  :  Inhibitor of Apoptosis Protein  
iCAD  :  Inhibitor of Caspase-Activating DNase  
ICE  :  Interleukin-1β Converting Enzyme  
IKK  :  IκB Kinase  
IMM  :  Inner Mitochondrial Membrane  
IMS  :  Inter-Mitochondrial Membrane Space  
IP  :  Immunoprecipitation  
IP3R  :  Inositol 1,4,5-trisphosphate Receptor  
IRE  :  Inositol Requirement  
JNK  :  c-Jun N-terminal Kinase  
Kd  :  Dissociation Constant  
LB-broth  :  Luria-Bertani broth  
Mfn  :  Mitofusin  
MHC  :  Major Histocompatibility Complex  
MOMP  :  Mitochondrial Outer Membrane Permeabilisation  
mRNA  :  Messenger RNA  
NAD  :  Nicotinamide Adenine Dinucleotide  
NB domain  :  Nucleotide-Binding Domain  
NFκB  :  Nuclear Factor-κB  
NT  :  Non-treated  
OMM  :  Outer Mitochondrial Membrane  
Opa1  :  Optic Atrophy 1  
PAGE  :  Polyacrylamide Gel Electrophoresis  
PAK2  :  p20-Activated Kinase 2  
PARP  :  Poly ADP-Ribose Polymerase  
PBS  :  Phosphate Buffered Saline  
PBS-T  :  PBS with 0.1% Tween  
PCR  :  Polymerase Chain Reaction  
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PERK  :  PRKR-Like Endoplasmic Reticulum Kinase  
PI  :  Propidium Iodide  
PIDD  :  p53-induced Protein with a Death Domain  
Pol  :  Reverse Transcriptase  
PS1 : Presenilin 1 
PS2 : Presenilin 2 
PT  :  Permeability Transition  
PTP  :  Permeability Transition Pore  
PVDF  :  Polyvinylidene Fluoride  
RAIDD  :  RIP-Associated ICH-1/CED-3 Homologous Protein with 
Death Domain  
Rev  :  Reverse Transcriptase  
RING  :  Really Interesting New Gene  
RIP  :  Receptor Interaction Protein  
RNA  :  Ribonucleic Acid  
ROCK1  :  Rho-Associated Coiled-Coil Containing Protein Kinase 1  
ROS  :  Reactive Oxygen Species  
RT  :  Room Temperature  
RyR  :  Ryanodine Receptor  
S.D.  :  Standard Deviation  
SC  :  Scrambled  
SDS  :  Sodium Dodecyl Sulfate  
SERCA  :  Sarcoplasmic/Endooplasmic Reticulum Calcium ATPase  
shRNA  :  Short Hairpin RNA  
siRNA  :  Short Interfering RNA  
Smac  :  Second Mitochondria Derived Activator of Caspase  
SODD  :  Silencer of DD  
STS  :  Staurosporine  
TAE buffer  :  Tris-acetate-EDTA buffer  
tBid  :  Truncated Bid  
TBS  :  Tris Buffered Saline  
TBSS  :  TBS with 0.02% w/v saponine  
TE buffer  :  Tris-EDTA buffer  
TEMED  :  Tetramethylethylenediamine  
TG :  Thapsigargin  
TM  :  Tunicamycin 
TMRE  :  tetramethylrhodamine ethyl ester  
TNF  :  Tumour Necrosis Factor  
TNF-R  :  TNF Receptor  
TRADD  :  TNF-R1-associated Death Domain Protein  
TRAF2  :  TNF Receptor-associated Factor 2  
TRAIL-R  :  TNF-related Apoptosis Inducing Ligand Receptor  
UPR  :  Unfolded Protein Response  
UT : Untreated 
UV  :  Ultraviolet  
VDAC  :  Voltage-Dependent Anion Channel  
vDED  :  Variant of DED  
vMIA  :  Viral Mitochondria-Localised Inhibitor of Apoptosis  
VSVG  :  Vesicular Stomatitis Virus Glycoprotein  
WT  :  Wild Type  
XBP  :  X-Box Protein  
YFP  :  Yellow Fluorescent Protein  
β-gal  :  β-galactosidase  
ΔΨm  :  Mitochondrial Electrochemical Protein Gradient  
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Chapter 1    
General introduction 
 
1.1  Apoptosis 
1.1.1  Overview of apoptosis  
The term “apoptosis” was coined in 1972 by Kerr and colleagues (Kerr et al, 1972).    
It was used to describe a series of morphological changes, which are important for cellular 
suicide and are regarded as hallmarks of apoptosis. Characteristics of apoptotic cells include 
nuclear and cytoplasmic condensation, nuclear fragmentation, plasma membrane blebbling, 
and phagocytic removal. Unlike necrosis, apoptosis is a non-inflammatory and energy-
requiring, intracellular process (Kerr et al, 1972) and it also allows for the selective removal 
of specific target cells without surrounding tissue damage (Danial & Korsmeyer, 2004; 
Duprez et al, 2009; Kroemer et al, 2009). This process is therefore important for 
physiological processes such as embryonic development, normal cell turnover and 
elimination of infected or damaged cells (Opferman, 2008; Penaloza et al, 2008; Vaux & 
Korsmeyer, 1999).   
The process of apoptosis comprises specific morphological and chemical changes. In 
apoptotic cells, their morphological characteristics are altered, such as cell shrinkage, DNA 
condensation, membrane blebbing, cell detachment (if adherent), and apoptotic body 
production (Kerr et al, 1972).  Apoptotic cells also undergo a series of biochemical changes 
such as the increase of free cytoplasmic Ca2+, which triggers a downstream apoptotic 
signalling cascade, loss of mitochondrial membrane potential, activation of cysteine-
dependent aspartate-directed proteases (caspase) (Alnemri et al, 1996), and phosphotidyl 
serine (PS) externalisation (Martin et al, 1995b).  According to these features, molecular 
techniques can distinguish between live and dead cells.  
Apoptosis or programmed cell death is a crucial biological process in cellular 
development and disease. Cell death signals eliminate superfluous cells during development 
and remove damaged or pathogen-infected cells (Duprez et al, 2009; Penaloza et al, 2008; 
Vaux & Korsmeyer, 1999). The apoptotic pathway must be kept in balance with the survival 
pathway. Once normal cell-death regulation is disrupted, this can cause a variety of 
diseases. Excessive cell death may lead to atrophy, or degenerative diseases, while 
inappropriate cell death inhibition may result in proliferative disorders, such as cancer and 
autoimmunity (Hotchkiss et al, 2009; Mehta et al, 2007; Zhivotovsky & Orrenius, 2010). 
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Therefore, the apoptotic pathways are important in multicellular organisms and need to be 
properly controlled. Recently, there has been growing interest in the field of apoptosis, 
particularly in respect to cancers and degenerative diseases. 
Cell death pathways, which are initiated by extrinsic and intrinsic signalling events 
are regulated by gene products and/or signalling molecules. Once a cell-death signal is 
induced by extracellular molecules, such as a receptor ligand, this pathway is termed 
“extrinsic pathway”. The activation of this pathway is mainly based on ligand binding to death 
receptors on cell membranes that brings about the recruitment of caspases to induce 
apoptosis. On the other hand, the “intrinsic pathway” is regulated by intracellular molecules, 
such as hormones, and reactive oxygen species, through a mitochondrial signalling 
pathway. Pharmacological manipulation of cell death pathways via cell death molecules 
engaged in those signalling pathways is promising for targeted therapies.   
The study of apoptosis in disease-related fields is fuelled by the hope for finding 
novel treatment and prevention options. As mentioned above, there are many target proteins 
in apoptotic pathways, which were discovered to be up-regulated or down-regulated in 
particular diseases. For example, the application of the cancer-targeting proteins in cancer 
patients may be a better alternative for treatment compared to chemotherapy or radiation 
treatment alone. They can potentially better reach targets to induce cell death specifically in 
cancer cells. Tailored treatments can potentially be applied to the individual patient based on 
his/her gene profile. Cell death-related diseases are widely accepted to cause a huge 
burden on patients and carers in terms of psychological, economical, and social aspects. 
The more researchers understand cell death signalling, the more the quality of life, it is 
hoped, can be improved.   
1.1.2   Apoptosis in nematodes and mammals  
The molecular mechanisms of the signalling pathways for apoptosis initiation, 
mediation and execution have been studied initially in the nematode Caenorhabditis elegans 
(Brenner, 1974; Ellis & Horvitz, 1986; Liu & Hengartner, 1999; Sulston, 1976). Single-gene 
mutations in genetic screens have revealed genes playing a role in apoptotic processes. The 
genes encoding ced-3, ced-4 and ced-9 have been characterised as central regulators in 
this pathway. In healthy cells, the association of the anti-apoptotic ced-9 with the pro-
apoptotic ced-4 keeps ced-4 inactive (Shaham & Horvitz, 1996).Under apoptotic conditions, 
egl-1 antagonises ced-9 thereby releasing ced-4 from the complex (Chen et al, 2000). The 
protease ced-3 is then activated by binding to the released ced-4 for apoptosis induction 
(Yang et al, 1998). 
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The apoptosis signalling pathway in mammals is more diverse and mammalian 
homologous genes, which function in an equivalent way have been studied. In mammals, 
the anti-apoptotic Bcl-2 family members are homologous to ced-9; initiator caspases in 
mammals resemble ced-3; BH3-only proteins of Bcl-2 family members are similar to egl-1; 
and the caspase adaptor protein Apaf-1 is homologous to the pro-apoptotic ced-4 protein 
(Table 1-1). 
Table 1-1 : Cell death proteins between C. elegans and mammals 
Function C. elegans Mammals 
Anti-apoptotic Bcl-2 family  ced-9  Bcl-2, Bcl-XL, etc  
Caspase activator  ced-4  Apaf-1  
Initiator caspase  ced-3  Caspase-1, -2, -8, -9  
BH3-only protein of the Bcl-2 
family  
egl-1  Bid, Bim, Puma, Noxa, etc  
 
 The identification of ced-3, ced-4 and ced-9 homologous proteins in mammals 
confirmed the evolutionary conservation of the basic apoptotic pathway (Hengartner & 
Horvitz, 1994; Vaux et al, 1992).However, in mammals the regulation of apoptosis seems to 
be more complex. Although its activation in mammals are rather similar to C. elegans, some 
aspects are still different. As mentioned above, in C. elegans, the binding of the anti-
apoptotic ced-9 to the pro-apoptotic ced-4 keeps ced-4 inactive (Shaham & Horvitz, 1996).In 
mammals, apoptosis inhibition with anti-apoptotic Bcl-2 family members (ced-9 homologue) 
through Apaf-1 (ced-4 homologue) association seems to be indirect. The indirect role of anti-
apoptotic Bcl-2 family members to inactivate Apaf-1 is via the inactivation of pro-apoptotic 
Bcl-2 family members, such as Bax or Bak, which further activate Apaf-1 (Figure 1-1).     
Apaf-1, cytochrome c and procaspase-9 form the apoptosome for caspase-9 (ced-3 in        
C. elegans) activation, which then activates effector caspases, such as procaspase-3, -6 or -
7 for apoptosis. 
 The protein homologue of ced-4 in mammals remains controversial. The different 
regulation of anti-apoptotic Bcl-2 family members between C.elegans and mammals raises 
the possibilities that first, the apoptotic regulation in mammals might be different to 
C.elegansas mentioned above, and secondly, there are other proteins which are also 
potential ced-4 functional homologues that have not been identified based on their amino 
acid sequence, or characterised for their death domain and the mechanism of their 
regulation. Hence, searching for ced-4 homologues in mammals has been a growing interest 
in the field.    
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Figure 1-1 :  Apoptosis pathways in C.elegans and mammals 
C.elegans pathway  
In healthy cells, ced-9 interacts with ced-4. Upon apoptosis induction, Egl-1 binds to ced-9 
and this interaction induces the dissociation of ced-9 and ced-4. The released ced-4 
consequently activates ced-3 for apoptosis.   
Mammalian pathway  
The BH3-only proteins both inhibit anti-apoptotic Bcl-2 and activate apoptosis through pro-
apoptotic Bcl-2 proteins, such as Bax, Bak. Activated pro-apoptotic Bcl-2 family members 
then indirectly activate adaptor proteins to form an initiator caspase activation platform. 
Activated initiator caspases further cleave and activate effector caspases for apoptosis.  
Figure is modified from (Cory et al, 2003). 
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1.1.3   Caspase: executioners and their substrates 
1.1.3.1  Caspase classification  
Execution of apoptosis in mammals is regulated by cysteine-dependent aspartate-
specific proteases (caspases) (Alnemri et al, 1996; Martin & Green, 1995). Caspases use 
their cysteine residue as a nucleophilic group for substrate binding and then cleave the 
substrates at the C-terminal end of the substrate‟s aspartic acid residue (Stennicke & 
Salvesen, 1998). Caspases target substrates at a P4-P3-P2-P1-P1‟ cleavage motif. The 
cleavage occurs between P1 and P1‟ and P1 is always an aspartic acid residue; P1‟ is 
preferentially a small, uncharged residue; P2 to P4 (in particularP4) are also important for 
substrate specificity (Stennicke et al, 2000; Thornberry et al, 1997; Timmer & Salvesen, 
2007). The preferred substrate sequences of particular caspases were shown in Figure 1.2. 
Caspases have been identified in mammals and classified into different groups 
depending on their sequence similarities, structures, functions, and substrate preferences.       
To date, 12 human caspases (caspase-1 to 10, 13, 14), and 10 murine caspases (caspase-
1, 2, 3, 6, 7, 8, 9, 11, 12 and 14) have been identified. Although most of them play a role in 
the apoptosis execution process, some of them (caspase-1, 4, 5, 13, 14, and murine 
caspase-11, 12) also act as cytokine activators involved in the inflammatory response. 
Proapoptotic caspases can be divided into two groups: initiator caspases (caspase-2, 4, 8, 9, 
10) and effector caspases (caspase-3, 6, 7). The initiators are characterised by the presence 
of long prodomains containing either “Death Effector Domain (DED)” (Caspase-8 and -10) or 
“Caspase Recruiting Domain (CARD)” (Caspase-2, 4, 9,) (Fernandes-Alnemri et al, 1996; 
Muzio et al, 1996). DED and CARD domains mediate homotypic interactions between 
molecules that contain either DED or CARD domains (Ashkenazi & Dixit, 1998; Hofmann et 
al, 1997). The phylogenetic tree of mammalian caspases is shown in Figure 1.2. The primary 
role of initiator caspases is the cleavage and activation of effector caspases. They also 
cleave a limited number of caspase substrates. In contrast, effector caspases can cleave a 
wide range of substrates (Li & Yuan, 2008; Pop & Salvesen, 2009; Taylor et al, 2008).  
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Figure 1-2 : Classification of caspases 
The phylogenetic tree of 12 mammalian caspases and 2 murine caspases (mCaspase) is 
shown. Caspases are classified based on their sequence homology, structure, function and 
substrate preference. Caspases are divided into three sub-groups: initiator caspases, 
effector caspases and cytokine activators. All caspases contain large and small subunits of 
protease domains. In addition, the initiator caspases also contain a long prodomain of either 
death effector domain (DED) or caspase recruiting domain (CARD). The preference 
recognition sequence of their substrates is also listed. 
Figure is modified from (Thornberry et al, 1997). 
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1.1.3.2  Activation of caspases  
Both initiator and effector caspases are constitutively expressed as inactive 
zymogens or procaspases. Procaspases consist of an N-terminal (N-T) prodomain, an 18 
KDa large subunit (p18), and a 10 KDa small subunit p10) (Figure 1-3). Initiator and effector 
procaspases are activated via different mechanisms. Although the activation of initiator 
caspases mainly requires a dimerisation-induced conformational change, the activation 
mechanisms of each initiator caspase still varies. For example, an interdomain (auto) 
proteolytic processing is required for caspase-8 activation, but it plays a negative regulatory 
role in caspase-9 for its activation. In contrast, all effector caspases are activated by the 
cleavage between the large subunit (p18) and the small subunit (p10), followed by 
prodomain removal. The p18 and p10 are still associated upon proteolytic cleavage and the 
mature effector caspases are homo- or heterodimers; tetramers of two p18 and two p10. The 
domains and activation mechanisms of initiator and effector caspases are shown in       
Figure 1-3. 
 
1.1.3.3 Caspase substrates   
The physiological and biochemical changes of apoptosis, such as DNA degradation, 
mitochondrial dysfunction, membrane blebbing and cell detachment, are consequences of 
apoptosis pathways. Caspases play a pivotal role in apoptotic processes by cleaving cellular 
proteins involved in cell cycle, DNA repair, DNA degradation, respiratory and structural 
proteins. The most prominent caspase substrates are caspase themselves; for example, the 
effector caspase (caspase 3, 6, 7) are cleaved in response to activated initiator caspases 
(more detail in section 2.2). The examples of caspase substrates related to particular 
biological functions are listed in Table 1-2.  Additionally, the identified caspase substrates, 
consequences of their proteolysis, and their site(s) of cleavage are listed in the caspase 
substrate database (http://bioinf.gen.tcd.ie/casbah/). 
In my study, Bap31, which is an ER-localised protein and a component of the 
ARCosome complex, is also a caspase substrate. Bap31 can be cleaved at two caspase 
cleavage sites (AAVD) at amino acid 164 and 238 by caspases 8, 3, and 10 (Fischer et al, 
2006). The consequence of Bap31 cleavage is the pro-apoptotic p20Bap31, which results in 
Ca2+ release from the ER to the mitochondria for apoptosis induction (Iwasawa et al, 2011).   
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Figure 1-3 : The domains and activation mechanisms of initiator and effector 
caspases 
(A) Initiator caspases (caspase 2, caspase 8 and caspase 9) contain  a pro-domain, a large 
subunit and a small subunit, whereas executioner caspases (caspase 3, caspase 6 and 
caspase 7) only consist of a large subunit and a small subunit without a pro-domain in 
contrast to initiator caspases. (B) The activation mechanism of initiator caspases differs from 
that of executioner caspases. Dimerisation is required for the activation process of initiator 
caspases but not for executioner caspases. In initiator caspases, for example caspase-8 in 
this case, recruit upon death ligand binding caspase-8 monomers to the adaptor molecule 
FAS-associated death domain protein (FADD) leading to their dimerisation, which is required 
for interdomain cleavage. Executioner caspases are usually formed by a dimer for 
intramolecular rearrangement to facilitate protease cleavage resulting in the enzymatically 
active form.                                                                    
Figure is modified from (Tait & Green, 2010).  
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Table 1-2 : Examples of caspase substrates and their consequences of caspase 
proteolysis   
Group Protein Consequences Reference 
 
1. cell cycle  
 
retinoblastoma (Rb) 
- Rb degradation  
- neuronal apoptosis 
- alteration of chromatin 
susceptible for nuclease 
(An et al, 
1997; Dou et 
al, 1997; 
Janicke et al, 
1996) 
2. DNA repair 
Poly ADP-ribose 
polymerase (PARP) 
disruption of DNA repair 
function   
(Tewari et al, 
1995) 
3. DNA 
degradation 
inhibitor of Caspase-
activated DNase (iCAD) 
50-200bp DNA 
fragmentation 
(Enari et al, 
1998) 
4. respiratory 
 
NADH dehydrogenase 
ubiquinone Fe-S protein 1 
(NDUS1) 
- mitochondria dysfunction 
- outer mitochondria 
membrane permeabilisation  
- disruption of electron 
transport chain for ATP 
production 
(Ricci et al, 
2004) 
5. pro-apoptotic 
kinase 
Rho-associated coiled-coil 
containing protein kinase 1 
(ROCK1) 
                                                         
membrane blebbing  
 
 
 
(Coleman et 
al, 2001) 
 
p21-activated kinase 2 
(PAK2) 
 
apoptosis body formation 
(Lee et al, 
1997; Rudel & 
Bokoch, 
1997) 
6. structural 
protein 
fodrin and gelsolin 
 
- disruption of actin filament 
networks 
- loss of cell shape 
(Kothakota et 
al, 1997; 
Martin et al, 
1995a) 
β-catenin, plakoglobin γ-
catenin 
disruption of the cell-cell 
communication 
(Schmeiser et 
al, 1998) 
nuclear lamin A and C nuclear condensation 
(Lazebnik et 
al, 1995; Rao 
et al, 1996) 
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1.2  The two main pathways of apoptosis : extrinsic and intrinsic pathway 
 Apoptosis signalling pathways are orchestrated by many proteins. However, in 
mammalian cells, there are two main pathways: the extrinsic or “death receptor” pathway 
and the intrinsic or “mitochondrial” pathway (Li & Yuan, 2008). The biggest difference 
between these two pathways is in the initial step. The extrinsic pathway is activated through 
ligand binding with specific pro-apoptotic receptors on the cell membrane. The intrinsic 
pathway is initiated in response to cellular signals within the cells and the signalling for this 
pathway is through mitochondria activation. 
1.2.1  Extrinsic (death receptor mediated) apoptosis  
As mentioned, in the extrinsic pathway the apoptosis activation occurs through ligand 
binding with plasma membrane receptors leading to receptor clustering and downstream 
caspase activation (Ashkenazi and Dixit 1998). The tumour necrosis factor (TNF) receptor 
superfamily is responsible for this task. This group of receptors is characterised by the 
presence of two to five copies of cysteine-rich extracellular repeats. This superfamily is 
composed of TNF-receptor-1 (TNF-R1), Fas (also known as CD95 or Apo-1), TNF-related 
apoptosis inducing ligand receptor-1 (TRAIL-R1), TRAIL-R2, death receptor-3 and death 
receptor-6. There has been growing interest in TNF-R1 and Fas receptor mediated 
pathways over the years and many aspects are now known. 
1.2.1.1  TNF receptor-mediated extrinsic pathway 
The tumour necrosis factor (TNF), which is produced by macrophages, is a pro-
inflammatory cytokine. Upon ligand binding to TNF-R1 on the plasma membrane, they form 
a homotrimer. The death domain (DD) of the TNF-R1, which is facing the cytosol, recruits 
several adaptor proteins to form a death-inducing signalling complex (DISC). This complex 
brings about initiator caspases, namely caspases 8, 10, activation. In healthy cells, in the 
absence of TNF, the DD domain of the receptor is bound to a negative regulator of this 
pathway, silencer of DD (SODD). In the presence and upon binding of TNF to the receptor, 
SODD dissociates from the receptor and this allows exposure of the DD to another DD-
containing protein, “TNF-R1-associated death domain protein” (TRADD). Upon TRADD 
binding to the receptor, there are two caspase cascade activation pathways.  
 In the first scenario, the “receptor interaction protein (RIP)”and “TNF receptor-
associated factor-2 (TRAF2)” are recruited to DD of TRADD (Chen & Goeddel, 2002; Hsu et 
al, 1996b). This protein complex containing TNF-R1, TRADD, RIP and TRAF2 is known as    
complex I (Figure 1-4). This complex results in the activation of nuclear factor-kappa B (NF-
kB) for cell survival. Heterodimers of NF-KB (p55 and p65) translocate to the nucleus and 
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promote the transcription of survival genes such as Bcl-2 and c-IAPs (Robbesyn et al, 2004). 
This signalling is regulated by several proteins; the details are shown in Figure 1-4. In the 
second scenario, the RIP-associated ICH-1/CED-3 homologous protein with death domain 
(RAIDD) associates with RIP (Ahmad et al, 1997; Duan & Dixit, 1997). The initiator 
procaspase-2 is activated through a domain similar to the caspase-recruitment domain 
(CARD) of RAIDD (Duan & Dixit, 1997).In this scenario, complex I activates c-Jun N-terminal 
kinase (JNK), which phosphorylates and activates transcription factors in the nucleus such 
as c-Jun and ATF-2. These transcription factors govern the regulation of c-IAP and c-FLIP to 
prevent apoptosis induction (Hu et al, 1997; Srinivasula et al, 1997). 
TNF-R1-mediated apoptosis can be activated through another TRADD-dependent 
pathway but different sets of proteins play a role in this pathway. TRADD associates with 
TNF-R1 through its DD domain. This complex further recruits Fas-associated death domain 
(FADD), which contains a DD for TRADD binding and a death effector domain (DED) for 
recruiting DED-containing initiator caspases (procaspase-8, 10).  The complex composing of 
TNF-R1, TRADD, FADD and caspase-8 or -10 is known as complex II (Figure 1-4). The 
clustering of procaspase around TNF-R1 in apoptotic conditions facilitates the proximity-
induced dimerisation to activate caspase-8 or -10. This leads to the activation of effector 
caspases-3 and -7 for apoptosis. TNF-R1-induced apoptosis is governed by a variety of pro-
apoptotic and anti-survival proteins. The balance between these two signalling pathways 
needs to be tightly regulated.  
1.2.1.2  Fas receptor mediated extrinsic pathway 
 Fas ligand, which is a glycosylated protein mainly involved in T-cell mediated cell 
death, ligates to homotrimerised Fas receptor via the DD of Fas receptor on the plasma 
membrane known as “death inducing signalling complex (DISC)” (Boldin et al, 1995; 
Chinnaiyan et al, 1995; Kischkel et al, 1995). This ligation causes FADD adaptor protein 
recruitment to the Fas receptor. Procaspase-8, 10 are recruited to the complex through the 
DED of FADD. The increase of procaspase on the plasma membrane induces caspase-8, -
10 activation similar to TNF-induced cell death mechanism (Boatright et al, 2003; Donepudi 
et al, 2003; Walczak & Krammer, 2000). The active caspase-8 or -10 further activate 
downstream effector procaspase-3, -7 (Stennicke et al, 1998)and their substrates (Figure 1-
4). This pathway is also controlled through the inhibition effect of “cellular FADD-like ICE 
inhibitory protein (cFLIP)”. It acts as a competitive antagonist of procaspase-8 at the DISC 
since cFLIP contains tandem DED repeats, which are highly homologous to those of 
procaspase-8 (Krueger et al, 2001).  
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1.2.2 Intrinsic pathway 
 The intrinsic or mitochondria-dependent pathway is initiated by conditions inside cells 
such as DNA damage, hypoxia, growth factor deficiency, cellular stress, and loss of cell 
survival factors (Boesen-de Cock et al, 1999; Debatin et al, 2002; Fulda et al, 2001; Huang 
et al, 2003). This pathway mainly induces apoptosis through mitochondrial outer membrane 
permeabilisation (MOMP) (Green & Kroemer, 2004). The details of MOMP signalling and 
their regulators will be covered in a later section (topic 1.3.4). Briefly, Bax seems to be 
required for MOMP (Dejean et al, 2010; Dewson & Kluck, 2009; Kumarswamy & Chandna, 
2009; Sharpe et al, 2004) but anti-apoptotic Bcl-2 family members play an inhibitory role for 
Bax activation (Mathai et al, 2005; Wang et al, 2011). 
 Upon Bax activation and the induction of MOMP, pro-apoptotic proteins are released 
from the mitochondria into the cytosol such as Smac/Diablo, Omi/Htra2, endonuclease G 
(End. G), apoptosis inducing factor (AIF) and, most importantly, cytochrome c (cyt.c) (Liu et 
al, 1996). Cytosolic cyt.c associates with the adaptor protein containing CARD domain 
“apoptotic peptidase activating factor 1” (Apaf-1) to form the heptameric complex called 
apoptosome in an ATP-dependent manner(Hakem et al, 1998; Kuida et al, 1998). The 
CARD domain of Apaf-1 then recruits procaspase-9 resulting in caspase-9 activation. The 
active capsase-9 further activates effector caspase-3 and -7 for apoptosis execution (Figure 
1-4)(Li et al, 1997; Pan et al, 1998a; Shi, 2002). 
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Figure 1-4 : Extrinsic and intrinsic apoptosis pathway  
Schematic illustration of extrinsic and intrinsic apoptosis pathway. See text for more detail. 
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1.3  Bcl-2 family members : regulators of cell death 
1.3.1   Bcl-2 structure and classification 
Bcl-2 was first identified as a candidate oncogene in human follicular lymphomas.         
Its function was revealed to be involved in cell growth and proliferation to promote cell 
survival (Tsujimoto et al, 1985; Vaux et al, 1988). The Bcl-2 family proteins play an essential 
role in cell death, which is considered as one of the six hallmarks of cancer (Hanahan & 
Weinberg, 2000; Yip & Reed, 2008). Bcl-2 family members play their roles in both pro- and 
anti-apoptotic functions, which are related to their Bcl-2 homology (BH) domains. Bcl-2 
proteins can be classified into three functional groups: the anti-apoptotic (pro-survival), the 
pro-apoptotic multi-BH (effector) and the pro-apoptotic BH3-only group.  
The anti-apoptotic Bcl-2 proteins contain BH domains 1 to 4 and some also contain 
membrane-targeting sequences at their C-terminus (Figure 1-5). The BH1-3 domains of anti-
apoptotic Bcl-2 proteins form a groove for binding the BH3 domain of pro-apoptotic BH3-only 
proteins (Hinds & Day, 2005; Petros et al, 2004; Sattler et al, 1997). The members in pro-
apoptotic multi-BH proteins (effector) contain BH domains 1 to 3 or 1 to 4. The most 
prominent proteins in this group, which play a role in the apoptotic pathway, are Bax and 
Bak. They contain BH domains 1 to 3 without the BH4 domain at the N-terminus and the 
membrane targeting sequence at the C-terminus (Figure 1-5). They form a pore within MOM, 
which is involved in MOMP. In healthy cells, Bax, a soluble cytosolic protein, is an inactive 
monomer, and Bak is localised within the MOM. Upon receiving apoptotic stimuli, Bax and 
Bak undergo conformational changes leading to membrane integration, oligomerisation and 
pore formation within MOM. The anti-apoptotic Bcl2 family members, including Bcl-XL, Bcl-2, 
Bcl-W, Mcl1 and A1, can inhibit apoptosis by acting as an antagonist of Bax/Bak activation 
and/or pore formation. The pro-apoptotic BH3 only proteins, such as Bim, Bik, Bad, Bim, 
Puma, Noxa, Bmf and Nip3, act as an apoptotic inducer via the binding to anti-apoptotic Bcl-
2 proteins as mentioned above. The BH3-only protein-mediated apoptosis is a downstream 
consequence of many types of stress; for example, Bik, Noxa and Puma are transcribed in 
response to the tumour suppressor p53 upon DNA damage. Bad is dephosphorylated and 
activated following growth factor withdrawal (Chipuk et al, 2010; Dewson & Kluck, 2009; 
Leber et al, 2010; Yip & Reed, 2008). 
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Figure 1-5 : The classification of Bcl-2 family members 
(A) Bcl-2 family members can be divided into three groups according to BH domains: anti-
apoptotic, pro-apoptotic and BH3-only proteins. (B) Anti-apoptotic proteins contain four BH 
domains (BH1, 2, 3 and 4). Prominent pro-apoptotic members, namely Bax and Bak, 
possess only three BH domains (BH1, 2 and 3). BH3-only proteins contain the BH-3 domain 
with or without the transmembrane domain for membrane localisation.       
Figure is modified from (Chao & Korsmeyer, 1998). 
 
1.3.2  Interaction among Bcl-2 family members  
There is a growing number of studies showing that the interplay between the three 
Bcl-2 family subgroups (anti-apoptotic, effector and BH3-only proteins) is important in cell 
death regulation. The interaction and regulatory mechanisms of Bcl-2 family proteins are 
rather complex and incompletely understood. Two models, “direct” and “indirect activation”, 
of the interaction among Bcl-2 family members in cell death control have been proposed 
(Figure 1-6). In the first model, only activators (Bid, Bim and Puma) can directly bind and 
activate Bax/Bak. Direct or indirect in this sense is referred to the direct interaction of BH3-
only proteins with Bax/Bak for Bax/Bak oligomerisation. In contrast, in the indirect model, 
BH3-only proteins bind directly to anti-apoptotic Bcl-2 proteins instead of Bax/Bax to release 
Bax/Bak from the anti-apoptotic Bcl-2 proteins. The available Bax/Bak can then form 
Bax/Bak oligomers for MOMP. In the direct model, the repressor (for example Bad in Figure 
1-6) displaces Bim, which binds to anti-apoptotic proteins to inhibit apoptosis. This brings 
about free Bim from the anti-apoptotic Bcl-2 family to associate with and activate Bax/Bak. 
On the other hand, in the indirect activation model, Bim competitively titrates out the anti-
apoptotic Bcl-2 proteins from Bax/Bak resulting in Bax/Bak oligomerisation (Figure 1-6). 
Hence, the regulation mechanism of Bcl-2 family members is not affected by one inducer 
alone but they corporately play a role in apoptosis control as a network (Chipuk et al, 2008; 
Gallenne et al, 2009; Kim et al, 2006; Kuwana et al, 2005; Letai et al, 2002). The difficulty to 
elucidate the interaction models of Bcl-2 family proteins might be caused by the dynamic or 
transient interaction of the various members. The interaction of Bcl-2 members related to 
Bax/Bak activation is likely to depend on cell type, and strength of stress as well as the 
environment. Bcl-2 family members are also regulated by other mediators, such as lipids and 
non-Bcl-2 family proteins. For example, p53 can directly activate Bax/Bak and/or neutralise 
Bcl-2/Bcl-XL(Speidel, 2010). 
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Figure 1-6 :  Regulation models of Bax/Bak : direct and indirect activation  
Schematic illustration of the interactions of Bcl-2 family members in the two models : direct 
(A) and indirect activation (B). See text for details. 
Figure is modified from (van Delft & Huang, 2006). 
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1.3.3  Role of Bcl-2 family members at the ER 
The ER has recently been acknowledged as a central organelle in apoptotic 
pathways. The importance of Bcl-2 family members has been increasingly revealed at this 
organelle. They play a pivotal role in several activities, including modulation of ER Ca2+ 
signalling, release of ER Ca2+ and activation of ER-associated initiator caspases (Heath-
Engel et al, 2008; Rong & Distelhorst, 2008). Apoptosis mediated by the overexpression of 
ER-restricted Bax/Bak induces a transient rise in ER Ca2+ followed by store depletion from 
the ER (Chami et al, 2004; Nutt et al, 2002; Zong et al, 2003). Conversely, overexpression of 
wild-type (WT) or ER-localised BclXL/Bcl-2 leads to reduced ER Ca
2+ release into the cytosol 
and/or mitochondria (Pinton & Rizzuto, 2006; Szegezdi et al, 2009). Bcl-XL and Bcl-2, at 
least in this case, regulate ER Ca2+ signalling through IP3R interaction (Hanson et al, 2008; 
Rong & Distelhorst, 2008; White et al, 2005) and/or alteration of the IP3R phosphorylation 
state (Oakes et al, 2005; Xu et al, 2007). Bcl-XL and Bcl-2 regulate ER Ca
2+ uptake via 
SERCA inactivation (Dremina et al, 2004; Dremina et al, 2006) as well as alteration in 
IP3R/SERCA expression levels (Kuo et al, 1998; Li et al, 2002). The role of Bcl-XL and Bcl-2 
may differ and depend on the relative expression levels of IP3R or SERCA isoforms and/or 
the presence of other regulatory factors (Chang et al, 2010; Xu et al, 2008).  
In addition to ER-localised Bax/Bak, BH3-only proteins have also been shown to be 
localised to the ER and play a role in apoptosis control. Bax/Bak oligomerisation and 
membrane permeabilisation can also be activated by BH3-only proteins at the ER and this 
event can be inhibited by anti-apoptotic Bcl-2 family members. ER-restricted Bik, Bim and 
Puma can induce ER Ca2+ and/or the release of proteins in a Bax/Bak-dependent manner 
(Germain et al, 2002; Klee et al, 2009; Wang et al, 2011). ER-localised Bcl-2 can inhibit the 
Bik-mediated apoptotic pathway by sequestration of either Bik and/or Bax/Bak (Mathai et al, 
2005). In addition, Bcl-XL can inhibit truncated Bid (tBid)-activated Bax, which results in 
increased ER membrane permeability (Wang et al, 2011). Wild-type (WT) or ER-targeted 
Bim or Puma can induce apoptosis in cells, in the absence of endogenous Bax/Bak, when 
ER-localised Bak is reconstituted. This indicates that ER-restricted Bak alone, at least under 
some conditions, is sufficient to promote apoptosis by these BH3-only proteins, in this case 
WT/ER-targeted Bim or Puma (Klee et al, 2009).  Although Bax/Bak oligomerisation has 
been shown to relate with Ca2+ and/or ER-protein release from the ER, the pores or 
channels responsible for this are not well understood. It is possible that the release of Ca2+ 
or proteins, at least in some cases, is differentially regulated. 
Bcl-2 family proteins also participate in ER stress-mediated apoptosis and/or ER-
associated initiator caspases. In a mouse model, caspase-12 activation is responsible for 
apoptosis dependent on Bax/Bak but is independent of the mitochondrial apoptotic pathway. 
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This process can be inhibited by Bcl-XL (Ruiz-Vela et al, 2005; Zong et al, 2003). The 
activation of caspase-12 by ER-targeted Bak could be related to the regulation of ER Ca2+ 
stores since an initial rise in [Ca2+]ER leading to Ca
2+ depletion is a consequence of Bax/Bak 
upregulation (Chami et al, 2004; Nutt et al, 2002; Zong et al, 2003). Tunicamycin, an ER-
stressor, causes Bim translocation to the ER prior to apoptosis induction in a caspase-12- 
but not mitochondria-dependent pathway. Additionally, apoptosis induced by the ectopic 
expression of ER-targeted Bim can be inhibited by the suppression of caspase-12 
(Morishima et al, 2004). This information confirms the requirement of caspase-12 in Bim-
induced apoptosis. In the same study, Bcl-XL could inhibit both Bim translocation and 
apoptosis and the association of Bcl-XL and Bim was also demonstrated (Morishima et al, 
2004). Furthermore, another BH3-only protein, Puma, was shown to induce apoptosis 
through caspase-12 activation. Apoptosis induced by Puma can be reduced if caspase-12 is 
abrogatedby down-regulation or deficiency (Shibue et al, 2006). In addition to the ability of 
Bim and Puma to induce apoptosis at the ER, it is possible that other BH3-only proteins 
trigger apoptosis via a similar pathway.            
Bim and Puma were shown to activate apoptosis through the IRE1α-TRAF2-JNK 
signalling pathway in an ER-restricted, Bak-dependent manner, which required Ca2+ 
mobilisation and sustained JNK phosphorylation (Klee et al, 2009). The Bim/Puma-mediated 
apoptotic pathway relates to IRE1 signalling but not PERK or ATF-6 arms of the UPR (see 
detail in topic 4.1). In addition, in an independent study the direct interaction of Bax/Bak and 
IRE1α was shown to play a role in the ER-stress adaptive response (Hetz et al, 2006). Of 
note, the activation of IRE1α can be inhibited by the anti-apoptotic protein Bl-1, which may 
occur through the sequestration of Bax/Bak (Lisbona et al, 2009). In some cases, the 
reconstitution of mitochondria-targeted Bax is sufficient to restore ER-stress induced cell 
death in the absence of endogenous ER localised Bax/Bak cells (Hetz et al, 2006; Scorrano 
et al, 2003). Hence, it raises the possibility that the role of Bax/Bak in this pathway may 
depend on type, strength and/or duration of the ER stress signal as well as the physiological 
background of different cell types. Alternatively, other regulators, such as BH3-only proteins, 
pro-apoptotic members and/or [Ca2+], may be required to cooperate with Bax/Bak in IRE1α 
activation in the adaptive or pro-apoptotic role at the ER.   
 
1.3.4   Role of Bcl-2 family members at the mitochondria 
There have been a growing number of studies showing that Bax and Bak are 
indispensable for the mitochondria-dependent pathway in response to different types of 
stimuli (Wei et al, 2001; Zong et al, 2001).  MOMP is accepted as a key event for the 
mitochondria apoptotic pathway. MOMP can presumably be induced by two signalling 
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pathways: Bax/Bak and mitochondrial permeability transition (MPT) activation. In the 
Bax/Bak dependent MOMP, Bax and Bak play their role via oligomerisation, leading to pore 
formation in the MOM. The pore formation may be modulated by Bax/Bak alone or 
associated with other proteins and/or lipids. However, the precise nature of this pore remains 
poorly understood (Dejean et al, 2010; Dewson & Kluck, 2009; Kumarswamy & Chandna, 
2009; Sharpe et al, 2004). It has also been demonstrated that pro- and anti-apoptotic Bcl-2 
family members play a role in Bax/Bak-mediated MOMP. 
 Alternatively, MOMP can be achieved through induction of the MPT but independent 
of Bax/ Bak (Garrido et al, 2006; Giorgi et al, 2008; Zhivotovsky et al, 2009). In this scenario 
MPT happens as a result of the opening of the permeability transition pore (PTP), a non-
selective MIM channel. Ca2+ and oxidative stress can cause sustained PTP opening and this 
leads to matrix swelling, inner membrane expansion, loss of mitochondrial membrane 
potential () and MOM rupture (Halestrap, 2009). Adenine nucleotide translocase (ANT), 
VDAC and the matrix peptidyl-propyl cis-trans isomerase (PPIase) cyclophilin D (CypD) 
have been characterised as the key components of PTP (Halestrap, 2009; Rasola et al, 
2010). (Alavian et al, 2014). However, the molecular compositions and the regulatory 
mechanisms of PTP remain an important challenge in the field. The molecular regulation of 
Bax/Bak- and MPT-mediated MOMP may overlap and/or crosstalk between these two 
pathways or may vary depending on cellular contents, cell types, types or strength of 
inducers. Although MPT does not require Bax/Bak for MOMP, pro- and anti-apoptotic Bcl-2 
family members have been shown to interact with the mediators of PTP, which affects PTP 
regulation and MPT (Heath-Engel & Shore, 2006; Juhaszova et al, 2008; Kumarswamy & 
Chandna, 2009; Smith et al, 2008; Zhivotovsky et al, 2009). In addition to the role of MPT in 
apoptosis, it is also associated with necrosis (Baines et al, 2005; Halestrap, 2005; Halestrap, 
2009; Nakagawa et al, 2005). Necrotic cell death can be inhibited by pro-apoptotic Bcl-2 
proteins (Amarante-Mendes et al, 1998; Fombonne et al, 2004; Haraguchi et al, 2000; 
Saldeen, 2000; Tsujimoto et al, 1997). The BH3-only protein Bmf was identified as a core 
component of the DR-associated necroptotic machinery (Hitomi et al, 2008). Bmf and anti-
apoptotic Bcl-2 proteins may suppress each other in MPT-dependent necrosis. Bcl-2 family 
proteins regulate both apoptosis and necrosis through the disruption of mitochondria, which 
is a central modulator in both forms of cell death (Halestrap, 2009; Pradelli et al, 2010; Tait & 
Green, 2008). 
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1.4  Endoplasmic reticulum (ER) and mitochondria in apoptosis regulation 
  
1.4.1   Endoplasmic reticulum (ER), a sensor of cell death signals 
 In addition to mitochondria, the endoplasmic reticulum (ER) also harbours diverse 
regulators and signalling pathways to regulate apoptosis. The ER regulates protein 
synthesis, folding and secretion in the secretory pathway as well as Ca2+ storage. The 
accumulation of unfolded proteins and/or alteration of Ca2+ levels result in ER stress. Cells 
have evolved protective mechanisms in short- and long-term responses so as to survive and 
recover from stress. Specific signalling pathways including the unfolded protein response 
(UPR), the ER-overload response (EOR), and the ER-associated degradation (ERAD) are 
activated to deal with ER-stress. The ultimate goal of these three pathways is to reduce the 
amount of newly synthesised proteins, increase translocation and degradation of misfolded 
proteins, and raise the ER protein folding capacity.   
 The UPR is an intracellular signalling pathway, which eukaryotic cells rely on in order 
to control the quality of protein folding and to sense environmental perturbation. Protein 
folding stress in the ER can arise from a number of insults, for example pharmacological 
agents, radiation, viral infection, nutrient deprivation, as well as genetic mutation (Imaizumi 
et al, 2001). This response pathway functions through the action of three key ER-resident 
transmembrane proteins including activating transcription factor 6 (ATF6), inositol-requiring 
kinase 1 (IRE1), and PRKR-like ER kinase (PERK) (Rutkowski & Kaufman, 2004). The 
activation of these three sensors is controlled by the titration of the protein chaperone 
glucose-regulated protein 78 kDa (GRP78 or BiP), which preferentially binds to unfolded 
proteins, releasing ATF6, Ire1, and PERK (Bertolotti et al, 2000; Liu et al, 2000; Shen et al, 
2002). BiP dissociation then mediates ATF6 translocation from the ER to the Golgi 
apparatus through which ATF6 is cleaved by S1P and S2P to generate a cytosolic 
transcription factor. Active ATF6 translocates to the nucleus and activates ER-stress gene 
expression (Chen et al, 2002; Haze et al, 1999; Okada et al, 2003; Shen et al, 2002; Wang 
et al, 2000). This event also facilitates the serine/threonine kinase PERK and IRE1 for 
homodimerisation, auto-phosphorylation, and activation (Ma et al, 2002a). PERK is a kinase 
family member phosphorylating eukaryotic translation initiation factor 2 (eIF2). This event 
leads to an inhibition of 80S ribosome assembly and protein synthesis. IRE1 phosphorylation 
activates an endoribonuclease activity of cytosolic domain resulting in catalytic removal of a 
26-base intron from Xbp1 mRNA to generate active Xbp1 transcription factor (Figure 1-
7)(Calfon et al, 2002; Chen et al, 2002; Lee et al, 2002; Yoshida et al, 2001).        
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Figure 1-7 : Unfolded protein response (UPR) signalling pathway   
ER-stress induces the unfolded protein response (UPR) signalling pathway. Upon ER-stress 
conditions Grp78, which binds to Ire1, PERK, and ATF6 under normal conditions to keep 
them inactive, preferentially binds to misfolded or unfolded proteins. The dissociation of 
Grp78 from Ire1, PERK, and ATF6 activates these three branches of the UPR pathway. 
ATF6 is then translocated from the ER to the Golgi apparatus and cleaved. The ATF6 
fragment further translocates to the nucleus and induces the expression of Grp78, CHOP 
and XBP-1. PERK is activated via their oligomerisation and transphosphorylation and the 
phosphorylated PERK further phosphorylates eIF2 to inactivate its transcription activity. The 
consequence of PERK activation is the activation of genes, prominently ATF-4. ATF-4 also 
translocates to the nucleus and turns on the transcription of stress-response genes as well 
as CHOP. Similar to PERK, IRE1 also oligomerises and is phosphorylated. Activated IRE1 
brings about XBP1 mRNA splicing, which is then translated and translocated to the nucleus 
and expresses genes involved in ERAD, ER chaperones, lipid synthesis and ER biogenesis.      
Figure is modified from (Szegezdi et al, 2006).  
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1.4.1.1   ER stress-mediated cell death 
Excessive or prolonged UPR brings about apoptotic cell death. When cells cannot 
overcome cellular stresses sensed by the ER, the organisms need to protect healthy cells by 
demolishing damaged cells via the cell death pathway in order to save nutrients and energy. 
Cell death mechanisms resulting from ER-stress activation are diverse, consisting of both 
caspase-dependent apoptosis, caspase-independent necrosis (Egger et al, 2003), and 
autophagic pathways (Bernales et al, 2006; Ogata et al, 2006). The best-characterised pro-
apoptotic protein generated in the UPR pathway is the CHOP/GADD153 transcription factor, 
which is transcribed by ATF4, ATF6, and XBP1 activation (Fawcett et al, 1999; Ma et al, 
2002b; Okada et al, 2002).   
1.4.1.1.1 Caspases respond to ER-stress in a mouse model 
Activation of the caspase cascade is also a central player in ER stress-mediated cell 
death. Among 14 known caspases, caspase-12 plays an important role in ER stress-induced 
apoptosis in the mouse. Pro-caspase-12 is localised at the ER and cleaved upon exposure 
to ER-stressors, tunicamycin or thapsigargin, but not by ER-overload inducers such as 
cyclohexamide, TNF, or anti-FAS (Nakagawa et al, 2000). Ca2+ homeostasis and 
mobilisation are specifically activated by this pathway. Caspase-12-deficient cortical neurons 
are also inhibited for sensitisation to apoptosis induced by amyloid-β protein (Nakagawa et 
al, 2000). These results show that this pathway responds to cell death with pathological 
relevance. 
The question concerning the cleavage activity for generating active caspase-12 had 
been unanswered until Nakagawa and Yuan presented that the cleavage activity is 
associated with calpain, a cysteine protease family for Caspase-12 (Nakagawa & Yuan, 
2000). The cleavage activity of caspase-7 on caspase-12 has also been proposed according 
to caspase cleavage sites in the caspase-12 amino acid sequence. Caspase-7 has been 
shown to associate with caspase-12 and to cleave the predomain to generate active 
caspase-12 at DEDD (94) and VETD (341) induced by ER-stress (Rao et al, 2001). 
Interestingly, downstream caspase activation in ER-stress induced cell death has also been 
revealed. ER-stress triggers a specific caspase-12, caspase-9, and caspase-3 cleavage in a 
cytochrome c-independent manner (Morishima et al, 2002). To fill the gap in this signalling 
pathway, tumour necrosis factor receptor-associated factor 2 (TRAF2) has been shown to 
interact with procaspase-12 and promote its cleavage in response to ER-stress. TRAF2 acts 
as the apoptosis-signalling adaptor between Ire1, an ER-stress sensor, and caspase-12 to 
activate c-Jun N-terminal kinase signalling, resulting in cell death (Yoneda et al, 2001).  
52 | P a g e  
 
1.4.1.1.2   Caspases respondto ER-stress in a human model 
The role of caspase-12 involvement in ER stress-mediated cell death in humans is 
controversial. Many reports have presented data that most humans lack caspase-12 due to 
polymorphism that created a nonsense mutation during evolution (Qiao et al, 2002). 
Therefore, the response pathway in ER-stress/cell death signalling is a challenge to be 
answered. The promising caspase candidate playing a role is caspase-4, as it possesses 
similar sequence and localises within the same chromosome. Procaspase-4 amino acid 
sequence is 59 % identical to procaspase-12 and it is localised within the caspas-1/ICE gene 
cluster including caspase-1, caspase-4, caspase-5, and caspase-12 on chromosome 
11q22.3 (Fischer et al, 2002). This postulate was proven in 2004. Human caspase-4 has 
been shown to fulfill the caspase-12 function of ER-stress-induced cell death in human 
neuroblastoma and HeLa cell lines. In the same way with caspase-12 in the mouse, 
caspase-4 is cleaved upon tunicamycin, thapsigargin, or amyloid-β treatment. Furthermore, 
reduction of caspase-4 by small interfering RNA decreases ER-stress mediated cell death 
(Hitomi et al, 2004). 
ER-stress signalling in spontaneous apoptosis of B-chronic lymphocytic leukemia (B-
CLL) cells is orchestrated by caspase-4, -8, and -3. Caspase-8 and caspase-3 function 
downstream of caspase-4 processing, during the spontaneous apoptosis of B-CLL cells. In 
ER-stress treatment with tunicamycin and thapsigargin, only tunicamycin treatment results in 
caspase-4 cleavage (Rosati et al, 2010).  Interestingly, cleavage of procaspase-8 and 
Bap31, which is known to propagate signals from the ER to the mitochondria (Breckenridge 
et al, 2003), is activated in this cellular system under both tunicamycin and thapsigargin 
treatment. ER-stress induced apoptosis in B-CLL is involved in CHOP/GADD153 up-
regulation and JNK1/2 phosphorylation (Rosati et al, 2010).  
1.4.2   Mitochondria  
Mitochondria are organelles responsible for ATP production, lipid metabolism, 
hormone synthesis, cellular calcium homeostasis and the production of most reactive 
oxygen species (Brini, 2003; Cannino et al, 2007; Gunter et al, 2000; Gunter et al, 2004; 
Maechler, 2002). The balance of a long interconnected tubular and a small spherical 
morphology of mitochondria is dynamic and regulated by a fusion and fission machinery 
(Bereiter-Hahn, 1990; Bereiter-Hahn & Voth, 1994; Chan, 2006; Okamoto & Shaw, 2005). In 
mammalian cells the translocation of the cytosolic dynamin related GTPase dynamin-relate 
protein 1 (Drp1) to the MOM is required for mitochondrial fission. hFis1, a MOM adaptor 
protein in (de)phosphorylation and sumoylation, plays a role to regulate Drp1 recruitment 
and stabilisation at the mitochondria (Fekkes et al, 2000; Mozdy et al, 2000; Tieu & Nunnari, 
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2000). The large GTPases mitofusin (Mfn) 1 and Mfn2 at the MOM, and the dynamin related 
GTPase Opa1 at the MIM are necessary for mitochondrial fusion in mammalian cells (Chan, 
2006; Chen & Chan, 2005; Chen et al, 2005a; Lee et al, 2004; Liesa et al, 2009).  
The perturbation of fusion and fission regulation results in many disorders, such as 
neurodegenerative diseases, metabolic abnormality and development delay (Nunnari et al, 
1997; Verstreken et al, 2005; Waterham et al, 2007). The multiple-site mutation of the Opa1 
gene, which is associated with mitochondria fusion, brings about a dominant optic atrophy, 
an inherited autosomal dominant blindness (Alexander et al, 2000; Delettre et al, 2000; 
Delettre et al, 2002). The number and the integrity of mitochondrial DNA are pivotal factors 
in neurodegenerative diseases, such as Parkinson‟s disease, Alzheimer‟s disease and 
amyotrophic lateral sclerosis (ALS) (Petrozzi et al, 2007). In viral-infected cells, vMIA (viral 
mitochondria-localised inhibitor of apoptosis), which induces mitochondrial fission, interacts 
with Bcl-2 family members to inhibit cell death of host cells (Arnoult et al, 2004; McCormick 
et al, 2003; Poncet et al, 2004). 
 
1.4.2.1  Mitochondrial dynamics and apoptosis 
 In healthy cells, mitochondria fission and fusion are well-balanced and continuously 
take place; nevertheless, the disintegration of the mitochondrial network resulting in 
mitochondrial fragmentation occurs during apoptotic cell death (Figure1-8)(Breckenridge et 
al, 2003; Desagher & Martinou, 2000; Iwasawa et al, 2011; Karbowski et al, 2002; Karbowski 
& Youle, 2003). However, the question whether mitochondria fragmentation is required for 
apoptosis induction or whether it is merely an epiphenomenon during apoptosis is still 
controversial. Several studies showed that mitochondrial fragmentation happens prior to 
caspase activation and at the same time with Bax translocation to OMM and cytochrome c 
release (Frank et al, 2001; Karbowski & Youle, 2003; Youle & Karbowski, 2005). In contrast, 
some independent reports demonstrated that MOMP and cyt.c release occur before the 
fission event (Arnoult et al, 2005; Dinsdale et al, 1999; Esseiva et al, 2004). Interestingly, the 
release of cyt.c is delayed when Drp1 and hFis1 fission proteins are inhibited (Estaquier & 
Arnoult, 2007; Parone et al, 2006). In addition, fission alone does not cause apoptosis and 
mitochondria fragmentation cannot be inhibited by the pan-caspase inhibitor zVAD-fmk 
(Frank et al, 2001; Lee et al, 2004). This information raises the possibility that fission might 
not be necessary for apoptosis. Rather, mitochondria fragmentation and apoptosis controlled 
by fission proteins might happen separately. In 2011, Iwasawa et al revealed that Fis1 can 
induce apoptosis by acting as an ER-mitochondria platform for caspase-8 activation. This 
complex was therefore coined “ARCosome” to describe the bridge between these two 
organelles. Furthermore, mitochondria fragmentation-induced by Fis1 does not require 
caspase activation. Hence, apoptosis induced by Fis1 happens separately from 
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mitochondria fragmentation (Figure 1-9)(Iwasawa et al, 2011). Furthermore, mitochondria 
fission is not required for Bap31 cleavage for apoptosis (Figure 1-10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-8 : Morphology of mitochondria upon Fis1 down/up-regulation 
Mitochondria morphology was determined in cells in which Fis1 was down-regulated by 
shRNA (left) and up-regulated by ectopic Fis1 overexpression (right). In Fis1 down-regulated 
cells, mitochondria were found tubulated, whereas it was spherical and fragmented when 
Fis1 was overexpressed.    
Figure is reprinted from (Iwasawa et al, 2011).  
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Figure 1-9 : Caspase activation is not required for Fis1-induced fission 
HeLa cells were transfected with β-gal (A) or Fis1 (B,C) in combination with mock and        
zVAD-fmk treatment. Mitochondrial morphology was determined using TMRE staining and 
the images were captured using confocal microscopy. Three independent pictures taken 
from each condition are shown.  
Figure is reprinted from (Iwasawa et al, 2011).  
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Figure 1-10 : Bap31 cleavage does not require mitochondria fission 
HeLa cells were treated with DMSO as mock (A) or 100 µM etoposide (B) for 30 hours. 
Mitochondria morphology was analysed using TMRE staining and the images were captured 
using laser scanning confocal microscopy. Three independent pictures taken from each 
condition are shown.  
Figure is reprinted from (Iwasawa et al, 2011).  
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1.4.3  Physical interaction of ER-mitochondria  
The communication of the ER and mitochondria is found to play a role in lipid 
synthesis and transfer, calcium transport, mitochondria ATP production, and apoptosis 
(Voeltz et al, 2002).  While it has long been established that a physical interaction between 
them exists, detected by electron microscopy and cell fractionation studies (Csordas et al, 
2006; Meier et al, 1981; Shore & Tata, 1977), only few factors have been shown to act as 
inter-organelle mediations, such as the ER resident Ca2+ channel, inositol-1,4,5-
trisphosphate (Ins(1,4,5)P3) receptor (IP3R), (Rizzuto et al, 1998), the mitochondrial voltage-
dependent anion channel (VDAC)(Hajnoczky et al, 2002), the chaperones Grp75(Szabadkai 
et al, 2006), the sorting protein PACS-2, Mitofusin 2 (de Brito & Scorrano, 2008b), and 
Mmm1/Mdm10, 12, 34 (Kornmann et al, 2009).    
Since mitochondria fission and their disintegration are acknowledged to be 
associated with cell death, fission factors are characterised as one of the mitochondrial 
regulators of this process. Mitochondria disintegration has been reported to happen prior to 
caspase activation, but at approximately the same time as active Bax translocation and 
cytochrome c release (Arnoult et al, 2003; Kirkland & Franklin, 2003; Takahashi et al, 2005). 
This evidence has been supported by the lack of any inhibitory effect of the pan-caspase 
inhibitor zVAD-fmk for mitochondria fragmentation (Breckenridge et al, 2003; Frank et al, 
2001). Mitochondria fragmentation observed during apoptosis requires Drp1 and hFis1, but 
the inhibition of these proteins only delays, but does not prevent cells from undergoing 
apoptosis (Estaquier & Arnoult, 2007; Parone et al, 2006). However, the requirement of 
mitochondria fragmentation for apoptosis induction remains controversial and unanswered.  
 
 
 
 
 
 
 
 
 
58 | P a g e  
 
1.4.4  The calcium-apoptosis link 
 The calcium ion (Ca2+) represents one of the most important secondary messengers 
that regulate a wide range of signalling pathway such as cell proliferation, differentiation, as 
well as the modulation of cell death pathways. Cytoplasmic Ca2+ is maintained at a relatively 
low level of around 100nM, while it is around 1.2 mM in extracellular environments. The Ca2+ 
uptake from the extracellular space is regulated by Ca2+ channels, namely receptor-
operated, store-operated and voltage-sensitive channels. The gradient of Ca2+ between 
extra and intracellular space is also controlled by Na+/Ca2+ exchangers in bilateral directions 
(Figure 1-11). Additionally, the concentration of Ca2+ in the nucleus and mitochondria is 
maintained to be around 100nM. The nuclear pore is larger than Ca2+ molecule; therefore, 
Ca2+ ion can pass through to the nucleus by passive diffusion. As mentioned before since 
the ER is an organelle for Ca2+ storage, the Ca2+ concentration in the ER or the sarcoplasmic 
reticulum in muscle cells are relatively high (ranges between 100-1000 μM). Therefore, the 
Ca2+ concentration in the cytoplasm depends on two sources: Ca2+ transport through the 
plasma membrane and Ca2+ transport from or to the endoplasmic reticulum or the 
sarcoplasmic reticulum (ER/SR), (Berridge et al, 2000b). Hence, Ca2+ release from the ER is 
an important signalling event for cell death control, especially through the mitochondria-
dependent apoptosis pathway. Once calcium is imported through the plasma membrane, it 
can either interact with calcium binding proteins or localise to the ER by the action of sarco 
(endo) plasmic reticulum calcium ATPase (SERCA) pump. In addition, IP3R and ryanodine 
receptor (RyR) mediate the release of calcium ion from the ER (Berridge et al, 2000a; 
Berridge et al, 2000b). The mitochondria take up the calcium ion through the uniporter, and 
release it via the Na+/H+-dependent Ca2+ exchange and the permeability transition pore 
(PTP)(Frangioni et al, 1992) (Figure 1-11).       
Since Ca2+ is taken up by mitochondria primarily through the uniporter, a low affinity 
transporter, high local Ca2+ concentrations are required. The uniporter was suggested to act 
like a channel once local cytoplasmic Ca2+ concentration is high (Gunter et al, 2000; Rizzuto 
et al, 2000; Rizzuto et al, 2009; Rizzuto et al, 1998). The ER-mitochondria Ca2+ transfer is 
facilitated by the close contact of these two organelles. This is supported by the forming of 
interconnected tubular network of mitochondria, which is in close contact with the ER/SR 
(Rizzuto et al, 1998). Additionally, within mitochondria-associated membranes (MAMs), the 
ER-mitochondria membrane tethering part, the low affinity mitochondrial uniporter is in close 
proximity with ER Ca2+ release channels and this therefore facilitates Ca2+ transfer between 
these two organelles. Although the importance of MAMs in Ca2+ transfer has been 
demonstrated, its molecular mechanism remains unclear (Giorgi et al, 2009; Hayashi et al, 
2009; Rizzuto et al, 2009).    
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Figure 1-11 : Cellular Ca2+ channels  
This figure illustrates the major calcium channels found on the cell membrane, the 
endoplasmic reticulum (ER) and mitochondria as well as their inhibitors. On the plasma 
membrane, three calcium channels (receptor-operated, store-operated and voltage-sensitive 
channels) are responsible for Ca2+ import into the cells. Sarcoplasmic and endoplasmic 
reticulum calcium ATPase (SERCA) regulate Ca2+ influx into the ER. Inositol 1,4,5-
trisphosphate receptor (IP3) and ryanodine receptor regulate the efflux of calcium ions from 
the ER. On the mitochondrial membrane, the calcium uniporter takes up Ca2+ from the 
cytosol. PT-pore or calcium-sodium/hydrogen exchanger mediates the egression of calcium 
from mitochondria to the cytosol. The direction of ion movement is demonstrated by arrows.  
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In addition to the uniporter, Voltage Dependent Anion Channel (VDAC), a component 
of the PT-pore, is also required for Ca2+ import into the mitochondria (Bathori et al, 2006; 
Gincel et al, 2001; Kirichok et al, 2004). This is supported by data showing that the activation 
of VDAC and the uniporter is Ca2+-dependent (Bathori et al, 2006; Gincel et al, 2001; Rapizzi 
et al, 2002). The movement of Ca2+ is driven by the electrochemical gradient of the 
mitochondrial membrane potential (ΔΨm) to maintain the homeostasis of Ca2+ concentration 
between the cytoplasm and mitochondria. Cell death could be prevented by mitochondrial 
Ca2+ uptake inhibtitors, namely ruthenium red and cyclosporine A (Zhivotovsky & Orrenius, 
2011). This demonstrates the importance of massive mitochondrial Ca2+ uptake for cell 
death induction. 
Calcium triggers the mechanism of inner mitochondria membrane (IMM) 
permeabilisation through the opening of a permeability transition pore (PTP) acting as a 
voltage-operated channel. The persistent efflux of mitochondrial Ca2+ is maintained when 
cytosolic Ca2+ concentration is at a high level. This causes the continuous opening of PT-
pore leading to Ca2+ and low-molecular weight matrix components being transported out of 
mitochondria into the cytosol. Water and solutes then influx from the cytosol into 
mitochondria, which undergo swelling and OMM disruption leading to the MOMP and cell 
death. Although VDAC and Adenine Nucleotide Translocase (ANT) were identified as PT-
pore components, the requirement of these two proteins in PT-pore activation for MOMP is 
still controversial. The removal of these two proteins can still induce PT-pore activation 
(Baines et al, 2005; Kokoszka et al, 2004).Hence, the mechanism of how Ca2+ activates 
mitochondrial cell death still remains to be investigated. Additionally, as previously 
mentioned about the role of the c-subunit ring of the FO of the F1FO ATP synthase in PTP for 
cell death, high Ca2+ in matrix is also a key regulator in this process. The enlargement of F0 
subunit of ATP synthase results from the binding of matrix Ca2+ to the c-subunit ring of F0 
ATP synthase. This structural alteration leads to the dissociation of F1 subunit from F0 
subunit of ATP synthase bringing about PTP opening and cell death (Alavian et al, 2014). In 
addition, the β-subunit of ATP synthase regulated by Bcl-XL can inhibit the c-subunit channel 
(Alavian et al, 2011).  
In addition to the role of PT-pore activation in apoptotic cell death, it is also involved 
in necrosis.  One way to elucidate its role is via the overexpression and down-regulation of 
CypD, a crucial component of the pore complex. CypD overexpression can inhibit both 
apoptosis and necrosis depending on the inducers (Baines et al, 2005; Li et al, 2004; Lin & 
Lechleiter, 2002; Nakagawa et al, 2005; Schubert & Grimm, 2004). For example, cells 
undergo apoptosis while NO- is inhibited and cells are treated with staurosporine; in contrast, 
cells would switch to necrosis if NO- is provided in CypD overexpressed cells (Li et al, 2004). 
In addition, CypD-deficient cells die normally in response to apoptotic stimuli yet they were 
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resistant to ROS-induced necrotic cell death (Baines et al, 2005). Moreover, CypD-deficient 
mice have shown resistance to ischemia/reperfusion-induced cardiac injury, suggesting that 
CypD-dependent necrosis is possibly a cause of this disease (Nakagawa et al, 2005). 
Additionally, the regulation of mitochondrial metabolism is related with Ca2+. This is 
supported by data presenting the requirement of Ca2+ for four metabolic enzyme activities, 
namely phosphate-, pyruvate-, α-ketoglutarate- and isocitrate- dehydrogenases, which are 
important for ATP production (Denton et al, 1972; Denton et al, 1978; Hansford & Chappell, 
1967; McCormack & Denton, 1979; McCormack & Osbaldeston, 1990; Nichols & Denton, 
1995). In addition, both the increase of mitochondrial Ca2+ concentration as well as ATP 
production are inhibited when cells are subjected to BAPTA treatment, a cytosolic calcium 
chelator (Jouaville et al, 1999). This data also reveals that the mitochondrial Ca2+ 
concentration depends on that of the cytoplasm. The uncontrolled Ca2+ regulation and its 
subsequent signalling are associated with diseases. For example, the function of the 
mitochondrial Na+/Ca2+ exchanger can be reversed for calcium transport into mitochondria 
instead of its normal function to release this ion from this organelle under hypoxia condition, 
which is generally found in solid tumours (Griffiths et al, 1998). This might play a role in cell 
death signalling or metabolic control of mitochondria, especially ATP production, which 
depends on Ca2+ signalling. It has been also reported that oxidative stress results in an 
increase in cytoplasmic Ca2+concentration in which the source of Ca2+ ion might be different 
depending on types and concentration of oxidants (Doan et al, 1994; Renard et al, 1992; 
Roveri et al, 1992). Under oxidative stress conditions, Ca2+ signalling can switch from a 
physiologically beneficial process to cell death signalling. 
Ca2+, which its passive diffusion into the nucleus, plays a role under physiological 
conditions and in cell death control. Ca2+ was found to induce the typical apoptotic DNA 
fragmentation through the activation of Ca2+- and Mg2+- dependent endonuclease in isolated 
thymocyte nuclei (Wyllie, 1980). Recently, it has been shown that nicotinic acid adenine 
dinucleotide phosphate (NAADP) induces Ca2+ release from the nuclear envelop 
(Gerasimenko et al, 2003). The fluctuation of Ca2+ level in the nucleus is related to chromatin 
organisation, which affects gene expression, epigenetic processes and DNA degradation. It 
also induces several enzyme activities, such as protein kinases, endonucleases and 
proteases (Nicotera et al, 1994). Chromatin compaction can delay apoptotic cell death, 
possibly through the inhibition of DNA fragmentation (Dypbukt et al, 1994). Most studies 
focus on the activity of caspase-3-activated endonuclease for DNA fragmentation. However, 
chromatin fragmentation can also occur by the incubation of isolated cell nuclei with Ca2+ 
and ATP without caspase-mediated DNA cleavage activity (Liu et al, 1998). This raises the 
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possibility that other nucleases within the nucleus may play the role in overall DNA 
degradation.   
 
1.4.5  Mitochondrial respiratory chain  
The cellular respiratory chain evolutionally emerged to convert hydrogen atoms as 
well as reduction equivalents produced from mitochondrial oxidations of the tricarboxylic acid 
(TCA) cycle to ATP and water. Proton translocation from the mitochondrial matrix to the 
intermembrane space generates the electrochemical proton gradient (∆µOH+), which is a 
consequence of the electron transfer. The generated proton gradient is responsible for ATP 
synthesis from ADP and Pi via the ATP synthase activity, a process known as oxidative 
phosphorylation. The mitochondrial respiratory chain is composed of four major multi-subunit 
complexes designated as Complex I (NADH-Coenzyme Q), Complex II (Succinate 
Dehydrogenase), Complex III (Ubiquinol-cytochrome c reductase), and Complex IV 
(cytochrome c oxidase) (Figure 1-12). Complex I and III has been reported to be major sites 
of superoxide formation. However, recent studies showed that complex II also plays an 
important role for ROS generation (Grimm, 2013; Lemarie et al, 2011). Complex II is an 
entry point for reducing equivalents, along with complex I, generated from the oxidation of 
succinate to fumarate of the TCA cycle. This complex is unique amongst other complexes in 
the respiratory chain since proton pumping across the IMM does not take place at this 
complex as others do (Rutter et al, 2010). At this complex, coenzyme Q is reduced to 
ubiquinol prior to continuing down to complex III of the respiratory chain. Complex II is 
comprised of two IMM transmembrane proteins, SDHC and SDHD, as well as two 
mitochondrial matrix proteins, SDHA and SDHB (Sun et al, 2005). Based on the latest 
findings from our group upon cell death induction, which activates Ca2+ influx into 
mitochondria, Ca2+ ion binds cardiolipin at this complex and upon this binding it clusters and 
dissociates from complex II.  This induces the release of the sub-complex SDHA and SDHB 
from the membrane-anchoring SDHC and SDHD sub-complex (Hwang et al, 2014). 
Electrons from the substrate succinate are then transferred to oxygen molecules resulting in 
ROS production and PT-pore activation for cell death (Albayrak et al, 2003; Hwang et al, 
2014; Lemarie et al, 2011)(see more details in topic 5.1.4). 
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Figure 1-12 : Respiratory chain  
The diagram illustrates the five complexes of the mitochondrial electron transport chain and 
ATP production. Please see text for more detail.  
Figure is reprinted from (Eng et al, 2003) 
 
 
1.5 The ARCosome in cell death  
1.5.1  ARCosome components  
1.5.1.1  Bap31 
B-cell activating protein 31(Bap31) is a 246 amino acid, integral ER membrane 
protein. It is composed of three transmembrane domains, a luminal N-terminal domain, and 
a cytosolic C-terminal domain. The C-terminal domain possesses a canonical ER retrieval 
motif (KKEE). However, this motif does not seem to be necessary for ER localisation (Ng et 
al, 1997). The C-terminal region of Bap31 also contains a leucine-zipper like repeat, and a 
variable DED domain, flanked by two caspase-recognition sites (AAVD) at amino acid 164 
and 238 (Figure 1-13). Bap31 can be cleaved by caspase 8, 3, 10 (Fischer et al, 2006). 
Bap31 is ubiquitously expressed in all cell types of human (see GeneCards: 
http://www.genecards.org/cgi-
bin/carddisp.pl?gene=BCAP31&search=29a78f13941df1aee82f45a42b7cedb2).Bap31 
shares 50% amino acid sequence identity to Bap29 but they are encoded by different genes. 
Bap31 homodimerises and heterodimerises with this closely related Bap29 protein (Adachi 
et al, 1996; Ng et al, 1997) (Figure 1-14).   
 Bap31 processing has several roles in cell death signalling. Being a caspase-8 
substrate, Bap31 is cleaved at two caspase cleavage sites generating the pro-apoptotic 
fragment, p20Bap31 (Ng et al, 1997). p20Bap31 overexpression was shown to cause 
I 
II 
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apoptosis via the mobilisation of Ca2+ from the ER to the mitochondria. In addition, Bap31 
cleavage per se by caspase-8 was also shown to be an important part of apoptosis 
induction, which is supported by apoptosis inhibition by the caspase-resistant form of Bap31 
(crBap31). crBap31 inhibited cytoplasmic membrane blebbing and fragmentation, loss of 
membrane integrity, Bax/Bak activation and cytochrome c release (Nguyen et al, 2000; 
Wang et al, 2003). Bap31 cleavage by caspases has been observed in response to a variety 
of cell death stimuli (more detail in Chapter 3).  
 
 
 
 
 
 
 
 
 
 
Figure 1-13 :  Bap31 and p20Bap31 in apoptosis 
Bap31 is composed of three transmembrane domains at the N-terminus and vDED domain 
for caspase-8 recruitment as well as two caspase cleavage sites (D164 and D238) at the              
C-terminus. Upon caspase-8 cleavage at these two sites, pro-apoptotic p20Bap31 is 
generated leading to apoptosis.     
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Figure 1-14 :  Protein sequence alignment of human Bap31 and Bap29  
Human Bap31 and Bap29 show a 48.6% protein sequence identity (yellow) and are 62.3% 
protein sequence positive, which is the value of % identity combined with % similarity 
(green)(based on their chemical property). Amino acid sequence alignment was performed 
using Vector NTI software. Bap31 accession no: CAA57415.1 and Bap29: AAH08478.1 
(Bap29). Sequence highlighted in red (AAVD) indicates the caspase recognition sites.   
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In addition to its role in apoptosis, Bap31 also plays other cellular roles. The cytosolic 
domain of Bap31 interacts with -actin and non-muscle myosin (Ducret et al, 2003). This 
association helps to maintain the intracellular architecture of cells. In contrast, p20Bap31, 
the caspase cleavage product of Bap31, cannot maintain this function (Nguyen et al, 2000). 
Bap31 also plays a role in ER sorting and ER quality control. ER is an organelle for protein 
production and protein quality control. Only correctly folded proteins are allowed to exit from 
the ER. Misfolded or unfolded proteins are retained within the ER by the association with the 
ER quality control (ERQC) machinery until they are correctly folded and ready to be 
secreted. In the end, if this process cannot be achieved, these misfolded or unfolded 
proteins are degraded by the ER-associated degradation (ERAD) pathway (Maattanen et al, 
2010). Protein degradation via ERAD is a multi-step process, including protein recognition, 
targeting, retrotranslocation from the ER to the cytoplasm, ubiquitination and, ultimately, 
proteasomal degradation (Hebert et al, 2010; Tamura et al, 2008; Vembar & Brodsky, 
2008).Bap31 plays a role in this process by facilitating or preventing protein egress from the 
ER.  Bap31 can promote ER retention/retrieval, cell surface export, or survival/stabilisation at 
the ER. For example, Bap31 is involved in ER retention/retrieval of cytochrome P450 
CYP2C2 (Szczesna-Skorupa & Kemper, 2006), the immature form of the IgD receptor 
(Adachi et al, 1996; Schamel et al, 2003), and tyrosine phosphatase-like protein (Wang et al, 
2004). It also facilitates ER export of cellubrevin (Annaert et al, 1997), tetraspanins 
(Stojanovic et al, 2005)and major histocompatibility complex (MHC) class I molecules (Abe 
et al, 2009; Ladasky et al, 2006; Paquet et al, 2004; Spiliotis et al, 2000).  
 
1.5.1.2  Fis1 
 Human Fis1 is a 152-amino acid mammalian mitochondrial fission protein with a 
single transmembrane at its C-terminus, inserted in the outer mitochondrial membrane 
(OMM) with six cytosolic antiparallel α-helices (Figure 1-15). hFis1 induces mitochondrial 
fragmentation in a Drp1-dependent manner (Arai et al, 2004; Lee et al, 2004). Drp1 
translocates from the cytosol to punctuate spots, forming a ring structure. The constriction of 
the ring structure cleaves off one mitochondrion into two. This initially relies on hFis1 (Lee et 
al, 2004). Although hFis1 could be required for this event, the mechanism of fission protein 
recruitment for mitochondria fission remains unclear.  
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Figure 1-15 :  Amino acid sequence and structure of hFis1 
(A) The protein sequence of hFis1 (H.sapiens, gene ID 51024) and -helices (1- 6) is 
shown. (B) The 3D structure of hFis1 is depicted. The N-terminus contains six -helices (1- 
6) facing the cytosol. The C-terminus is localised in the outer mitochondrial membrane.    
 
 
In addition to promoting mitochondrial fission, Fis1 can also induce apoptosis in the 
mammalian system (James et al, 2003). The viability of a yeast strain lacking Fis1 increases 
when cells are treated with H2O2 and acetic acid (Fannjiang et al, 2004). Ectopic expression 
of Fis1 can induce the release of cytochrome c from mitochondria (Alirol et al, 2006; James 
et al, 2003). The co-transfection of Fis1 with Bcl-XL or the dominant-negative form of Drp1 
(Drp1 K38A) can inhibit both cytochrome c release and mitochondrial fission (James et al, 
2003).However, nuclear fragmentation, a physiological marker of apoptosis, can merely be 
inhibited by Bcl-XL but not by Drp1 K38A (James et al 2003). Although Fis1-induced 
apoptosis depends on Bax and Bak, mitochondrial fission mediated by Fis1 is Bax/Bak-
independent (Alirol et al, 2006). This raises the possibility that the role of Fis1 in 
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mitochondrial fission and apoptosis may be regulated through genetically distinct pathways 
or one is possibly activated upstream of the other. The abrogation of Fis1 by its down-
regulation makes cells resistant, as determined by Bax activation, cytochrome c release, 
caspase-3 activation and nuclear fragmentation, to several pro-apoptotic inducers, including 
etoposide, actinomycin D, staurosporine as well as the activation of Fas receptor (Lee et al, 
2004).  
 
1.5.2  ARCosome discovery & its role in cell death signalling 
Bap31 was first identified to be part of a complex including Bcl-XL/Bcl-2 and pro-
caspase-8L (pro-FLICE) when Bcl-XL, Bcl-2 and Bap31 were overexpressed in Hek293T 
cells (Ng et al, 1997). The p20Bap31-induced cell death signalling pathway was shown to 
proceed through Ca2+ signalling from the ER to the mitochondria (Granville et al, 1998; Ng et 
al, 1997; Nguyen et al, 2000). However, the mechanism that regulates Bap31 cleavage into 
the pro-apoptotic p20Bap31 had not been answered until Iwasawa et al demonstrated this 
point in a study in 2011. In this publication, fission protein Fission 1 homologue (Fis1), which 
was isolated from our genetic screen for apoptosis inducers (Albayrak & Grimm, 2003), was 
shown to interact with Bap31 and serve as an ER and mitochondria platform named the 
“ARCosome”. The ARCosome complex acts as a platform for caspase-8 recruitment and 
activation for Bap31 cleavage into p20Bap31. Additionally, the variant of dead effector 
domain (vDED) in Bap31 mediates procaspase-8 association and activation. This signalling 
pathway establishes Ca2+ release from the ER to the mitochondria for apoptosis (Iwasawa et 
al, 2011). This study showed that Fis1 conveys an apoptotic signal from the mitochondria to 
the ER. Ca2+ release from the ER activated by the ARCosome could function as an amplifier 
or sensitiser of cell death to the mitochondria. Importantly, Fis1 plays, according to this 
study, a role not only in fission per se but also in apoptosis induction via a separate pathway.      
Even though, Ng et al showed that Bap31 interacts with Bcl-XL/Bcl-2 and 
procaspase-8L (Ng et al, 1997)and that anti-apoptotic Bcl-XL can inhibit apoptosis mediated 
by Fis1 (Fannjiang et al, 2004), the role of Bcl-XL and Bcl-2 to protect Bap31 cleavage at the 
ARCosome complex remained unanswered. Here, in my study, I show for the first time that 
the binding of Bcl-XL and Bcl-2 to the ARCosome complex keeps the pre-formed ARCosome 
inactive in healthy cells by blocking procaspase-8 recruitment to the complex.   
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Importance and hypothesis of this study 
The endoplasmic reticulum (ER) and the mitochondria are key organelles in 
apoptosis control. The ER acts as a signal sensor and transports signals to downstream 
sensors and organelles, particularly the mitochondria. Mitochondrial proteins respond to 
signals from the ER and induce molecular signals for cell death. Hence, the ER and the 
mitochondria cooperate for cell-death control. While the cooperation between the ER and the 
mitochondria in this pathway has been discovered, defining the exact signalling between the 
organelles, which responds to the relevant signals in this process has been a challenge for 
the field. Recently, our group has presented evidence that Fission 1 homologue (Fis1) 
conveys an apoptotic signal from the mitochondria to the ER by interacting with Bap31, an 
integral ER membrane protein (Iwasawa et al, 2011). Their binding acts as a platform for 
procaspase-8 recruitment and activation. Activated caspase-8 cleaves Bap31 into the pro-
apoptotic p20Bap31. This signalling pathway then causes Ca2+ release from the ER to the 
mitochondria for apoptosis induction (Iwasawa et al, 2011). Hence, this complex, which 
spans the mitochondria-ER interface, was named the “ARCosome.” However, whether 
additional proteins act as regulators of the ARCosome complex in normal and apoptotic cells 
remain unanswered.   
 Pro- and anti-apoptotic members of the Bcl-2 super family have been identified as 
central regulators of cell death and found to be therapeutic targets (Cotter, 2009; Ni 
Chonghaile & Letai, 2008). As shown in Ng et al‟s study, Bap31 was first identified as a Bcl-2 
interacting protein (Ng et al, 1997). Importantly, anti-apoptotic Bcl-XL has been shown in 
yeast studies to repress apoptosis mediated by Fis1 (Fannjiang et al, 2004). The protective 
effects of Bcl-2 have also been demonstrated for cell death initiated by p20Bap31 at the ER 
(Heath-Engel et al, 2012). Despite this recent evidence, the question whether BclXL and Bcl-
2 act as key regulators for ARCosome activation was addressed in my study. The work 
presented in this thesis reveals the role of BclXL and Bcl-2 in ARCosome activation and 
apoptosis inhibition activated by Fis1 and Bap31. They play a vital role in keeping the pre-
formed ARCosome inactive in healthy cells. The initiating signals for ARCosome activation, 
including ER-stress, DNA damage, protein synthesis and ROS formation, was also 
addressed. The role of complex II of the respiratory chain as the downstream sensor at the 
mitochondria upon ARCosome activation was likewise elucidated. Finally, I investigated 
whether the ARCosome inducesnecroptosis, This research sheds new light on potentially 
novel therapeutic targets for relevant diseases such as Alzheimer‟s disease.  
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Chapter 2 
Material and method  
 
2.1  Reagents 
From Sigma-Aldrich 
Tunicamycin (T7765), brefeldin A (B5936), doxorubicin (D1515), arsenic trioxide (A1010), 
etoposide (E1383), actinomycin D (A1410), bongkrekic acid (BA, B6179), necrostatin-1 
(N9037),1x PBS buffer for cell culture (P8537), Dulbecco‟s modified eagle medium (DMEM) 
(D6429), heat inactivated foetal calf serum (FCS)(10500), glutamine (G7513), sodium 
pyruvate (S8636), penicillin/streptomycin (10000U/ml and 10mg/ml, respectively,P0781), 
Trypsin-EDTA solution (0.5%, 15400-54), puromycin dihydrochloride (P8833), propidium 
iodide (PI) solution (1mg/ml, P4864), saponine (47036), DCFDA (D6883),-
mercaptomethanol (M7154), methanol (32213), 30% acrylamide (N,N‟-methylene-bis-
acrylamide 37.5:1 (w/w) (A7168), ammonium persulphate (APS) (A3678), N,N,N‟,N‟-
tetramethyl-ethylenediamine (TEMED) (T9281), BSA (A7906), PBS (D8537) (for western 
blot), Tween®20 (P5927), sodium butyrate (303410), Polybrene® (H9268), dimethyl 
sulfoxide (D2650), HEPES (H3375), LB-broth (L3022), yeast extract (Y1625), NP-40 (I3021), 
sodium azide (S8032). 
From Invitrogen  
DAPI (D3571), MAX Efficiency® DH5α™ E.coli  bacteria Competent Cells  (18258-012),  
SOC medium (18258-012), Oligofectamine™ Transfection Reagent (12252-011), OPTI-
MEM (22600134), pcDNA3 vector (V79020), Alexa Fluor® 488 goat anti-rabbit IgG 
secondary antibody (A11034), HEK293FT cells (R700-07), pLKO.1 puro vector expressing 
plasmids encoding Vesicular Stomatitis Virus Glycoprotein (pVSV-G), group antigen and 
reverse transcriptase (pGag.Pol) and mRNA export helper protein (pRev) isolated from 
ViraPower™ lentiviral packaging mix. Note that all siRNA were purchased from Invitrogen.  
From Millipore 
CaspaTag™: Caspase-8 In situ assay kit fluorescein (APT408), PureProteome magnetic 
protein G beads (LSKMAGG10), PureProteome™ Magnetic Stand (LSKMAGS08), 0.45 μm 
PVDF membrane (IPVH00010), Millex-GS Syringe Filter Unit, 0.22 µm(SLGS033SS),Millex-
HA Syringe Filter Unit, 0.45 µm (SLHA033SS). 
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From Thermo Scientific  
Phusion High-Fidelity DNA Polymerase (F-534S), 16% w/v formaldehyde (28908), 4x 
Sample Loading Buffer (84788), Pierce™ Fast Semi-Dry Blotter (88217), Pierce® Crosslink 
Immunoprecipitation Kit (26147), Pierce® enhanced chemoluminescent (ECL) reagent 
(32106). 
From Bio-Rad 
Bradford Assay (500-0006), Tris/Glycine/SDS (TGS) buffer (1610772), 1 M Tris-HCl pH 6.8 
(161-0799), 1.5 M Tris-HCl pH 8.8(161-0798), 10% SDS (161-0416). 
 
From various suppliers 
Thapsigargin (586005), 2-APB (100065), dantrolene (251680) were purchased from 
EMD4Biosciences;  zVAD-FMK (O103) from MP Biomedicals; zIETD-FMK (219007),          
Z-DEVD-FMK (264155) Z-LEHD-FMK (218761) were purchased from Calbiochem; Maxi 
Prep Plasmid Preparation Kit (12162) from QIAGEN; JetPEI® Transfection Reagent (101-
10) from Polyplus; FACSCalibur™ from BD Biosciences; FlowJo programme from Tree Star 
Inc.;TCS SP5 Confocal Microscope from Leica; 3,3'-Dihexyloxacarbocyanine Iodide (DiOC6) 
(D273), MitoSOX (M36008), Alexa Fluor® 488 goat anti-mouse IgG secondary antibody (A-
11001), Fluo-4/AM (F14217), and Rhod-2/AM (R1245MP) from Molecular Probes; Annexin 
V-FITC and PI Apoptosis detection kit (BMS500FI/100) from eBioscience; Custom Neo-
epitope C-Terminal p20Bap31 Antibody from EuroGentec; protease inhibitor cocktail (R132) 
and PageRuler™ pre-stained protein ladder (26616) from Fermentas; FLUOstar OPTIMA 
from BMG Labtech; Hyperfilm ECL (28906839) from GE Healthcare; Interferon- (407306-
100) from VWR International Ltd;  Amyloid-β(1-42) (CP641-15-05) from Cambridge 
Bioscience Ltd. 
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2.2  Apoptosis/necroptosis inducer and inhibitor treatment  
 Cells were treated with apoptosis/necroptosis inducers and/or inhibitors to investigate 
the mechanism of the respective pathway. Most of them were treated at a concentration and 
time point to induce 50-60% cell death. The apoptosis/necroptosis inducers and inhibitors 
and their targets are listed in Table 2-1. 
 
Table 2-1 : Apoptosis/necroptosis inducers and inhibitors and their targets 
Drug Inducer Inhibitor Target/ function 
tunicamycin  ●  ER-stressor (N-glycosylation inhibitor) 
thapsigargin  ●  ER-stressor (SERCA inhibitor) 
brefeldin A  ●  inhibits protein transport from the 
endoplasmic reticulum (ER) to the 
Golgi apparatus 
doxorubicin ●  DNA intercalation compound 
cisplatin  ●  binds and crosslinks with DNA 
As2O3 ●  mitochondrial membrane potential 
damage  
etoposide ●  DNA strand break inducer 
actinomycin D ●  binds DNA at the transcription initiation 
complex and prevents RNA elongation 
dantrolene  ● ryanodine receptor (Ryr) inhibitor 
(ER calcium uptake inhibitor) 
2-aminoethoxydiphenylborate 
(2-APB) 
 ● inositol 1,4,5-triphosphate receptor 
(IP3R) inhibitor 
 (ER calcium uptake inhibitor) 
Ru360   ● Uniporter inhibitor, (mitochondrial 
calcium uptake inhibitor) 
bongkrekic acid  ● ANT inhibitor  
zVAD-FMK  ● pan-caspase inhibitor 
z-IETD-FMK  ● caspase-8 inhibitor 
z-DEVD  ● caspase-3 inhibitor 
z-LEHD  ● caspase-9 inhibitor 
interferon  ●  necroptosis inducer 
necrostatin-1  ● RIP1 inhibitor (necroptosis inhibitor) 
amyloid-β (1-42) ●  component of amyloid plaques in 
association with Alzheimer's disease 
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2.3  Common buffers used 
Table 2-2 : Common buffers used in this study 
Solution/Media Composition 
 
PBS  
 
137mM NaCl, 2.7mM KCl, 8mM Na2HPO4 and 2mM KH2PO4 
adjust pH to 7.4  
 
 
PBS-S 
 
PBS with 0.02% w/v saponine (Sigma-Aldrich) 
 
 
SOC medium  
 
 
2% tryptone, 0.5% yeast extract, 10mM NaCl, 10mM MgSO4,          
2.5mM KCl and 20mM glucose  
 
 
LB broth 
 
1% Bacto tryptone, 0.5% Bacto-yeast extract, 1% NaCl 
adjust pH to 7.5 by NaOH 
 
 
TE buffer  
 
 
100 mM Tris-HCl (pH 7.5) and 10 mM EDTA (pH 8.0) 
 
RIPA buffer  
 
 
150mM NaCl, 1% NP40, 0.5% w/v sodium deoxycholate,              
0.1% w/v SDS, 50mM Tris-HCl pH 8  
 
 
Resolving gel 
 
10-15% polyacrylamide, 375mM Tris-HCl pH 8.8, 0.1% SDS,          
0.1% APS and 0.05% TEMED 
 
 
Stacking Gel 
 
4.8% polyacrylamide, 125mM Tris-HCl pH 6.8, 0.1% SDS, 
0.1% APS and 0.1%TEMED 
 
 
TGS buffer  
 
25mM Tris, 192mM Glycine and 0.1% w/v SDS; pH 8.3 
 
Transfer Buffer 
 
 
20% methanol in TGS buffer  
 
 
 
2X HBS 
 
 
50mM HEPES, 280 mM NaCl, 1.5mM Na2HPO4                                       
adjust pH to 7.06-7.08 and filter sterilise 
 
 
 
 
75 | P a g e  
 
2.4  Plasmid vectors 
Mammalian expression plasmids used in this study were cloned into pcDNA3Δ, 
which was modified from pcDNA3 to eliminate the neomycin resistance gene cassette. Fis1 
was isolated from a genetic screening of apoptosis inducer (Albayrak & Grimm, 2003)and 
hemagglutinin (HA) was C-terminally tagged (Iwasawa et al, 2011). The pro-apoptotic 
cleaved fragment of Bap31 (p20Bap31-myc), full length Bap31-Flag, Bap31 ΔvDED-Flag, 
Bap31 ΔCC/vDED-flag, Bcl-XL, Bcl-2, Bcl2-ER localised, Bcl2-mitochondria localised, 
caspase-8, and caspase-2 were produced in our lab. Other plasmids were obtained through 
the courtesy of sources, namely Bap31-myc and tBid (Mund et al, 2003), Bax (Schoenfeld et 
al, 2004). 
Short hairpin RNAs (shRNA) against target sequence of scrambled (as negative 
control), Fis1, and Bap31 were cloned into pLKO.1 puro Lentiviral shRNA vectors (Sigma-
Aldrich) with forward and reverse primers as shown in Table 2-3 by a previous PhD student 
(Iwasawa et al, 2011). pLKO.puro caspase-8, Bcl-XL, and Bcl-2 shRNA were purchased from 
Sigma-Aldrich. The detail of these shRNA was listed in Table 2-4.  
Table 2-3 : Primers for pLKO.1 puro lentiviral shRNA vectors 
shRNA Target  sequence 5‟ → 3‟ 
accession 
number 
 
 
 
scrambled 
 
forward 
 
CCGGCCTAAGGTTAAGTCGCCCTCGCTCT
AGCGAGGGCGACTTAACCTTAGGTTTTTG  - 
 
reverse 
 
AATTCAAAAACCTAAGGTTAAGTCGCCCTC
GCTCTAGCGAGGGCGACTTAACCTTAGG  
 
Fis1 
 
forward 
 
CCGGCAAGAGCACGCAGTTTGAGTACTCG
AGTACTCAAACTGCGTGCTCTTGTTTTTG   
NM_025562.3 
 
reverse 
AATTCAAAAACAAGAGCACGCAGTTTGAGT
ACTCGAGTACTCGAGTACTCAAACTGCGTG
CTCTTG 
Bap31 
 
forward 
 
CCGGGACGCCTGGTGACTCTCATTTCTCG
AGAAATGAGAGTCACCAGGCGTCTTTTTG  
  
NM_001139441  
reverse 
 
AATTCAAAAAGACGCCTGGTGACTCTCATT
TCTCGAGAAATGAGAGTCACCAGGCGTC  
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Table 2-4 : pLKO.1 puro lentiviral shRNA purchased from Sigma-Aldrich 
shRNA Target sequence 5‟ → 3‟ 
accession 
number 
 
 
TRCN number 
caspase-8 
CCGGGACATGAACCTGCTGGATATT
CTCGAGAATATCCAGCAGGTTCATGT
CTTTTT 
NM_001228.x-
758s1c1 
 
 
TRCN0000003576 
 
Bcl-XL 
CCGGGCTCACTCTTCAGTCGGAAAT
CTCGAGATTTCCGACTGAAGAGTGA
GCTTTTTG 
NM_001191.2-
857s1c1 
 
TRCN0000033499 
 
Bcl-2 
CCGGTGGATGACTGAGTACCTGAAC
CTCGAGGTTCAGGTACTCAGTCATC
CATTTTTG 
NM_000633.x-
557s1c1 
TRCN0000010303 
 
 
2.4.1  E.coli transformation 
Plasmid DNA was transformed into MAX Efficiency® DH5α™ E.coli bacteria Competent 
Cells (Invitrogen). Plasmid DNA was added to 10 l thawed competent cells on ice.  The 
mixture was incubated on ice for 30 minutes prior to heat shock for 45 seconds at 42C. The 
mixture was then quickly chilled on ice for 3 minutes before 1 ml SOC medium (2% tryptone, 
0.5% yeast extract, 10mM NaCl, 10 mM MgSO4, 2.5 mM KCl, 20 mM glucose)(Invitrogen) 
was added to the transformed cells and incubated at 37C, 250 rpm shaker for 1 hour. 
Bacteria were plated on LB agar plates (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% 
agar) containing 100 g/ml ampicillin and cultured at 37C overnight.  
2.4.2  Plasmid DNA extraction 
Transformed bacteria were cultured in LB broth supplemented with 100 g/ml ampicillin 
in a shaking incubator at 37C overnight. The plasmid DNA was extracted from bacteria 
using the Plasmid Maxi Prep kit (QIAGEN). DNA concentration was measured with 
NanoDrop (ThermoScientific).   
 
 
 
 
 
77 | P a g e  
 
2.5  Cell culture  
HeLa (human cervical carcinoma), HEK293FT (human embryonic kidney cells, for viral 
production), SHSY5Y (human neuroblastoma) cells were cultivated in high glucose (4.5g/L) 
Dulbecco‟s modified eagle medium (DMEM, Sigma-Aldrich) supplemented with 10% v/v heat 
inactivated foetal calf serum (FCS) (Sigma-Aldrich), 2mM L-glutamine (Sigma-Aldrich), 2mM 
sodium pyruvate (Sigma-Aldrich), penicillin and streptomycin (10000U/ml and 10mg/ml, 
respectively, Sigma-Aldrich).  
 HEK293T (human embryonic kidney), HEK293T Presinilin1 dominant/negative, 
HEK293T Presinilin1 overexpressing cell lines were obtained by the courtesy of Dr. 
Magdalena Sastre and cultured as above.  
 HeLa cells stably downregulated of Bap31, Fis1, or caspase-8 by Lentiviral shRNA 
were cultured as above in the presence of 4 μg/ml puromycin (Sigma-Aldrich) in selecting 
media and 1μg/ml puromycin in maintaining media. 
 Cells were cultured in tissue culture plates, dishes, or flasks and maintained in 5% 
atmospheric CO2 at 37 ℃ in a humidified incubator. Cells were routinely passaged to a new 
plate, dish, or flask upon reaching confluency every 3-4 days. Cells were washed with PBS 
once and then 2 ml (for 10 cm2 dish) of trypsin-EDTA solution (final concentration of 0.05% 
diluted in PBS, Sigma-Aldrich), which was incubated with the cells for 5 minutes in 5% 
atmospheric CO2 at 37 ℃ in a humidified incubator. Culture media mentioned above was 
added and trypsinised cells were pipetted up and down to obtain single cells. Proper dilution 
of the cells was transferred to a new plate and mixed well.   
 
2.6  Transfection 
2.6.1   Plasmid vector transfections 
HeLa cells were plated onto either 24-well (1.5x104 cells/well) or 6-well (1.3x105 
cells/well) plates one day prior to transfection to obtain 60-70% confluency on the day of 
transfection. JetPEI® (Polyplus) was used to transfect plasmid DNA into HeLa cells. Per well 
of a 24-well plate, 0.5 g DNA was added to 150 mM NaCl to a final volume of 50 µl and the 
mixture was then vortexed gently. In another tube, 2 µl of JetPEI® reagent was added to 150 
mM NaCl to a final volume of 50 µl and the mixture was then vortexed gently. 50 µl of 
JetPEI® solution was added drop-wise to the DNA solution. The mixture was vortexed gently 
and incubated at room temperature for 20 minutes. The mixture was added drop-wise into 
the well containing 400 µl culture medium and the medium was changed after 5 hours after 
transfection. Note that the amount of DNA, JetPEI®, and NaCl for other plate sizes was 
calculated according to the well surface area.  
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2.6.2  siRNA transfections 
 Cells were transiently downregulated with the target sequence of scrambled, Fis1, 
Bap31, and caspase-8 siRNA (Table 2-3) using Oligofectamine (Invitrogen). The specificity 
of the target sequence was confirmed by BLAST-search to human genes. Cells were seeded 
the night before transfection to obtain approximately 40% confluent on the day of 
transfection. On the day of transfection, per well of 6-well plate, 4μl of Oligofectamine and 
15μl of OPTI-MEM (Invitrogen) were mixed in one tube. In another tube, 10μl of 20μM siRNA 
(Invitrogen) was diluted in 175μl of OPTI-MEM. Both tubes were incubated for 10 minutes at 
room temperature. Both tubes were mixed thoroughly by vortexing and further incubated for 
20 minutes.  The lipid-siRNA complex was then added drop-wise to the well containing 800 
μl of serum free medium and incubated for 5 hours prior to switching to normal growth 
medium. Plasmids of interest were consecutively transfected depending on experiments and 
knockdown levels.  
 
2.7   Apoptosis assays 
2.7.1  3,3-dihexaoxacarbocyanine Iodide (DiOC6) and propidium iodide (PI) staining 
To measure the percentage cells with mitochondrial outer membrane depolarisation 
and membrane permeability, the supernatant (containing floating cells) and adherent cells 
were harvested, centrifuged (1700rpm, 7 minutes) and resuspended in 200 μl of PBS.  Cells 
were stained with DiOC6 (final concentration of 40 nM, Sigma-Aldrich) and PI (final 
concentration of 6 g/ml, Sigma-Aldrich) in PBS. Cells were incubated in 5% atmospheric 
CO2 at 37 ℃ in a humidified incubator for 30 minutes and 25C for 30 minutes in the dark 
prior to flow cytometry analysis (FACSCalibur™, BD Biosciences) using FL-1 (for DiOC6 
staining) and FL-2 (for PI staining) channel. The percentage of dead cell was quantified by 
FlowJo software (Tree Star Inc.).   
2.7.2  Caspase-8 activity assay 
Caspase-8 activity assay was determined using CaspaTag™ Caspase-8 In situ 
assay kit (Millipore) according to the manufacturer‟s instructions. The supernatant and 
adherent cells were harvested, centrifuged (1700rpm, 7 minutes), and resuspended in 200 µl 
of PBS. 0.1 l of 150x FLICA (Fluorochrome inhibitors of caspase reagent) contained the 
peptide inhibitor of caspase-8 (carboxyfluorescein-labeled fluoromethyl ketone or FAM-
LETD-FMK) was then added to the tube and incubated in the incubator with 5% CO2 at 37C 
for 1 hour. After the incubation, cells were washed twice with 2 ml PBS and centrifuged at 
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1700 rpm for 7 minutes. The cells were resuspended in 200 l PBS and analysed with flow 
cytometer using FL-1 channel.  
2.7.3  Bax activity assay  
Cells with activated Bax were quantified using an immunofluorescence assay and 
flow cytometry analysis. Cells were probed with Bax primary antibody (556467, BD 
Pharmingen) which can only recognise activated form of Bax (Hsu et al, 1997; Hsu & Youle, 
1997). The supernatant and adherent cells were harvested, centrifuged (1700rpm, 7 
minutes), and fixed in 4% PFA (Thermo Scientific) in PBS for 20 minutes at 4C. Cells were 
permeabilised in PBS-S (PBS with 0.02% w/v saponine (Sigma-Aldrich)) and blocked in 3% 
BSA in PBS-S for 20 minutes in 5% atmospheric CO2 at 37 ℃ humidified incubator. Cells 
were then incubated with primary antibody at a 1: 200 dilution for 1 hour in the incubator. 
Cells were further washed with PBS-S two times prior to incubating with Alexa Fluor® 488 
goat anti-mouse IgG secondary antibody (Invitrogen) at 1: 500 dilution for 1 hour in the 
incubator. Cells were also further washed with PBS-S three times prior to flow cytometry 
analysis using FL-1 channel. The percentage of cells with activated Bax was quantified by 
FlowJo software.   
2.7.4  Annexin V-fluorescein isothiocyanate (FITC) / PI staining  
In healthy cells, phosphotidylserine (PS) is normally found on the intracellular leaflet 
of the cell membrane. On the other hand, PS translocates to the external leaflet during early 
apoptosis resulting in the loss of membrane asymmetry. Fluorochrome-labeled Annexin V 
therefore can be used to identify apoptosis cells. Double staining between Annexin V and PI, 
which determines membrane permeability, can be used to quantify the population of healthy 
cells (Annexin V negative / PI negative), early apoptotic cells (Annexin V positive / PI 
negative), necroptotic cells (Annexin V negative / PI positive), and secondary apoptotic cells 
(Annexin V positive / PI positive) as shown is Figure 2-1. 
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Figure 2-1 : Annexin V/ PI staining plot of apoptotic and necroptotic cells 
Jurkat cells were treated with anti-Fas antibody in combination with either 
cyclohexamide only (apoptosis induction) or cyclohexamide/zVAD (necroptosis induction) for 
10 hours. Cells were stained with Annexin V-EGFP and PI, and analyzed by FACS using 
FL1 (Annexin V) and FL3 (PI) channels. Boxes highlight the population of Annexin V+/PI− 
apoptotic and Annexin V-/PI+ necroptotic cells  
This assay was performed using Annexin V-FITC and PI Apoptosis detection kit 
(eBioscience). The supernatant (containing floating cells) and adherent cells were harvested, 
centrifuged (1700rpm, 7 minutes) and washed once in PBS by gentle shaking. Cells were 
then resuspended in 97.5 μl 1x binding buffer. 2.5 μl Annexin V-FITC was added to the cell 
suspension and incubated for 10 minutes at room temperature. Cells were further washed in 
PBS and resuspended in 190 μl of 1x Binding Buffer containing 10 μl  PI (20 μg/ml). Cells 
were analysed by Flow cytometor (BD Biosciences) using the FL-1 channel. 
Figure is reprinted from (Miao & Degterev, 2009).  
 
2.8  ROS measurement 
2.8.1  2’,7’ –dichlorofluorescein diacetate (DCFDA) staining 
 Hydroxyl, peroxyl and other reactive oxygen species (ROS) within the cell were 
measured using 2‟,7‟ –dichlorofluorescein diacetate (DCFDA). After passing through the cell 
membrane, DCFDA is deacetylated by cellular esterases to a non-fluorescent compound, 
which is later oxidised by ROS into a highly fluorescent compound, 2‟, 7‟–dichlorofluorescin 
(DCF). This compound can be detected by fluorescence spectroscopy with maximum 
excitation and emission spectra of 495nm and 529nm, respectively. 
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This assay was performed using DCFDA (Sigma-Aldrich). The supernatant 
(containing floating cells) and adherent cells were harvested, centrifuged (1700rpm, 7 
minutes) and washed once with PBS. Cells were then stained with 20 μM incubated for 30 
minutes in 5% atmospheric CO2 at 37 ℃ humidified incubator. Cells were further 
resuspended in 200 μl PBS. Finally, cells were analysed by Flow cytometer (BD 
Biosciences) using the FL-1 channel 
2.8.2  MitoSOX staining  
Mitochondria ROS activity within the cell was measured by MitoSOX (Molecular 
Probe).The supernatant (containing floating cells) and adherent cells were harvested, 
centrifuged (1700rpm, 7 minutes) and washed once with PBS. Cells were then stained with 5 
μM MitoSOX and incubated in the dark for 10 minutes in 5% atmospheric CO2 at 37 ℃ 
humidified incubator. Cells were further washed with PBS and resuspended in 200 μl PBS. 
Finally, cells were analysed by Flow cytometor (BD Biosciences) using the FL-2 channel. 
Note that 50 µM menadione was added directly to the cells in incubation buffer (PBS) and 
incubated for 10 minutes in the incubator as a positive control of this assay.  
 
Table 2-5 : Flow cytometry setting for apoptosis assay  
stainning assay FL channel 
number 
of cells 
FACS setup 
ssc FL1 FL2 FL3 
DiOC6+PI 
cell death/ 
apoptosis 
DiOC6 (FL1), 
PI(FL3) 
5000 245 245 450 370 
Annexin V-
FITC/PI 
necroptosis, 
apoptosis  
Annexin V-
FITC(FL1)/PI(FL3) 
10000 245 245 450 370 
DFHDA 
ROS 
production 
FL1 5000 245  
200 
linear 
1.5Amp 
450 370 
 
Note that all experiments were plotted in a logarithmic scale except DFHDA staining, which 
was plotted in a linear scale.   
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2.9  FRET efficiency ratio of YFP-SDHB acceptor and CFP-SDHD donor 
2.9.1 Plasmid vectors construction  
To elucidate the association and dissociation of SDHB and SDHD, which are the 
components of complex II of the respiratory chain, the novel technique relying on FRET 
efficiency ratio between CFP-SDHD donor and YFP-SDHB acceptor was developed in our 
lab (Hwang et al, 2014).   
  A set of specific primers was designed to amplify the PCR fragment encoding CFP 
and SDHD for CFP-SDHD donor fusion protein; YFP and SDHB for YFP-SDHB acceptor 
fusion protein. The peptide linker GGSGG (ggtggttctggtggt) was inserted in the fusion site of 
both FRET constructs to allow flexibility. Every primer contained the recognition site of the 
appropriate endonuclease restriction enzyme (EcoRI at 5‟ end, NotI at the 3‟ end of the DNA 
cassette) for cloning into pcDNA3.1 vector (Invitrogen). In addition, the translational stop 
codon was also integrated into 5‟ end of reverse primer. The cartoon of YFP-SDHB acceptor 
and CFP-SDHD donor constructs is shown in Figure 2-2 and the information of primers is 
shown in Table 2-6. 
 
 
 
 
 
 
Figure 2-2 : YFP-SDHB acceptor and CFP-SDHD donor constructs for FRET 
experiment  
MT sequence represents the N-terminal mitochondrial-targeting sequence that is cleaved off 
upon the protein‟s import into mitochondria. The FRET donor construct is composed of CFP 
fused to the N-terminus of SDHD. In addition, the sequence of the mature SDHD sequence 
was duplicated on the N-terminus of CFP following the MT sequence to ensure efficient 
cleavage site recognition. The FRET acceptor construct consists of YFP fused to the C-
terminus of SDHB via a linker sequence.  
  
  
 
CFP SDHD
linker
MT
SDHB YFP
linker
MT
SDHD
FRET Acceptor Construct 
FRET Donor Construct 
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 PCR amplification of each gene was performed using specific pairs of primers (forward 
and reverse primers) corresponding to the 5‟ and 3‟ end of the genes. The PCR was 
performed with PhusionTM DNA polymerase (Thermo Fisher Scientific) and PCR products 
were further digested with specific endonuclease restriction enzymes and ligated into 
pcDNA3.1 vector.  
 
Table 2-6 : Primers in FRET experiments 
gene primer sequence 
SDHD 
(upper) 
forward 5‟-ACTCTCGAATTCGCCGCCACCATGGCGGTTCT-3‟ 
reverse 5‟-CTCCTCGCCCTTGCTCAACATTGCAGCCTTGGAGC-3‟ 
SDHD 
(lower) 
forward 5‟-ACCGCCGCCGGTGGTTCTGGTGGTTCTGGCTCCAAGGCT-3‟ 
reverse 5‟-GAAGATGCGGCCGCCTAGAGCTTCCACAGCATG-3‟  
CFP 
forward 5‟-CACCATTCTGGCTCCAAGGCTGCAATGTTGAGCAAGGGCG-3‟ 
reverse 5‟-CTTGGAGCCAGAACCACCAGAACCACCGGCGGCGGTCAC-3‟ 
SDHB 
forward 5‟-ACTCTCGAATTCGCCGCCACCATGGCGGCG-3‟ 
reverse 5‟-CTCGCCCTTGCTCACCATACCACCAGAACCACCAACTGAAG 
CTTTCTTCTCCTT-3‟ 
YFP 
forward 5‟-GAGAAGAAAGCTTCAGTTGGTGGTTCTGGTGGTATGGTGA 
GCAAGGGC-3‟ 
reverse 5‟-GAAGATGCGGCCGCCTAGCCGAGAGTGATCCC-3‟ 
 
2.9.2   FRET efficiency calculation 
HeLa cells, stably expressing CFP-SDHD donor and YFP-SDHB acceptor were 
generated by infection with lentiviral particles, which produce the fusion proteins.  FRET was 
elucidated using the generated CFP-SDHD donor and YFP-SDHB acceptor fusion proteins 
with the Leica TCS SP5 Confocal and its respective FRET Sensitised Emission (SE) Wizard. 
The FRET efficiency was calculated using the Leica protocol with a specific equation.  
EA(i) = (B-Aβ-Cγ)/C 
EA(i) :  FRET efficiency  
A :  intensity of donor signal 
B :  intensity of FRET signal 
C :  intensity of acceptor signal 
α, β, and γ are the calibration factors generated by acceptor only and donor only  
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 FRET channels were defined first by the simultaneous excitation and detection of the 
donor and acceptor (Donor = CFP excitation 458 nm; emission 462-510 nm; Acceptor = YFP 
excitation 514 nm; emission 518-580 nm). The acceptor channel was likewise defined by 
reducing the donor excitation light down to 0% (the step by step protocol can be found 
at:https://workspace.imperial.ac.uk/imagingfacility/public/Leica-FRET_SE 
Application_Letter_20.EN.pdf). An average set of six start measurements of FRET efficiency 
were made along with an average set of six end measurements. The FRET efficiency ratio 
was calculated as the percent change between an average FRET efficiency of start 
measurements and such of end measurements. The FRET efficiency ratio was normalised 
to a set of calculations done on 4% formaldehyde fixed cells.    
2.10  Neo-epitope C-terminal p20Bap31 antibody production 
To develop a novel antibody that recognises only the pro-apoptotic cleavage form of 
Bap31 (p20Bap31), a novel technique developed by Dr. Robert Edwards, our colleague at 
Imperial College, was applied. According to his study (Robert J. Edwards et al, 2007) it was 
found that five amino acids at the C-terminus of proteins are enough to generate a specific 
antibody of those particular proteins and pivotal for its specificity. Therefore, five amino acids 
of the C-terminus of p20Bap31, GAAVD, were used to design a peptide to raise this antibody 
in rabbits. To prevent non-specificity of this antibody, this amino acid sequence was blasted 
with other caspase substrates in Casbah (The CAspase Substrate dataBAse 
Homepage)http://bioinf.gen.tcd.ie/casbah/. Fortunately, no other caspase substrates 
completely matched with p20Bap31 (detail in Table 2-7).  The peptide synthesis and 
antibody production procedure were done by EuroGentec Company. 
Table 2-7 :  Amino acid sequence blast with caspase substrate database 
c-terminal sequence number of caspase substrate  
GAAVD p20Bap31 
AAAVD 2 (hnRNP1(nucleus), 
protein 4.1 (erythrocyte)  
- - AVD 10 
- - - VD 124 
- - - - D 760 
- A - VD 4 
- AA - D 1 
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2.11  Immunofluorescence 
Immunofluorescence assay and flow cytometry analysis were used to quantify the 
population of cells with pro-apoptotic p20Bap31 positive signal. HeLa cells were probed with 
C-terminal p20Bap31 primary antibody (EuroGentec). The supernatant and adherent cells 
were harvested, centrifuged (1700rpm, 7 minutes), and fixed in 4% PFA (Thermo Scientific) 
in PBS for 20 minutes at 4C. Cells were permeabilised in PBS-S (PBS with 0.02% w/v 
saponine) and blocked in 3% BSA in PBS-S for 20 minutes in 5% atmospheric CO2 at 37℃ 
humidified incubator. Cells were then incubated with different dilutions of primary antibody 
from 1:500 to 1: 10000 for 1 hour in the incubator to determine the best dilution in term of 
high specificity and low background for further study. Cells were further washed with PBSS 
three times prior to incubating with Alexa Fluor® 488 goat anti-rabbit IgG secondary 
antibody (A11034, Invitrogen) at 1: 500 dilution for 1 hour in the incubator. Cells were also 
further washed with PBSS two times prior to flow cytometry analysis using the FL-1 channel.  
The percentage of cells with p20Bap31 was quantified by FlowJo software.   
 
2.12  Immunoprecipitation (IP) 
2.12.1 General immunoprecipitation 
Immunoprecipitation was performed to investigate the interaction of interested 
proteins using PureProteome magnetic protein G beads (LSKMAGG10, Millipore).To pull 
down endogenous proteins, for every IP reaction, three T175 flasks of HeLa cells were 
cultured, treated or transfected with the protein/gene of interest depending on the respective 
experiments prior to the pull-down procedure. The floating and adherent cells were 
harvested, centrifuged (1700rpm, 7 minutes), and washed once with PBS. Per IP reaction, 
500 μl cold RIPA (150 mM NaCl, 1% NP40, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS, 
50 mM Tris-HCl; pH 8.0) with protease inhibitor cocktail (Fermentas) was added to the cell 
pellet and lysed well by pipetting up and down with 200 μl pipette tip. The cell lysate was 
incubated on ice for 20 minutes prior to centrifugation at 13000 rpm for 15 minutes. To 
equilibrate protein G magnetic bead, 60 µl protein G magnetic beads was washed with 900 
µl RIPA buffer and PureProteome™ Magnetic Stand (LSKMAGS08, Millipore) was then 
used to aspirate RIPA buffer. 5 mg of total protein per IP reaction was incubated with 
equilibrated beads on a rotator for 30 minutes at 4C to reduce non-specific interaction. 10 
µg of antibody was incubated with the protein lysate on a rotator overnight at 4C. Proteins 
along with antibody were incubated with equilibrated beads on a rotator for 4-6 hours at 4C. 
Beads were washed three times with 900 µl cold RIPA buffer by incubating on the rotator for 
10 minutes at 4 C for each wash. 45 µl 2x Sample Loading Buffer (diluted from 4x Sample 
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Loading Buffer(40% glycerol, 4% lithium dodecyl sulfate (LDS),4% Ficoll™ 400, 0.8 M 
triethanolamine-Cl pH 7.6, 0.025% phenol red, 0.025% coomassie G250, 2mM EDTA 
disodium) (84788, Thermo Scientific))was added to the beads and boiled at 96C for 8 
minutes. The supernatant was separated from the beads and kept at -20C until protein 
analysis. Note that PureProteome™ Magnetic Stand was used to separate protein lysate 
from the magnetic beads in all steps. 
2.12.2     Crosslink immunoprecipitation  
Crosslink Immunoprecipitation was performed to investigate the interaction of 
interesting proteins without antibody contamination. Pierce® Crosslink Immunoprecipitation 
Kit (26147, Thermo Scientific) was used by covalently crosslinking antibodies onto Protein 
A/G resin. To pull down endogenous proteins, per one IP reaction, three T175 flasks of HeLa 
cells were cultured, treated or transfected with the protein/gene of interest depending on the 
experiments prior to the pull-down procedure. The floating and adherent cells were 
harvested, centrifuged (1700rpm, 7 minutes), and washed once with PBS. 300-400 μl of cold 
IP Lysis buffer (0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 1% NP-40, 5% glycerol; pH 7.4) 
with 1x protease inhibitor cocktail was added to cell pellet and lysed well by pipetting up and 
down with 200 μl pipette tip. The cell lysate was incubated on ice for 15 minutes prior to 
centrifugation at 13000 rpm for 15 minutes. 10 μg of antibody was bound and crosslinked to 
Protein A/G Plus Agarose (Thermo Scientific) in a Pierce Spin Column (Thermo Scientific) 
according to the product manual. 5 mg of total protein per IP reaction was incubated with 
antibody-crosslinked resin in the column. The column was gently mixed on the rotator 
overnight at 4C. Interacting proteins were eluted with 50 μl Elution Buffer (26147, Thermo 
Scientific) from the column. Protein lysate was diluted with 4x Sample Loading Buffer 
(Thermo Scientific) in the presence of -mercaptomethanol (final concentration of 2.5 % v/v) 
(Sigma-Aldrich) and boiled at 96C for 8 minutes. Proteins were kept at -20C until analysis.  
 
2.13    Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and 
Immunoblotting  
2.13.1   Preparation of whole cell lysate  
The floating and adherent cells were harvested, centrifuged (1700 rpm, 7 minutes), 
and lysed in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% w/v sodium deoxycholate, 0.1% 
w/v SDS, 50 mM Tris-HCl; pH 8). Total cell lysate was centrifuged at 13000 rpm for 10 
minutes at 4C. The supernatant was transferred to a new tube and stored at -20C until 
analysis. Protein lysate was diluted with 4x Sample Loading Buffer (Thermo Scientific)in the 
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presence of -mercaptomethanol (final concentration of 2.5 % v/v) (Sigma-Aldrich) and 
boiled at 96C for 8 minutes. Proteins were kept at -20C until analysis.  
2.13.2 Protein concentration measurement 
Protein concentration was measured using the Bradford Assay (500-0006, BioRad) in 
a flat-bottom 96-well plate. The absorbance of each well was measured at 595 nm using 
FLUOstar OPTIMA (BMG Labtech). The resulting absorbance were plotted against a BSA 
standard curve and calculated back to the protein concentration. 
2.13.3 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
     Protein lysate was separated by SDS-PAGE (separating gel: 10-15% 
polyacrylamide, 375 mM Tris-HCl, pH8.8, 0.1% SDS, 0.1% APS, 0.05% TEMED; stacking 
gel: 4.8% polyacrylamide, 125 mM Tris-HCl, pH6.8, 0.1% SDS, 0.1% APS, 0.1% TEMED) 
(protein gel recipes were shown in Table 2-8. The protein profile was resolved in 1x 
Tris/Glycine/SDS (TGS) buffer (25mM Tris, 192mM Glycine and 0.1% w/v SDS; pH 8.3     
(Bio-Rad) at constant voltage. PageRuler™ pre-stained proteinladder (Fermentas) was used 
for the protein size estimation. Proteins were transferred to 0.45 μm PVDF membrane 
(Millipore) by semi-dry Electroblotting (Bio-Rad) with transfer buffer (20 % methanol in PBS 
buffer) at constant 500 mA and 20 limited voltage for 90 minutes and 60 minutes for two gels 
and one gel, respectively.  
 
 
 
 
 
 
 
 
 
 
 
88 | P a g e  
 
Table 2-8 : Component of SDS-PAGE for protein analysis  
solution 
stacking (ml) separating (ml) 
6% 10% 12% 15% 
40% acrylamide 0.34 2.5 3.0 3.75 
H2O 1.9 3.7 3.2 2.45 
0.5 M Tris-HCl pH 6.8 0.75 - - - 
1.5 M Tris-HCl pH 8.8 - 3.75 3.75 3.75 
10% SDS 0.030 0.1 0.1 0.1 
10% APS 0.009 0.1 0.1 0.1 
TEMED 0.005 0.01 0.01 0.01 
total volume 3.00 10.00 10.00 10.00 
 
Acrylamide : N,N‟-methylene-bis-acrylamide 30:1 (w/w) 
APS         =   ammonium persulphate 
TEMED   =   N,N,N‟,N‟-tetramethyl-ethylenediamine 
 
 
2.13.4   Immunoblotting  
The membranes were blocked with 3% BSA (Sigma-Aldrich) in PBS (Sigma-Aldrich) 
containing 0.1% Tween (Sigma-Aldrich) (PBS-T) for 1 hour. The primary antibody diluted in 
1.5% BSA in PBS-T (dilution in Table 2-9) was incubated with shaking on the membrane at 
25C for 1 hour. The membrane was then washed with PBS-T three times (10 minutes 
each). The membrane was further incubated with horseradish peroxidase-conjugated 
isotype-matched secondary antibody (dilution in Table 2-9) at 25C for 1 hour. The 
membrane was washed three times as mentioned above and incubated with enhanced 
chemoluminescent (ECL) reagent (Pierce®) for one minute 30 seconds and subjected to 
autoradiography using Hyperfilm ECL (GE Healthcare).          
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Table 2-9 : Primary and secondary antibodies for immunoblotting 
Antigen Source Clonality Dilution Company Cat. no 
Protein 
size (KDa) 
Bap31 Rabbit polyclonal 1: 3000 ProteinTech 11200-1 28 
C-ter p20Bap31 Rabbit polyclonal 1: 500 
custom antibody            
(Euro Gentec) 
- 20 
Fis1 Rabbit polyclonal 1 :1000 Self-made - 17 
caspase-8 mouse monoclonal 1: 1000 
Enzo 
Lifesciences 
ALX-804-429 56 
caspase-8 mouse monoclonal 1: 1500 Cell Signaling 9746 
56, 43/41, 
18 
Bcl-XS/L mouse monoclonal 1: 1000 
Santa Cruz 
Biotechnology 
sc-23958 30 
Bcl-2 mouse monoclonal 1: 1000 
Santa Cruz 
Biotechnology 
sc-7382 
 
26 
Bax rabbit polyclonal 1: 500 santa cruz sc-493 23 
BIK rabbit polyclonal 1: 500 GeneTex GTX59922 17 
BID rabbit polyclonal 1: 500 Cell Signaling 2002 22 
Bad mouse monoclonal 1: 500 santa cruz C-7, sc-8044 25 
PARP rabbit polyclonal 1: 1000 Cell Signaling 9542S 116,89 
Flip mouse monoclonal 1: 500 
Enzo Life 
Sciences 
ALX-804-428 55 
RIP mouse monoclonal 1: 500 BDbioscience BD610459 74 
GAPDH mouse monoclonal 1: 1000 
Santa Cruz 
Biotechnology 
SC-32233 36 
SDHA mouse polyclonal 1: 1000 
Santa Cruz 
Biotechnology 
sc-166909 70 
CHOP/GADD153 mouse monoclonal 1: 500 Abcam Ab11419 31 
HA 
mouse 
mono 
monoclonal 1: 1000 Sigma-Aldrich H3663  
Flag rabbit polyclonal 1: 1000 Sigma-Aldrich F7425  
GFP HRP Rabbit polyclonal 1: 1000 
Santa Cruz 
Biotechnology 
SC-8334 
 
 
Mouse HRP Goat  1:3000 Invitrogen G21040  
Rabbit HRP Goat  1:10000 Sigma-Aldrich A0545  
Goat HRP Rabbit  1:30000 Sigma-Aldrich A5420  
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2.14   Production of lentiviral particles  
2.14.1   Viral particles production 
Lentiviral particles, which express shRNA of scrambled (negative control), Fis1, 
Bap31, caspase-8 (sequence in Table 2-3) was produced in HEK293FT cells (Invitrogen). 
pLKO.1 puro vector (Sigma-Aldrich) expressing these genes combination with plasmids 
encoding Vesicular Stomatitis Virus Glycoprotein (pVSV-G), group antigen and reverse 
transcriptase (pGag.Pol) and mRNA export helper protein (pRev) isolated from ViraPower™ 
lentiviral packaging mix (Invitrogen) were transfected into the cells. 293FT cells were plated 
onto 10cm2 dishes so that the plate would be approximately 50-60% confluent on the day of 
transfection. 5.4μg of the pVSV-G, 3.8μg of the pRev, 7.8μg of the pGag.Pol, 9μg of the 
pAdVantage and 20μg of the lentiviral recombinant plasmid were mixed well with H2O to 
achieve a final volume of 437.5 μl. 62.5μl of 2M CaCl2 was then added to the mixture, mixed 
thoroughly and incubated for 5 minutes. In another tube, 500 μl of 2x HBS (50mM HEPES, 
281mM NaCl, 1.5mM Na2HPO4; pH 7.08-7.1) was aliquoted into 15-ml falcon tube. The 
DNA/CaCl2 mixture was added drop by drop to 2x HBS tube while it was vigorously shaken 
on a vortex machine. This mixture was added drop-wise to the dish. The culture medium 
with 1 mM sodium butyrate (Sigma-Aldrich) was replaced after 16 hours transfection. Note 
that sodium butyrate stock was prepared fresh in PBS in every experiment. After 2 to 3 days 
post transfection, the supernatant was harvested and centrifuged (1800 rpm, 10 minutes) to 
remove cells and large debris, then passed through a 0.45μm sterile filter. 
 
2.14.2  Stable cell line production 
To infect HeLa cells with the virus, cells were seeded into 6-well plate on the day 
before infection to achieve 30% confluence on the day of infection. On the day of infection, 
cells were transduced with the viral supernatant supplemented with 1μg/ml of Polybrene® 
(Sigma-Aldrich) for 24 hours. Then, fresh medium was added to the infected cells prior to 
selection. The infected HeLa cells were selected with 4 μg/ml puromycin (Sigma-Aldrich) for 
2 days. Note that non-transfected HeLa cells were used as a negative control to verify the 
concentration of puromycin that can kill all of the cells. A concentration of 1μg/ml of 
puromycin was used for long-term culture of infected cells.  
 
 
2.15  Cytosolic and mitochondrial calcium using Fluo-4/AM or Rhod-2/AM  
 To measure the cytosolic and mitochondrial calcium level, Fluo-4/AM and Rhod-
2/AM, which are membrane non-permeable and permeable fluorogenic probes for 
intracellular Ca2+, were used to stain HeLa cells prior to flow cytometry analysis. Fluo-4/AM 
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andRhod-2/AM are calcium indicators and their fluorescence intensity increases upon 
binding Ca2+ in fluorescence excitation at 488 nm and 552nm, respectively.   
On the day of investigation, cells were harvested, resuspended in PBS containing 
2μM of Fluo-4/AM (Molecular Probes) and 1.0μg/ml of Rhod-2/AM (Molecular Probes) and 
incubated for 45 minutes in 5% atmospheric CO2 at 37 ℃ in a humidified incubator with 
frequent agitation. Cells were then washed twice with PBS and further analysed by flow 
cytometry (BD Bioscience) using the CellQuest programme (BD Biosciences). Under the 
“Acquisition & Storage” dialog box, Time Parameter was used instead of Event Counter.  
The time resolution of 500msec was used throughout the experiment. The parameter setting 
used was as follows: FSC (7.00), SSC (238), FL-1(530), FL-2(450), FL-3 (370) for Fluo-4/AM 
and FSC (7.00), SSC (238), FL-1(530), FL-2 (620), FL-3 (370) for Rhod-2/AM.   
Kinetic analysis was performed with the FlowJo programme (Tree Star Inc.). The 
relative cytosolic and mitochondrial calcium concentration was calculated from the average 
of Fluo-4/AM or Rhod-2/AM fluorescence intensity. The relative calcium concentration was 
calculated as a percentage of -gal transfected (negative control) population, which was set 
to 100. Note that PBS used in the experiment was calcium or magnesium free. FL-1 
channels in Fluo-4/AM and FL-2 channels in Rhod-2/AM experiment were in a linear scale 
rather than in a logarithmic scale.   
 
2.16  Densitometry analysis (Image J) 
A scanned image of a western blot was opened with ImageJ programme and 
inverted from black to white colour. The band of interest was selected with the rectangular 
tool. The intensity of the band was analysed and subtracted with the intensity of the 
background.   
 
2.17  Alzheimer’s disease (AD) tissue samples 
Pro-apoptotic p20Bap31 expression level in Alzheimer‟s disease tissue samples was 
analysed by western blot with the C-terminal p20Bap31 antibody. Alzheimer‟s disease tissue 
samples with their details such as age, sex, post-mortem delay (hour) were obtained from 
London Neurodegenerative Diseases Brain Bank through the cooperation of Dr. 
Magdalena Sastre, Imperial College.   
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2.18  Statistical analysis  
Statistical analysis was performed using unpaired student‟s t-test. Two samples were 
regarded to have an equal variance when the t-test between two sample sets gave p>0.05. 
Data were regarded as statistically significant (*** if p<0.001, ** if p<0.01, * if p<0.05) based 
on the t-test.  
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Chapter 3 
BclXL/ Bcl-2 dissociate from the ARCosome complex for 
cell death induction 
 
3.1 Introduction 
3.1.1 Interaction among Bcl-2 family members and other proteins for cell death control 
 Bcl-2 family proteins play an important role in cell death control initiated by both 
intrinsic and extrinsic stimuli (Danial & Korsmeyer, 2004). The anti-apoptosis role of these 
proteins at the outer mitochondrial membrane (MOM) has been well characterised. At this 
location, the activation and oligomerisation of Bax and Bak results in MOM permeabilisation 
and release of pro-apoptotic intermembrane factors such as cytochrome c (cyt.c)(Liu et al, 
1996; Lomonosova & Chinnadurai, 2008). Cyt.c then binds to APAF-1, which recruits 
caspase-9 to form the Apoptosome (Acehan et al, 2002; Srinivasula et al, 1998; Stennicke et 
al, 1999; Zou et al, 1999). Anti-apoptotic Bcl-2 proteins were shown to inhibit Bax/Bak 
oligomerisation (Chipuk et al, 2010; Yip & Reed, 2008). In contrast, proapoptotic BH3-only 
members of the Bcl-2 family induce Bax/Bak activation by either directly activating Bax/Bak 
oligomerisation or by neutralising the inhibitory effect of anti-apoptotic Bcl-2 family members 
(Chipuk et al, 2008; Gallenne et al, 2009; Kim et al, 2006; Kuwana et al, 2005; Letai et al, 
2002). Conversely, the anti-apoptotic Bcl-2 proteins promote cell survival through 
sequestration of the apoptosis activator “BH3-only” proteins (Brunelle & Letai, 2009; Kim et 
al, 2009; Shore & Nguyen, 2008).  
 In addition to the anti-apoptotic role of Bcl-2 family members at the mitochondria, 
their apoptotic inhibitory effect at the ER was also found to regulate ER calcium (Ca2+) stores 
and/or signalling (Heath-Engel et al, 2008; Rong & Distelhorst, 2008). The best-
characterised ER-restricted BH3-only protein is the p53-inducible protein Bik (Germain et al, 
2005; Germain et al, 2002; Mathai et al, 2002; Mathai et al, 2005). Induction of Bik results in 
ER Ca2+ release, mitochondria Ca2+ uptake, followed by organelle fission and cristae 
remodeling (Germain et al, 2005). ER-restricted Bcl-2 can inhibit Bik-initiated ER Ca2+ 
release through the inhibition of Bak oligomerisation at the ER (Mathai et al, 2005). High 
levels of Bik expression can overcome the Bcl-2 rescue effect and Bik was shown to bind 
Bcl-2 but does not directly activate Bax/Bak (Boyd et al, 1995; Chen et al, 2005b; Elangovan 
& Chinnadurai, 1997; Han et al, 1996; Kim et al, 2006; Letai et al, 2002). Interestingly, Bik 
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was also found to disrupt the interaction between Bcl-2 and Bak at the ER (Heath-Engel, 
2010). Hence, the interaction among Bcl-2 family members controls not only mitochondrial 
apoptosis, but also ER apoptosis signalling. However, the question how Bcl-2 family 
members regulate the release of ER Ca2+ and ER proteins has been a challenge to the field. 
Anti-apoptotic Bcl-2 proteins were shown to interact with the IP3R ER Ca
2+ release channel 
(Rong & Distelhorst, 2008); therefore, one possibility is that this interaction might be involved 
in the apoptosis repression exerted by these factors. However, a causal relationship 
between Bax/Bak oligomerisation and the release of luminal proteins and/or Ca2+ has yet to 
be demonstrated. It is possible that Bax/Bak oligomerisation at the ER might play a role in 
the formation of large, non-selective pores for the release of luminal proteins and/or Ca2+.In 
order to investigate the above question, Bcl-XL and Bcl-2 were shown to dissociate from the 
ARCosome complex upon etoposide treatment- and Fis1 upregulation-induced cell death. 
This dissociation, my work shows, allows caspase-8 recruitment and activation for apoptosis. 
Hence, the results presented in this chapter demonstrate the role of Bcl-XL and Bcl-2 in 
ARCosome activation and apoptosis inhibition. They could play a vital role in keeping the 
pre-formed ARCosome inactive in healthy cells. 
 
3.1.2  C.elegans CED-4 in cell death control and its comparison to Apaf-1 in mammals  
 Comparing cell death control in C. elegans and mammals has been studied by a 
large number of researchers in the cell death field. Although mammalian signalling pathways 
are more diverse, homologous genes in C.elegans in the apoptosis signalling pathways were 
identified. The anti-apoptotic CED-9, for example, corresponds to anti-apoptotic Bcl-2 family 
members (Hengartner & Horvitz, 1994; Vaux et al, 1992); the pro-apoptotic CED-4 protein is 
homologous to the caspase adaptor protein Apaf-1; and CED-3 is similar to initiator 
caspases in mammals; EGL-1 resembles BH3-only proteins of the Bcl-2 family (Table 3-1).In 
C. elegans, the activation of CED-3, a representative of a caspase protease family, requires 
the adaptor protein CED-4. In healthy cells CED-4 is sequestered by CED-9 (the mammalian 
Bcl-2 homolog). In dying cells, on the other hand, EGL-1 (the mammalian BH3-only protein 
analog) binds to CED-9 and this leads to CED-4 release from the complex. CED-4 octamers, 
which are formed after releasing from CED-9, then recruit two molecules of CED-3 to the 
complex and this facilitates CED-3 dimerisation and activation of its protease activity (Figure 
3-1). Apaf-1 is a 130 KDa protein that was identified as a CED-4 homolog from HeLa cell 
cytosol. It was shown that 320 amino acids in the centre of the Apaf-1 sequence display 22% 
identity and 48% similarity to CED-4 (Zou et al, 1997). Bcl-2 was shown to inhibit the 
association of caspase-9 with Apaf-1 to form the Apoptosome for effector caspase activation 
(Hu et al, 1998). (Hu et al, 1998; Huang et al, 1998; Pan et al, 1998b). Although Apaf-1 was 
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identified as a CED-4 homolog protein, there are some important differences between Apaf-
1 compared to CED-4 in C. elegans (see Discussion).   
 
 
Table 3-1 :  Cell death proteins between C. elegans and mammals 
Function C. elegans Mammals 
Anti-apoptotic Bcl-2 family  Ced-9  Bcl-2, Bcl-XL, etc  
Caspase activator  Ced-4  Apaf-1  
Initiator caspase  Ced-3  Caspase-1, -2, -8, -9  
BH3-only protein of the Bcl-2 
family  
Egl-1  Bid, Bim, Puma, Noxa, etc  
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Figure 3-1 : Models for Bcl-2 survival activity in C. elegans and mammals 
(A)  C. elegans: sequestration of a caspase activator  
CED-9, the Bcl-2 homolog, binds the adaptor protein CED-4 and prevents CED-4 to activate 
CED-3 initiator caspases homolog. In cell death conditions, EGL-1 (mammalian BH3-only 
protein analog) binds to CED-9 and this leads to CED-4 to release from the complex. CED-4 
recruits CED-3 to the complex and this activates its protease activity.  
(B) Mammals: protection of mitochondrial integrity. 
Anti-apoptotic Bcl-2 proteins maintain mitochondrial membrane integrity by preventing 
Bax/Bak oligomers forming by neutralising BH3-only proteins.  Bax/Bak homo-oligomers at 
the outer mitochondrial membrane result in the release of cytochrome c, which activates 
Apaf-1, allowing it in turn to activate caspase-9. Omi and Diablo, which antagonise inhibitor 
of apoptosis proteins (IAPs), are also released from the mitochondria for apoptosis.  
Figure is reprinted from (Cory & Adams, 2002). 
 
(A) 
(B) 
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2.2  Results 
 
3.2.1 Bap31 and caspase 8 are required for Fis1-induced cell death. 
The mammalian mitochondrial fission protein, Fis1, was first identified in 2003 as a 
pro-apoptotic protein and plays an important role in mitochondrial fragmentation (James et 
al, 2003). Fis1 was also isolated from our genetic screening from apoptosis 
inducers(Albayrak & Grimm, 2003). In this and a previous study, the mechanism of Fis1-
induced apoptosis has been studied. In 2011, we found that the Fis1-Bap31 complex 
(ARCosome) acts as a platform forcaspase-8 activation and Bap31 cleavage into the pro-
apoptotic p20Bap31. This induces Ca2+ release from the ER, its mitochondrial uptake, and 
eventually apoptosis (Iwasawa et al, 2011). Since Fis1 can promote both fission and 
apoptosis in the mammalian system (James et al, 2003), the questions whether Fis1 induces 
apoptosis and mitochondria fission through genetically distinct pathways and whether cell 
death is due to ARCosome activation not fission per se were addressed. 
 To answer this question, Fis1-induced apoptosis was tested in scrambled control, 
Bap31-, and caspase-8-stable knockdown Hela cells. Cells were harvested and stained with 
DiOC6 and PI for cell death 20 and 30 hours post-transfection. The percentage of the 
population with DiOC6-negative and PI-positive cells within each sample was taken as dead 
cells. After 20 hours of Fis1-upregulation, 7.7% and 6.8% of Bap31 and caspase-8 HeLa 
stable knockdown cells, respectively, underwent cell death while 18.3% of the cells died in 
the control group (scrambled knockdown) (Figure 3-2A). Following 30 hours of Fis1 
overexpression, the percentage of dead cells was also significantly reduced in Bap31 and 
caspase-8 stable knockdown HeLa cells (54.4% and 56.4%, respectively) compared to the 
control cells (72.2%) (Figure 3-2A). In addition, to address the question whether caspase-8 
is activated in Fis1-induced cell death, its activation was measured using an assay with the 
specific inhibitor of caspase-8 FAM-LETD-FMK. The percentage of cells with activated 
caspase-8 was quantified via FACS 30 hours post Fis1 transfection. Again, the percentage 
of cells with activated caspase-8 was significantly lower in Bap31 and caspase-8 stable 
knockdown HeLa cells compared to the control cells. 41.7% and 44.2% of the cells died in 
Bap31 and caspase-8 HeLa stable knockdown cells, respectively, while 59.4% did in the 
control group. The down-regulation of Bap31 and caspase-8 was confirmed via western blot 
(Figure 3-2).  
  Moreover, the question which caspases are required for cell death upon ectopic Fis1-
upregulation was investigated. HeLa cells were transfected with Fis1 in the absence and 
98 | P a g e  
 
presence of caspase inhibitors, namely the pan-caspase inhibitor zVAD (50 μM), the 
caspase-8 inhibitor Z-IETD-FMK (50 μM), the caspase-3 inhibitor Z-DEVD-FMK (20 μM), 
and the caspase-9 inhibitor Z-LEHD-FMK (20 μM). Cells were harvested 24 hours post-
transfection and stained with DiOC6 and PI for cell death as before.  Significantly decreased 
cell death was observed in Fis1-transfected cells treated with the pan-caspase and the 
specific caspase-8 inhibitor (Figure 3-3). In addition, it appears that there was a partial 
rescue effect in cells treated with the caspase-3,-9 inhibitor (Figure 3-3). This data indicates 
that caspase-8 is required for Fis1-induced cell death. Caspase-3 and -9 might also play a 
role in this pathway as part of downstream steps of the caspase activation cascade induced 
by caspase-8.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2 :  Bap31 and caspase-8 are required for Fis1-induced cell death. 
(A) Scrambled, Bap31, caspase-8 stable knockdown HeLa cells were transfected with Fis1 
and harvested at 20 and 30 hours post-transfection (left panel). p20Bap31 and caspase-2 
were used as a positive control for cell death induction (right panel). Cells were harvested 
and stained with DiOC6 and PI for cell death. The FACS results were used to determine the 
percentage of dead cells (DiOC6-negative and PI-positive) within each sample. (B) Caspase-
8 activation was measured by CaspaTag™ caspase-8 In Situ Assay kit (Millipore) under the 
same conditions as in A. The percentage of activated caspase-8 was quantified by FACS. 
Data are presented as means ± S.D. n=3 *** p<0.001 (student‟s t-test). 
 
(B)
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GAPDH
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Figure 3-3  :  Caspase 8 is required for Fis1-induced cell death. 
HeLa cells were transfected with Fis1 in the absence (untreated, UT) and presence of 
caspase inhibitors, namely the pan-caspase inhibitor zVAD (50 μM), the caspase 8 inhibitor 
Z-IETD-FMK(50 μM), the caspase 3 inhibitor Z-DEVD-FMK (20 μM), the caspase 9 inhibitor 
Z-LEHD-FMK(20 μM). Cells were harvested at 24 hours post-transfection and stained with 
DiOC6 and PI for cell death. The FACS results were used to determine the percentage of 
dead cells (DiOC6-negative or PI-positive) within each sample. Data are presented as means 
± S.D. n=3, *** p<0.001 (student‟s t-test). 
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3.2.2 Bcl-XL and Bcl-2 inhibit Fis1-induced cell death. 
 Pro- and anti-apoptotic members of the Bcl-2 super family have been identified as 
central regulators of cell death and applied as therapeutic targets (Cotter, 2009; Ni 
Chonghaile & Letai, 2008). It was reported that Bcl-XL inhibits Fis1-induced apoptosis but not 
mitochondrial fragmentation (James et al, 2003). The rescue effect of anti-apoptotic Bcl-XL in 
Fis1-mediated apoptosis was shown in a yeast study (Fannjiang et al, 2004). The protective 
effect of Bcl-2 was also demonstrated in cell death initiated by p20Bap31 at the ER (Heath-
Engel et al, 2012). Therefore, to elucidate the mechanism of how the ARCosome is kept 
inactive in healthy cells, Bcl-XL and Bcl-2 were identified as promising targets since Bap31 
was first identified as a Bcl-2 interacting protein (Ng et al, 1997). Hence, the question 
whether Bcl-XL and Bcl-2 are key regulators for ARCosome activation was addressed.  
As a first step to determine the rescue effect of Bcl-XL and Bcl-2 for Fis1-induced cell 
death, various ratios between Fis1 and Bcl-XL or Bcl-2 - 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:3 - were 
transfected into HeLa cells and the percentage of dead cells was quantified with DiOC6 and 
PI staining using FACS as described before. It was observed that the rescue effect of Bcl-XL 
and Bcl-2 progressed in a dose-dependent manner and efficiently reduced cell death. This 
result indicates that both Bcl-XL and Bcl-2 exert an activity that strongly inhibits Fis1-induced 
cell death (Figure 3-4A, B). In addition, the activation of caspase-8 was investigated in a 
CaspaTag assay upon Bcl-XL or Bcl-2 cotransfection together with Fis1 and quantified by 
FACS. The results indicate that the activation of caspase-8 was likewise significantly 
reduced by Bcl-XL and Bcl-2. (Figure 3-5).  
In order to address the question whether ER- or mitochondrial-localised Bcl-2 lead to 
different rescue effects when co-transfected with Fis1, ER- or mitochondria-localised Bcl-2 
plasmids were we co-transfected with Fis1 in HeLa cells in a 1:1 plasmid ratio. The 
percentage of dead cells in the cell population was measured with DiOC6 and PI staining via 
FACS 24 hours post-transfection. While we detected 63.9% cell death in Fis1-upregulated 
HeLa cells, the percentage of dead cells was significantly reduced to 8.2%, 8.1%, and 22.1% 
by wild type Bcl-2, ER-localised Bcl-2, and mitochondria-localised Bcl-2 cotransfection, 
respectively (Figure 3-6A). Judged by the data, ER-localised Bcl-2 seems to exhibit a 
stronger rescue effect when compared with mitochondrial-localised Bcl-2. ER-localised Bcl-2 
might be more directly involved in the mechanism of ARCosome activation as Bap31 is also 
an ER-localised protein.  
In addition to Fis1-induced cell death, etoposide, a drug that activates the ARCosome 
(Iwasawa et al, 2011), was used to verify the Bcl-XL and Bcl-2 rescue effect. HeLa cells were 
transfected with β-gal (as a negative control), ER-localised Bcl-2, and mitochondria-localised 
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Bcl-2, and treated with 150 μM etoposide 18 hours post-transfection. Cells were harvested 
30 hours following treatment and stained with DiOC6 and PI for cell death as described 
above. The data indicates that Bcl-XL, Bcl-2, ER-localised Bcl-2 and mitochondria-localised 
Bcl-2 were able to inhibit etoposide-induced cell death to the same extent. Taken together 
and compared with the Fis1 overexpression data, we observed a weaker effect of Bcl-2 
family inhibition with etoposide treatment. Fis1 might act as a more specific inducer than 
etoposide since etoposide treatment might also activate other pathways for cell death.  
 Moreover, HeLa cells underwent cell death when either Bcl-XL or Bcl-2 was down-
regulated (data not shown). If my hypothesis is correct that Bcl-XLor Bcl-2are part of the 
complex and can inhibit caspase-8 activation and cell death, the cell rescue effect should be 
more pronounced when ARCosome components are abrogated in combination with Bcl-
XLand Bcl-2 knockdown. To address the role of Bcl-XLand Bcl-2 specific to the cell death 
induced via the ARCosome, the percentage of dead cells caused by Bcl-XL and Bcl-2 
knockdown in combination with the knock down of the ARCosome components, namely 
Fis1, Bap31 and caspase-8, was determined. Scrambled, Fis1, Bap31 or caspase-8 stable 
knockdown HeLa cells were transfected with either Bcl-XL shRNA (Figure 3-7A) or Bcl-2 
shRNA (Figure 3-7B). Cells were harvested 30 hours post-transfection to analyse for cell 
death by DiOC6 and PI staining. The percentage of dead cells with DiOC6-negative and PI-
positive cells within each sample was quantified by FACS analysis and normalised with 
72.5%±0.75 of GFP transfection efficiency. In addition, the expression levels upon Bcl-XL 
and Bcl-2 shRNA transfection of the two proteins 30 hours post-transfection were verified by 
western blot analysis (Figure 3-7F). It was found that 63.3% of HeLa cells died upon Bcl-XL 
knockdown by shRNA transfection. Surprisingly, the knock down cells of the ARCosome 
components (Fis1, Bap31 and caspase-8) were significantly rescued compared with the 
control cells (14.1%, 20.8% and 18.4% cell death in Fis1, Bap31 and caspase-8 stable 
knockdown HeLa cells, respectively) (Figure 3-7A). Similarly, it was also found that Fis1, 
Bap31 and caspase-8 knockdown HeLa cells died less upon Bcl-2 shRNA transfection 
compared to scrambled cells. 81.6%, 44.4%, 43.8% and 41.3% dead cells were detected in 
scrambled, Fis1, Bap31 and caspase-8 stable knockdown Hela cells, respectively. 
Moreover, scrambled shRNA and tBid expression plasmids were used as a negative and 
positive control for this experiment. The results showed that both negative and positive 
control plasmids induced cell death to the same extent (Figure 3-7C, D). This indicates that 
the survival effect exerted by Bcl-XL and Bcl-2 is at least in part specific to the ARCosome-
induced cell death pathway.  
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Figure 3-4  :  Rescue Effect of Bcl-XL and Bcl-2 in Fis1-induced cell death in a dose 
dependent manner 
HeLa cells were cotransfected with Fis1 and either Bcl-XL (A) or Bcl-2 (B) in different ratios of 
plasmid number (8:1, 6:1, 4:1, 2:1, 1:1, 1:2, and 1:3). A βgal plasmid was added to equalise 
the total DNA in each condition. Cells were harvested 24 hours post-transfection and stained 
with DiOC6 and PI for cell death quantification via FACS. The FACS results were used to 
determine the percentage of dead cells with DiOC6-negative or PI-positive cells within each 
sample. Data are presented as means ± S.D. n=3, *** p<0.001 (student‟s t-test). 
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Figure3-5 :  Caspase 8 activation is inhibited by Bcl-XL and Bcl-2 in Fis1-induced cell 
death. 
HeLa cells were cotransfected with Fis1 and either Bcl-XL or Bcl-2 in a 1 : 1 ratio. Cells were 
harvested 24 hours post-transfection and caspase-8 activation was determined by 
CaspaTag™ caspase-8 In Situ Assay kit (Millipore). The percentage of cells with activated 
caspase-8 was quantified using FACS analysis. Data are presented as means ± S.D. n=3 *** 
p<0.001 (student‟s t-test). 
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Figure 3-6 : The rescue effect of ER- and mitochondria-localised Bcl-2 upon Fis1 
upregulation- and etoposide treatment-induced cell death. 
(A)  HeLa cells were cotransfected with Fis1 and either βgal, Bcl-2, Bcl2-ER, or Bcl2-
mitochondria in a 1 : 1 ratio.Cells were harvested 24 hours post-transfection and stained with 
DiOC6 and PI for cell death quantification by FACS. (B) HeLa cells were transfected with 
Bgal, Bcl-2, Bcl2-ER, or Bcl2-mitochondria and treated with 150 μM etoposide 18 hours 
post-transfection. Cells were harvested 30 hoursfollowing the start of treatment and stained 
with DiOC6 and PI for cell death quantification via FACS. The FACS results were used to 
determine the percentage of dead cells with DiOC6-negative or PI-positive cells within each 
sample. Data are presented as means ± S.D. n=3, *** p<0.001 (student‟s t-test). 
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Figure 3-7 : The survival effect of endogenous Bcl-XL and Bcl-2 is mediated by the 
ARCosome components Bap31, Fis1, caspase-8.  
HeLa cells were transfected with Bcl-XL(A), Bcl-2 (B), scrambled (C), and tBid (D) shRNA 
into scrambled, Fis1, Bap31 or caspase-8 HeLa stable knockdown cells and harvested 30 
hours post-transfection. Cells were stained with DiOC6 and PI for cell death quantification via 
FACS. The results were used to determine the percentage of dead cells with DiOC6-negative 
and PI-positive cells within each sample. The percentage of cell death were normalised with 
72.5%±0.75 of GFP-transfected efficiency. Data are presented as means ± S.D. n=3 *** 
p<0.001 (student‟s t-test). (E) The protein expression of Fis1, Bap31, and caspase-8 in 
stable knockdown cells were analysed by using appropriate antibodies. (F) The protein 
expression of Bcl-XL and Bcl-2 48 hours following Bcl-XL and Bcl-2 shRNA transfection into 
scrambled stable HeLa knockdown cells were analysed by using the appropriate antibodies.  
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3.2.3 Endogenous Bcl-XL and Bcl-2 are part of the ARCosome complex. 
 According to my previous experiments (Figure 3-4, 3-6), it was shown that Bcl-XL and 
Bcl-2 can inhibit cell death upon Fis1 upregulation and etoposide treatment in HeLa cells. 
Subsequently, the mechanism of how Bcl-XL and Bcl-2 keep the ARCosome inactive in 
healthy cells was elucidated. The next question, whether Bcl-XL and Bcl-2 dissociate from 
the ARCosome complex during apoptosis conditions was investigated. Since Iwasawa et al 
has shown that the ARCosome is a novel platform for initiator caspase activation, caspase-8 
in this case, which is upstream of the signalling pathway (Iwasawa et al, 2011), my 
hypothesis was that the dissociation of Bcl-XL and Bcl-2 from the ARCosome complex 
leading to cell death is a key regulator and happens as an early event in the signalling 
pathway. First, the question whether Bcl-XL and Bcl-2 are part of the ARCosome complex in 
HeLa cells was addressed. To address this question, the interaction between Bcl-XL or Bcl-2 
and Bap31 as well as Fis1 was investigated using the co-immunoprecipitation technique. 
First, the interaction between overexpressed Bcl-XL or Bcl-2, overexpressed Fis1, and 
endogenous Bap31 was examined. HeLa cells were transfected with Bcl-XL/Bcl-2 and Fis1 
(see method), the cells were harvested 24 hours post-transfection and lysed with lysis buffer 
(Pierce® Crosslink Immunoprecipitation Kit, 26174). 1 mg of protein extract was precipitated 
with a BclXS/L antibody (Figure 3-8A) or a Bcl-2 antibody (Figure 3-8B) and further probed 
with specific antibodies: a BclXS/L , a Bap31 and Fis1 antibody. The results show that they 
are in the same complex.  
 Importantly, the interaction of endogenous Bcl-XL/Bcl-2, Fis1, and Bap31 was further 
investigated since Bap31 was first identified to be part of the complex including Bcl-XL/Bcl-2 
and pro-caspase-8 (pro-FLICE) by Ng et al. in HEK293 cells only overexpressing Bcl-XL, 
Bcl-2 and Bap31 (Ng et al, 1997). According to my co-immunoprecipitation of the 
endogenous proteins Bcl-XL/Bcl-2, Fis1, and Bap31 are in the same complex (Figure 3-9).  
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Figure 3-8  :  Bcl-XL and Bcl-2 are in a complex with Bap31 and Fis1.  
(A) HeLa cells were transfected with Fis1 and Bcl-XL. HeLa cells were harvested and lysed  
with lysis buffer (Pierce® Crosslink Immunoprecipitation Kit, 26174).  3 mg of protein extract 
was precipitated with BclXS/L antibody (sc23958) and probed with the following antibodies: 
BclXS/L antibody (sc23958), Bap31 antibody (protein tech, 11200-1-AP), and Fis1 (self-
made). (B) The same condition in (A) was set up but Bcl-2 was transfected and pulled down 
instead of BclXL by Bcl-2 antibody (sc7382).  
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Figure 3-9  : Endogenous Bcl-XL and Bcl-2 are in a complex with Bap31 and Fis1.  
(A) HeLa cells harvested and lysed with lysis buffer (Pierce® Crosslink Immunoprecipitation 
Kit, 26174). 3 mg of protein extract was precipitated with BclXS/L antibody (sc23958) and 
probed with antibodies against BclXS/L (sc23958) and Bap31 (protein tech, 11200-1-AP). 
(B)The same condition in (A) was set up but Bcl-2 was pulled down instead of BclXL by Bcl-2 
antibody (sc7382).  
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3.2.4 Procaspase-8 recruitment to the ARCosome complex upon etoposide treatment   
 The association between the long isoform of procaspase-8 (procaspase-8L) and 
Bap31 was previously demonstrated upon expression of the proapoptotic adenoviral E1A 
protein (Breckenridge et al, 2002). Our lab also demonstrated that pro-caspase-8 is recruited 
to the ARCosome complex when cells were treated with 10μM actinomycin D for 4 hours 
and 100μM etoposide for 30 hours (Iwasawa et al, 2011). To confirm this result, HeLa cells 
were treated with 100μM etoposide for 30 hours and investigated for the association of pro-
caspase-8 with the complex. Endogenous Fis1 was precipitated with Fis1 antibody and 
probed with antibodies against Bap31and caspase-8. The data shows that procaspase-8 
was only associated with the ARCosome complex upon etoposide treatment (Figure 3-10). 
More importantly, this occurred early in the cell death signalling pathway since only 15% of 
the cells were dead at this time point (data not shown). Therefore, this result confirms that 
the ARCosome complex acts as a structural platform for procaspase-8 recruitment leading to 
cell death upon etoposide treatment.      
 
 
 
 
 
 
 
 
Figure 3-10 : Procaspase-8 is recruited to the ARCosome complex upon etoposide 
treatment. 
HeLa cells were treated with etoposide (100 μM) for 30 hours and lysed with RIPA buffer.     
3 mg of protein extract was precipitated with a Fis1 (sc48865) antibody and probed with 
suitable antibodies against Bap31 (Protein Tech,11200-1-AP) or caspase-8 (Cell Signaling, 
9746).   
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3.2.5 Bcl-XL and Bcl-2 dissociate from the ARCosome complex for cell death 
induction. 
 Although Bap31 was identified to be part of the Bcl-XL/Bcl-2 and pro-caspase-8L 
(pro-FLICE) complex (Ng et al, 1997), the role of Bcl-XL/Bcl-2 for cell death induction in this 
complex remained unknown. Therefore, the association and dissociation of Bcl-XL andBcl-2 
from the ARCosome complex was determined upon 100 µM etoposide treatment for 30 
hours (15% cell death, data not shown). 3 mg of endogenous protein extract was 
precipitated with a BclXS/L or a Bcl-2 antibody and further probed with a BclXS/L antibody 
(Figure 3-11A) or a Bcl-2 antibody (Figure 3-11B) and a Bap31 antibody. Interestingly, the 
data shows that Bcl-XL dissociates from Bap31 upon etoposide treatment. The interaction 
between Bcl-XL/ Bcl-2 and Bap31 was investigated with densitometry analysis by Image J 
software. According to the co-immunoprecipitation result, Bcl-XL and Bcl-2 were associated 
with Bap31 in healthy, non-treated HeLa cells. When cell death was induced, both Bcl-XL 
and Bcl-2 dissociated from Bap31. The interaction between Bcl-XL and Bap31 was reduced 
to 21% when normalised to 100% in healthy, non-treated cells (Figure 3-11A). In the same 
way, the results show that the interaction between Bcl-2 and Bap31 was decreased to 44% 
compared to healthy cells (Figure 3-11B).   
 In addition, the dissociation of the two proteins was also elucidated in Fis1 
overexpression-induced cell death, one of the potent inducers of the ARCosome (Iwasawa 
et al, 2011). HeLa cells were transfected with Fis1 and harvested 24 hours post-transfection 
for immunoprecipitation. 5 mg of the protein extract was immunoprecipitated with either a 
Bcl-XS/L or a Bcl-2 antibody and probed with specific antibodies against Bcl-XS/L, Bcl-2, 
Bap31 and Fis1. The interaction between Bcl-XL and Bap31 was likewise reduced to 67% 
(Figure 3-12A) and 50% for Bcl-2and Bap31 interaction (Figure 3-12B) when normalised to 
100% in healthy non-treated cells. This data indicates that Bcl-XL and Bcl-2 might be a key 
regulator for cell death control in the ARCosome signalling pathway.  
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Figure 3-11 : Bcl-XL and Bcl-2 dissociate from the ARCosome complex upon 
etoposide treatment. 
HeLa cells were treated with etoposide (100 μM) for 30 hours prior to lysis with RIPA buffer. 
3 mg of protein extract was precipitated with a BclXS/L antibody (sc23958) (A) and Bcl-2 
antibody (sc7382) (B) and probed with a BclXS/L antibody (sc23958) or Bcl-2 antibody 
(sc7382) and a Bap31 antibody (Protein Tech, 11200-1-AP). The interactions between       
Bcl-XL/Bcl-2 and Bap31were quantified with densitometry analysis using the Image J 
software. 
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Figure 3-12 :  Bcl-XL and Bcl-2 dissociate from the ARCosome complex upon Fis1 
upregulation-induced cell death. 
HeLa cells were transfected with Fis1 and harvested 24 hours post-transfection for 
immunoprecipitation. Cells were lysed with lysis buffer (Pierce® Crosslink 
Immunoprecipitation Kit, 26174). 5mg of protein extract was precipitated with either a Bcl-
XS/L (sc23958) (A) or a Bcl-2 (sc7382) antibody (B) followed by a crosslink IP kit (pierce 
26147) and probed with specific antibodies: Bcl-XS/L(sc23958, 1:1000), Bcl-2 (sc7382, 
1:1000), Bap31 (Protein Tech, 1:3000), Fis1 (homemade, 1: 1000).  
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3.2.6 Bcl-XL and Bcl-2 inhibit the interaction between caspase-8 and the Bap31/Fis1 
sub-complex. 
 While the rescue effect of Bcl-XL and Bcl-2 upon etoposide treatment and 
Fis1upregulation-induced cell death was shown in previous results (Figure 3-6), the question 
whether these anti-apoptotic proteins can inhibit the recruitment of procaspase-8 to the 
ARCosome complex has not yet been elucidated. To address this, the interaction between 
endogenous procaspase-8, Bap31, and Fis1 was determined when Bcl-XL and Bcl-2 were 
upregulated in combination with 100 μM etoposide treatment for 24 hours. HeLa cells were 
transfected with Bcl-XL or Bcl-2 and treated with 100μM etoposide 18 hours post-
transfection. The cells were harvested 24 hours after treatment started for 
immunoprecipitation. 3 mg of the protein extract was immunoprecipitated with a caspase-8 
antibody followed by the crosslink IP kit (pierce 26147) and probed with specific antibodies 
against caspase-8, Bap31, Fis1, BclXS/L and Bcl-2. According to the results, the interaction 
between procaspase-8 and Bap31 was reduced to 57% when Bcl-XL was overexpressed in 
HeLa cells (note that the interaction was normalised to 100% with β-gal-transfected cells and 
the precipitation efficiency of the caspase-8 antibody). The interaction between procaspase-
8 and Fis1 was also reduced to 42% once Bcl-XL was overexpressed (Figure 3-13A).  In the 
same way, the interaction between procaspase-8 and Bap31 was diminished to 75% when 
Bcl-2 was overexpressed in HeLa cells. The interaction between procaspase-8 and Fis1 was 
also decreased to 65% once Bcl-2 was overexpressed (Figure 3-13B).   
 In addition to etoposide-induced cell death, Fis1 upregulation was also used as        
an inducer for ARCosome activation. To investigate the inhibitory effect of Bcl-XL and Bcl-2 
for procaspase-8 recruitment to the complex upon Fis1 overexpression, HeLa cells were 
transfected with Fis1 and either Bcl-XL or Bcl-2 and harvested 24 hours post-transfection for 
immunoprecipitation. 1 mg of protein extract was immunoprecipitated with caspase-8 
antibody followed by the crosslink IP kit (pierce 26147) and probed with the following 
antibodies: caspase-8, Fis1, and GAPDH for the internal control. From the 
immunoprecipitation results, we can conclude that, although Fis1 was expressed to the 
same extent in β-gal-, Bcl-XL-, or Bcl-2-overexpressed condition, the caspase-8/Fis1 
interaction was shown to be reduced to 26% and 4% when Bcl-XL and Bcl-2 was 
upregulated, respectively (Figure 3-14). Therefore, this data indicates that Bcl-XL and Bcl-2 
can inhibit the interaction between procaspase-8 and Fis1 in HeLa cells in both etoposide 
treatment-, and Fis1 upregulation-induced cell death. Since there is no report on the direct 
interaction of Fis1 and caspase-8 proteins, the interaction of these two proteins observed in 
Figure 3-14 is possibly mediated via Bap31.      
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 As shown in previous results Bcl-XL and Bcl-2 can inhibit the interaction between 
procaspase-8 and Fis1/Bap31. To further investigate their interaction for cell death control, 
the question whether Bcl-XL and Bcl-2 can also inhibit Bap31 and Fis1 interaction was 
addressed. HeLa cells were transfected with Fis1 in the absence and presence of Bcl-XL and 
Bcl-2 and harvested 24 hours post-transfection for immunoprecipitation. 3 mg of protein 
extract was immunoprecipitated with Bap31followed by the crosslink IP kit (pierce 26147) 
and probed with particular antibodies against Bap31, Fis1, BclXS/L, and Bcl-2. The result 
shows that the interaction between Bap31 and Fis1 did not change when Bcl-XL (Figure 3-
15A) or Bcl-2 (Figure 3-15B) was overexpressed. The data indicates that Bcl-XL and Bcl-2 
do not inhibit Bap31 and Fis1 interaction. Therefore, to sum up, inclusive of my previous 
result, Bcl-XL and Bcl-2 seem to play an important role for the specific procaspase-8 
recruitment to the complex and inhibit caspase-8 activation for cell death but not Bap31 and 
Fis1 interaction.  
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Figure 3-13 : Bcl-XL and Bcl-2 inhibit caspase-8/Bap31 and caspase-8/Fis1 interaction. 
HeLa cells were transfected with Bcl-XL (A) and Bcl-2 (B) and treated with etoposide (100 
μM) 18 hours post-transfection. Cells were harvested 24 hoursfollowing treatment for 
immunoprecipitation and lysed with lysis buffer (Pierce® Crosslink Immunoprecipitation Kit, 
26174). 3 mg of protein extract was immunoprecipitated with the caspase-8 antibody (Enzo 
Life Science ALX-804-429,1:500) followed by the crosslink IP kit (pierce 26147) and probed 
with specific antibodies: caspase-8 (Cell Signaling 9746), Bap31(protein tech,11200-1-AP), 
Fis1 (self-made), and BclXS/L antibody (sc23958) in (A) or Bcl-2 antibody (sc7382) in (B) .  
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Figure 3-14  :  Bcl-XL and Bcl-2 inhibit the interaction between caspase-8 and Fis1. 
HeLa cells were transfected with Fis1 and either Bcl-XL or Bcl-2 and harvested at 24 
hourspost-transfection for immunoprecipitation. Cells were lysed with lysis buffer (Pierce® 
Crosslink Immunoprecipitation Kit, 26174). 3 mg of protein extract was immunoprecipitated 
with the caspase-8 antibody (Enzo Life Science ALX-804-429,1:500) followed by the 
crosslink IP kit (pierce 26147) and probed with specific antibodies against caspase-8 (Cell 
Signaling, 9746), Fis1 (self-made), and GAPDH (sc32233).  
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Fgure 3-15  :  Bcl-XL and Bcl-2 do not inhibit Bap31 and Fis1 interaction. 
HeLa cells were transfected with Fis1 in the absence and presence of Bcl-XL (A) or            
Bcl-2 (B) and harvested at 24 hours post-transfection for immunoprecipitation. Cells were 
lysed with lysis buffer (Pierce® Crosslink Immunoprecipitation Kit, 26174). 3 mg of protein 
extract was immunoprecipitated with Bap31 (protein tech,11200-1-AP) followed by the 
crosslink IP kit (pierce 26147) and probed with antibodies against Bap31(protein tech,11200-
1-AP), Fis1 (homemade), and BclXS/L antibody (sc23958) in (A) or Bcl-2 antibody (sc7382) in 
(B).  
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3.2.7 Functional mapping of the Bcl-XL-, Bcl-2-Bap31 interaction 
 As mentioned in the introduction, the Death Effector Domain (DED) is a key 
component in initiator caspases (caspase-8 and -10) and also in some cytokine-activating 
caspases. This domain mediates homo/heterotypic interactions between adaptor molecules 
(Ashkenazi & Dixit, 1998). The variable DED (vDED) domain of Bap31 was shown to be 
necessary for procaspase-8 recruitment when HeLa cells were treated with actinomycin D or 
etoposide (Iwasawa et al, 2011). However, the question whether vDED and the adjacent 
coil-coil domain of Bap31 are indispensable for Bcl-XL and Bcl-2 interaction was not yet 
answered. Therefore, the binding capability of Bcl-XL, Bcl-2 with Bap31 deletion mutants, 
namely Bap31ΔvDED, Bap31 ΔCCΔ/vDED, was determined via immunoprecipitation. HeLa 
cells were transfected with Bap31 deletion mutants, Bap31-flag, Bap31ΔvDED, Bap31 
ΔCCΔ/vDED and harvested 24 hours post-transfection. 1 mg of protein extract was 
immunoprecipitated with BclXS/L antibody or Bcl-2 antibody followed by the crosslink IP 
protocol (Pierce® Crosslink Immunoprecipitation Kit, 26174) and probed with a flag antibody. 
The result shows that the vDED domain and the coil-coil domain of Bap31 are dispensible 
for the binding of Bcl-XL, Bcl-2, and Bap31, which consist of only three trans-membrane 
domains, was able to interact with Bcl-XL and Bcl-2 (Figure 3-16).  This result led us to 
consider the possibility that the deletion mutants of Bap31 might be heterodimerising with 
endogenous Bap31, which then interacts with Bcl-XL, Bcl-2. Therefore, these deletion 
mutants might indirectly interact with Bcl-XL and Bcl-2 through endogenous Bap31. 
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Figure 3-16 : Bcl-XL , Bcl-2 binding with Bap31 deletion mutants 
HeLa cells were transfected with Bap31 deletion mutants, namely Bap31-flag, 
Bap31ΔvDED, Bap31 ΔCCΔ/vDED for 24 hours. Cells were harvested and lysed with RIPA 
buffer. 1 mg of protein extract was immunoprecipitated with the Bcl-XS/L antibody (sc23958) 
(A) or Bcl-2 antibody (sc7382) (B) followed by the crosslink IP protocol (Pierce® Crosslink 
Immunoprecipitation Kit, 26174) and probed with the flag antibody (Sigma, F7425).  
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3.2.8 The interaction of BH3-only proteins with Bcl-XL and Bcl-2 upon ARCosome 
activation 
 As shown in previous experiments, Bcl-XL and Bcl-2 play an important role to inhibit 
procaspase-8 recruitment to the ARCosome complex and caspase-8 activation for cell 
death. Upon etoposide treatment and Fis1 upregulation, Bcl-XL and Bcl-2 were shown to 
dissociate from the complex and lead to procaspase-8 recruitment to the complex for cell 
death. However, the mechanism involved in the Bcl-XL and Bcl-2 dissociation from the 
complex was a question that I wanted to answer next. Our hypothesis was that BH3-only 
proteins might titrate Bcl-XL and Bcl-2 from the complex and this dissociation facilitates 
procaspase-8 recruitment. To answer this question, the interacting protein partners of      
Bcl-XLand Bcl-2 from the STRING database (http://string-db.org/) were examined. It was 
shown that there are some BH3-only protein candidates that interact with Bcl-XL and Bcl-2 in 
Homo sapiens (Figure 3-17). Bik, Bad and Bid were chosen to determine their interaction 
with Bcl-XL and Bcl-2 upon etoposide treatment in HeLa cells. Cells were treated with 100 
μM etoposide and harvested 24 hours following treatment for immunoprecipitation. 3 mg of 
protein extract was immunoprecipitated with either the BclXS/L antibody or the Bcl-2 antibody 
followed by the crosslink IP kit (pierce 26147). Pulled-down proteins were probed with 
antibodies against Bcl-XS/L, Bcl-2, Bik, Bad, Bid and Bap31. The results show that the 
interaction between Bcl-XL and Bik as well as Bcl-XL and Bad was increased when HeLa 
cells were treated with etoposide. In contrast, the interaction between Bcl-XL and Bid was 
not changed upon etoposide treatment (Figure 3-18, first panel).  In the same way, it was 
found that the interaction between Bcl-2 and Bik as well as Bcl-2 and Bad was increased 
upon etoposide treatment compared to non-treated cells. The interaction between Bcl-2 and 
Bid did not change upon etoposide treatment (Figure 3-18, second panel). This result 
indicates that BH3-only proteins, such as Bik and Bad, seem to titrate Bcl-XL and Bcl-2 from 
the ARCosome complex for cell death regulation. In addition, it is possible that Bik, an ER-
localised protein, might titrate Bcl-XLand Bcl-2 in the ER membrane out from the ARCosome 
complex.   
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Figure 3-17 :  Bcl-XL(Bcl2L1) and Bcl-2 interacting partners 
Known and predicted protein-protein interactions of human Bcl-XL(Bcl2L1) and Bcl-2 were 
analysed by the STRING database (http://string-db.org/).Types of evidence for the 
association were illustrated with different line coloourrs:  Neighbourhood, Gene Fusion, 
Cooccurrence, Coexpression, Experiments, Databases, Textmining, Homology.  
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Figure 3-18 : The interaction of BH3-only proteins with Bcl-XL and Bcl-2 upon 
etoposide treatment  
HeLa cells were treated with etoposide (150 μM) and harvested 24 hours after treatment for 
immunoprecipitation. Cells were lysed with lysis buffer (Pierce® Crosslink 
Immunoprecipitation Kit, 26174) prior to immunoprecipitation. 3 mg of protein extract was 
immunoprecipitated with the BclXS/L antibody (sc23958) and the Bcl-2 antibody (sc7382), 
followed by the crosslink IP kit (pierce 26147). Interacting proteins were probed with Bcl-
XS/L(sc23958), Bcl-2 (sc7382), Bik (GTX59922), Bad (sc-8044), Bid (Cell Signaling, 2002), 
Bap31(protein tech,11200-1-AP). 
 
BH3-only protein Localisation 
Bik 
endoplasmic reticulum membrane, mitochondrial membrane,  nuclear 
envelope,  cytoplasmic membranes 
Bad 
Mitochondrial outer membrane, cytoplasm                                        
Note: Upon phosphorylation, locates to the cytoplasm. 
Bid 
cytoplasm, mitochondrial membrane 
Note: When uncleaved, it is predominantly cytoplasmic 
 
Figure 3-19 :  The localisation of BH3-only proteins 
The localisation of BH3-only proteins, namely Bik, Bad and Bid are listed. This information is 
from the UniProt protein database (http://www.uniprot.org/uniprot/P55957). 
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3.2.9  Bap31 : CED-4 functional homolog in human 
 As shown in our results the association of Bcl-XL and Bcl-2 with the ARCosome 
complex blocks the recruitment of procaspase-8 to the complex for cell death induction.           
Therefore, a promising model is that Bap31 might be a ced-4 functional homolog with a 
similar mechanism in cell death control. To examine this model, the amino acid sequences 
of Bap31 and ced-4 were aligned by VectorNTI® software (Life Technologies). Figure 3-20 
shows that the sequence of Bap31 is 12.1% positive compared to the ced-4 sequence 
(Figure 3-20). The % positive was calculated from the % identical combined with the % 
similarity (in terms of chemical properties). This % positive value seems rather high when 
compared with APAF-1, a mammalian CED-4 homolog (12.4% identical in sequence 
alignment). 
 
  
 
 
 
 
 
 
 
 
Figure 3-20 : Bap31 and CED-4 amino acid alignment  
(A) The sequences of Bap31 and CED-4 were aligned and the percentage of homologous 
sequence was calculated by VectorNTI® software (Life Technologies). Boxes in green 
demonstrate blocks of similarity whereas those in yellow show blocks of identical sequence. 
(B) The percentage of positive amino acid sequences of Bap31, CED-4 and Apaf-1 was 
calculated from VectorNTI® software (Life Technologies). 
 
 
Bap31
CED-4
Concensus
Bap31
CED-4
Concensus
Bap31
CED-4
Concensus
Bap31
CED-4
Concensus
Bap31 CED-4            Apaf-1
12.1 % 12.4 %
4.3 %
block of similar
identical
(A)
(B)
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3.3  Discussion 
 In this study I demonstrated, for the first time, an interaction between endogenous 
Bcl-XL/Bcl-2 with Bap31 and Fis1 in HeLa cells and showed that this interaction can be 
disrupted by etoposide treatment and Fis1upregulation-induced cell death. However, Fis1 
seems to act as a more specific regulator than etoposide treatment since etoposide 
treatment might also activate other pathways for cell death. This, we believe, is the reason 
why the Bcl-2 family members are less efficient for inhibiting this signal (Figure 3-6). 
 Although Bap31 wasfirst identified to be part of a complex including Bcl-XL/Bcl-2 and 
pro-caspase-8L (pro-FLICE), both Bcl-XL, Bcl-2 and Bap31 were all overexpressed in 
Hek293T cells in this study (Ng et al, 1997). We focused on endogenous proteins for our 
study since ectopically overexpressed proteins could also affect other cell death signalling 
pathways. Increasing the ratio between Bcl-XL / Bcl-2 and Fis1 plasmid can induce cell 
survival in a dose-dependent manner. In addition, the rescue effect started already from a 
low ratio between Bcl-XL / Bcl-2and Fis1 (Figure 3-4). The data point out the importance and 
how strong Bcl-XL / Bcl-2 inhibit Fis1-mediated cell death. The presence of Bcl-XL / Bcl-2 
inhibited both cell death and caspase-8 activation in response to Fis1 upregulation in HeLa 
cells (Figure 3-4, 3-5). This data indicate that Bcl-XL and Bcl-2 do their job upstream of 
caspase-8 activation, likely at the ARCosome complex.  Bcl-XL and Bcl-2 were characterised 
as an anti-apoptotic proteins. When these proteins were knocked down, it led to cell death 
but it was unclear whether the signalling pathway comprising the ARCosome was involved. 
To address the role of Bcl-XL and Bcl-2 specific to ARCosome activation-induced cell death, 
the percentage of dead cells when Bcl-XL and Bcl-2 were downregulated in combination with 
targeting the ARCosome components, namely Fis1, Bap31 and caspase-8, was determined. 
Surprisingly, ARCosome component knockdown cells could be significantly rescued when 
Bcl-XL and Bcl-2 were downregulated (Figure 3-7). This result indicates that the survival 
effect exerted by Bcl-XL and Bcl-2 is specific to the ARCosome-induced cell death pathway.  
 Our results raised the possibility that Bcl-XL / Bcl-2 might affect the interaction of the 
ARCosome components especially through the inhibition of caspase-8 recruitment to the 
complex and caspase-8 activation. This hypothesis was supported by co-
immunoprecipitation experiments, which demonstrated that endogenous Bcl-XL / Bcl-2 
dissociate from the ARCosome complex upon both etoposide treatment and Fis1 
upregulation-induced cell death (Figure 3-11). In addition, ectopic expression of Bcl-XL and 
Bcl-2 inhibited caspase-8/Bap31 and caspase-8/Fis1 interaction (Figure 3-13, 3-14) but not 
Bap31 and Fis1 interaction itself (Figure 3-15). I then asked the question whether 
proapoptotic BH3-only proteins might titrate Bcl-XL / Bcl-2 from the ARCosome complex 
under apoposis conditions. The co-immunoprecipitation results showed that the interaction 
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between Bcl-XL/ Bcl-2 and Bik as well as Bcl-XL/ Bcl-2 and Bad was indeed increased when 
HeLa cells were treated with etoposide (Figure 3-18). Nevertheless, anti-apoptotic ER-
restricted Bcl-2 proteins were shown to directly bind Bak and this interaction could be 
disrupted by a BH3-only protein Bik (Heath-Engel, 2010). Therefore, this result is just a 
possible explanation not a formal proof of this hypothesis since Bcl-2 rescue effect might 
possibly target Bak at the ER in addition to ARCosome complex for cell death regulation. 
Our results also show that ER-restricted Bcl-XL / Bcl-2 provide a stronger protective effect 
than mitochondria-localised Bcl-XL / Bcl-2 with respect to death induced by both etoposide 
treatment and Fis1 upregulation-induced cell death (Figure 3-6). ER-localised Bcl-XL / Bcl-2 
might more directly interact with Bap31 in this signalling since Bap31 is also an ER-localised 
protein. The transmenbrane domain of Bap31 might play a role in Bcl-2 interaction. Although 
our result shows that the vDED domain and the coil-coil domain of Bap31 are dispensible for 
Bcl-XL and Bcl-2 binding (Figure 3-16), this result led us to consider the possibility that the 
deletion mutants of Bap31 might be heterodimerised with endogenous Bap31, which interact 
with Bcl-XL and Bcl-2. Therefore, these deletion mutants might only indirectly interact with 
Bcl-XL, Bcl-2 through endogenous Bap31. To confirm this, this experiment should be 
investigated in Bap31 knockdown/knockout cell lines.      
 As mentioned in the introduction, in mammals Apaf-1 was identified as a CED-4 
homologue in C. elegans (Zou et al, 1997). Although both Bcl-2 and Ced-9 were shown to 
inhibit cell death in this signalling pathway, the precise mechanisms of their inhibition are 
different. In C. elegans in normal cells CED-9 sequesters CED-4 at the outer mitochondrial 
membrane (OMM) by direct binding. For cell death induction EGL-1 (mammalian BH3-only 
protein analogue) binds to CED-9 (Pourkarimi et al, 2012). This results in CED-4 release 
from OMM and its accumulation in the perinuclear space in response to pro-apoptotic stimuli 
such as ionising radiation. CED-4 octamers then recruit two molecules of CED-3 to the 
complex and this facilitates CED-3 dimerisation for its protease activation. EGL-1 can 
increase this accumulation, which is abrogated in ced-9 mutants. However, apoptosis 
execution cannot be triggered only by CED-4 accumulation (Pourkarimi et al, 2012). It may 
only prime cells for apoptosis or may act as a platform for the activation of other proteins. In 
mammals, Bcl-2 inhibits apoptosis by preventing the release of cytochrome c, which binds 
Apaf-1 and caspase-9 to form the Apoptosome. Bcl-2 does not directly bind to Apaf-1 as 
CED-9 does with CED-4(Conus et al, 2000; Haraguchi et al, 2000; Moriishi et al, 1999; 
Newmeyer et al, 2000). When comparing Apaf-1 and Bap31 for the mechanism for cell death 
induction, the mechanism of Bcl-2 to inhibit cell death in a Bap31-dependent pathway is 
more similar to CED-9 compared to Apaf-1. Our model demonstrated, for the first time, that 
Bcl-XL and Bcl-2 bind Bap31 to inhibit procaspase-8 recruitment to the ARCosome complex 
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in healthy cells. Under cell death conditions, BH3-only proteins, such as Bik and Bad, are 
likely totitrate Bcl-XL/ Bcl-2 from the complex. This facilitates procaspase-8 recruitment and 
caspase-8 activation for cell death. Moreover, Bap31 seems to be not only a functional 
homolog, but also features sequence homology with CED-4. The sequence of Bap31 is 
12.1% positive to the CED-4 sequence. This seems rather high when compared with the 
well-characterised mammalian CED-4 homolog Apaf-1 (12.4% positive in sequence 
alignment).  
 In addition, CED-4 and Apaf1 are localised in different locales. CED-4 islocalised at 
OMM and translocates to the perinuclear space upon cell death induction; in contrast, Apaf-1 
is a cytoplasmic protein. The ARCosome is a complex that bridges the ER and mitochondria. 
Therefore, the activation of this signalling pathway through Bap31, which is an ER-restricted 
protein, seems to happen at the spots of close alignment between these two organelles.  
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Chapter 4    
The upstream signalling that activates the ARCosome 
complex  
 
4.1 Introduction  
4.1.1 Apoptosis and the endoplasmic reticulum (ER) 
 The ER has recently emerged as a central player in many apoptotic pathways, both 
upstream and downstream of the well-characterised mitochondria- and DR- mediated 
pathways. The ER is a major site of protein synthesis, protein folding, and protein secretion 
in the secretory pathway and intracellular Ca2+ storage. The accumulation of unfolded 
proteins or alteration in the Ca2+ level results in ER stress. Cells have evolved protective 
mechanisms so as to survive and recover from this stress. Specific signalling pathways 
including the unfolded protein response (UPR), the ER-overload response (EOR), and the 
ER-associated degradation (ERAD) are activated to deal with ER-stress. The UPR pathway 
functions through the action of three key ER-resident transmembrane proteins including 
activating transcription factor 6 (ATF6), inositol-requiring kinase 1 (Ire1), and PRKR-like ER 
kinase (PERK)(Rutkowski & Kaufman, 2004)(see more detail in topic 1.4.1). The ultimate 
consequence of these three pathways is a reduction of the amount of newly synthesised 
proteins, an increase of translocation and degradation of misfolded proteins, and the 
enhancement of the ER protein folding capacity. If, however, this cannot be achieved, the 
response to ER-stress is switched from survival to apoptotic cell death. The best-
characterised pro-apoptotic protein in the UPR pathway is the CHOP/GADD153 transcription 
factor, which is transcribed by PERK and ATF6 activation (Lee et al, 2002; Okada et al, 
2002; Yoshida et al, 2000). CHOP in turn results in upregulation of pro-apoptotic proteins 
and downregulation of anti-apoptotic proteins (Marciniak et al, 2004; McCullough et al, 
2001).Furthermore, the ER has been shown to play a role in Ca2+ signalling transfer to the 
mitochondria and also acts as a sensitiser for MOMP-mediated cytochrome c release.         
A deeper understanding in ER signalling for cell death regulation, especially in Ca2+ 
signalling, is a challenging task.  
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4.1.2 Caspase activation responses to ER-stress in the mouse model 
Activation of the caspase cascade is also a central feature in ER-stress mediated cell 
death. Caspase-12 was shown to play an important role in ER stress-induced apoptosis in 
the mouse. Pro-caspase-12 is localised at the ER and cleaved by calpain upon ER-stress 
(Nakagawa & Yuan, 2000). Caspase-7 was shown to associate withcaspase-12 and to 
cleave the prodomain at DEDD (94) and VETD (341) to generate active caspase-12 induced 
by ER-stress (Rao et al, 2001). Interestingly, the downstream caspase-9 and -3 are cleaved 
in a cytochrome c independent manner (Morishima et al, 2002). TRAF2 is an apoptosis-
signalling adaptor between Ire1, an ER-stress sensor, and caspase-12 to activate c-Jun N-
terminal kinase (JNK) signalling resulting in cell death (Yoneda et al, 2001).  
 
4.1.3 Caspase activation responses to ER-stress in human 
 The issue of caspase-12 involvement in ER stress-mediated cell death in humans is 
contentious. Many reports have presented data that most humans lack caspase-12 due to a 
polymorphism that created a nonsense mutation during evolution (Qiao et al, 2002). Human 
caspase-4 was shown to fulfill the caspase-12 function of ER stress-induced cell death in 
human cell lines in one study (Hitomi et al, 2004). ER-stress signalling in spontaneous 
apoptosis of B-chronic lymphocytic leukemia (B-CLL) cells was shown to be orchestrated by 
caspase-4, -8 and -3. CHOP/GADD153 up-regulation and JNK1/2 phosphorylation were also 
reported to be involved in ER stress-induced apoptosis in B-CLL (Rosati et al, 2010). 
However, the role of caspase-12/4 in ER stress-mediated cell death remains vague, since 
the inhibition or deletion of caspase-12/4 provided only partial protection against cell death 
(Hitomi et al, 2004; Kalai et al, 2003; Nakagawa et al, 2000; Obeng & Boise, 2005; Sanges & 
Marigo, 2006). In addition, the role of caspase-8 in this pathway has not been fully 
addressed and there is no firm evidence to support this (Orrenius et al, 2003; Rosati et al, 
2010; Ullman et al, 2011).  
 
4.1.4 Diseases related to ER-stress  
 The ER is a key organelle in protein synthesis and quality control prior to secretion of 
the proteins to their functional sites in the cell. UPR is critical for cell survival and recovery 
from stress. UPR can switch to an ER stress-induced cell death pathway if the cell survival 
outcome of the initial UPR pathway cannot be achieved. These two signalling pathways 
cooperate to accomplish the best condition for the whole organism to save nutrients and 
energy for their survival. As mentioned above, the regulation of the UPR pathway is 
conducted through the action of three branches of ER-resident transmembrane proteins, 
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namely ATF6, Ire1 and PERK (Rutkowski & Kaufman, 2004). Abnormalities in the ER stress-
induced UPR pathway lead to a diverse range of diseases. For example, in immune 
response the efficient secretion of antibodies require the kinase or endoribonuclease 
domains of IRE1, which was shown to be necessary for Xbp1 splicing (Back et al, 2005). 
Intramembrane proteolysis of CREB-H, a leucine zipper transcription factor, which promotes 
transcription of genes encoding the inflammatory components of the acute phase response, 
is mediated by UPR in the presence of proinflammatory cytokines or 
lipopolysaccharide(Zhang et al, 2006). The malfunction of these proteins, for example, 
results in autoimmune disease. In addition, chronic ER stress in pancreatic β-cells based on 
the misfolded mutant insulin can cause Type I diabetes in mouse (Ron, 2002). Type I 
diabetes is also connected with the over-activation of the PERK branch of UPR signalling in 
pancreatic β-cells (Harding et al, 2001; Scheuner et al, 2001). A phenotype resembling type 
II diabetes can be also developed in Xbp1+/- mice on a high-fat diet (Ozcan et al, 2004).  
 ER stress and UPR have also been observed in tumours but how this pathway 
contributes to cancer cell survival is not clear (Ma & Hendershot, 2004). UPR seems to be 
activated by hypoxia, a condition often found in the cores of solid tumours (Koumenis, 2006). 
Xbp1 splicing, BiP and GRP94 have been shown to be upregulated in hypoxia condition 
(Romero-Ramirez et al, 2004). It is possible that misfolded proteins and ER stress condition 
are caused by low oxygen levels in cancer cells, which disrupts the pro-oxidative 
environment for disulfide bond formation (Bi et al, 2005). In turn, ER stress seems to 
facilitate the phosphorylation of the tumour suppressor protein p53 and its modification can 
suppress p53-dependent apoptosis pathway. This may contribute to the growth of some 
tumours (Qu et al, 2004). 
 It was also reported that the formation of irregular protein inclusions or misfolded 
protein aggregation was found to accompany both familial and sporadic forms of 
neurodegenerative disorders (Selkoe, 2003). ER stress markers were also observed in 
postmortem brain tissues and cell culture models of many neurodegenerative diseases, such 
as Alzheimer‟s disease, Parkinson‟s disease, amyotrophic lateral sclerosis (ALS), 
Huntington‟s disease and spinocerebellar ataxias (Lindholm et al, 2006). 
 
4.1.5 Bap31/p20Bap31 and apoptosis  
B-cell activating protein 31(Bap31) is a 246 amino acid integral ER membrane 
protein. It is composed of three transmembrane domains, a luminal N-terminal domain, and 
a cytosolic C-terminal domain. The C-terminal domain possesses a canonical ER retrieval 
motif (KKEE), a leucine-zipper like repeat, and a variant death effector domain (DED 
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domain), which is flanked by two caspase-8/1 recognition sites at amino acid 164 and 238. 
The vDED domain of Bap31 is required for procaspase-8 recruitment (Iwasawa et al, 2011).  
 Bap31 processing plays several roles in cell death signalling. Being a caspase-8 
substrate, Bap31 is cleaved at two caspase cleavage sites thereby generating the pro-
apoptotic fragment, p20Bap31. (Ng et al, 1997). p20Bap31 overexpression was shown to 
cause apoptosis through mobilisation and release of Ca2+ from the ER to the mitochondria. 
In addition, Bap31 cleavage by caspase-8 was also shown to be important for apoptosis 
induction by the observed survival effect of a caspase-resistant form of Bap31 (crBap31) 
upon Fas stimulation (Nguyen et al, 2000). crBap31 inhibited cytoplasmic membrane 
blebbling and fragmentation, loss of membrane integrity, Bax/Bak activation and cytochrome 
c release (Nguyen et al, 2000; Wang et al, 2003). p20Bap31 was characterised as a pro-
apoptotic protein since ectopic expression of p20Bap31 initiates mobilisation of ER Ca2+ 
stores and mitochondria Ca2+ uptake, which leads to cytochrome c release (Granville et al, 
1998; Ng et al, 1997; Nguyen et al, 2000).In my work, p20Bap31 was used as an early 
marker for ARCosome activation since Bap31 cleavage into pro-apoptotic p20Bap31 was 
hypothesised to occur prior to ER Ca2+ stores opening, mitochondria Ca2+ uptake, and 
cytochrome c release. 
 Bap31 cleavage into the pro-apoptotic p20Bap31 has been observed in response to 
a variety of apoptotic stimuli, such as expression of the E1A oncogene (Ng et al, 1997), 
photodynamic therapy (PDT) (Granville et al, 1998), Fas stimulation (Nguyen et al, 2000), 
tunicamycin, tumour necrosis factor, cycloheximide, and staurosporine (Maatta et al, 2000), 
thapsigargin (in the human CEM and NKR T-lymphoblastoid leukemia cell lines) (Zuppini et 
al, 2002), etoposide (VP16) (Chandra et al, 2004), the polymerogenic mutant α1ATZ 
(Hidvegi et al, 2005), viral infection (associated with accumulation of ER proteins) (Li et al, 
2005; Liu et al, 2006) and induction of ER stress via accumulation of bile acid (Iizaka et al, 
2007). Since Bap31 is localised at the ER and it has been shown to be cleaved upon ER-
stress, such as tunicamycin, thapsigargin (Maatta et al, 2000; Zuppini et al, 2002), it has 
been presumed that ER-stress is an inducer for ARCosome activation. Although the 
cleavage of Bap31 into the pro-apoptotic p20Bap31 has been presumed in the ER stress 
dependent pathway, the question whether ARCosome activation is indeed switched on by 
ER-stress was a challenging task to be answered. It was suggested by the localisation of the 
ARCosome components between the two most important organelles for apoptosis, the ER 
and mitochondria. Additionally, the question if Bap31 cleavage is also induced by other 
inducers for cell death has not been properly determined and is poorly understood. This 
chapter therefore aims to demonstrate the effect of a variety of drugs for Bap31 cleavage-
induced cell death per se.  
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4.1.6 C-terminal p20Bap31 antibody production  
 In order to investigate the signalling pathway of ARCosome-induced cell death, we 
needed a good tool that could specifically recognise Bap31 in protein extracts analyzed by 
western blot and inside cells analyzed by flow cytometry. As mentioned in the introduction, 
Bap31 is cleaved into the pro-apoptotic form of Bap31 (p20Bap31) at the two caspase 
recognition sites under cell death conditions (Mund et al, 2003; Ng et al, 1997). In addition, it 
was reported that the p20Bap31 fragment induces mitochondrial fission and apoptosis in a 
calcium-dependent manner when expressed ectopically (Granville et al, 1998; Ng et al, 
1997; Nguyen et al, 2000).An agent that can recognise only the p20Bap31 cleavage form 
would, we reasoned, therefore be a helpful tool for my study. Although Bap31 antibodies 
were developed and relied on in many studies (Breckenridge et al, 2002; Breckenridge et al, 
2003) including my work, we needed to find an additional tool that can recognise only the 
p20Bap31 cleavage from and can be quantified by FACS.  
According to Dr. Robert Edwards'(a member of our Department) previous study, the 
specificity of proteins for antibody production relies on only five amino acids at their C-
terminus (Robert J. Edwards et al, 2007). Five amino acids at the C-terminus of p20Bap31, 
GAAVD, were therefore used as a peptide for antibody generation in rabbits. To prevent any 
non-specificity of this antibody, this amino acid sequence was validated in that no other 
caspase substrates contain this sequence at their C-terminal (for details see in the Material 
and Method Chapter). The peptide synthesis, antibody production and purification process 
were done by EuroGentec Company. 
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4.2 Result  
 
4.2.1 Verification of the unpurified C-terminal p20Bap31 antibody by dilution 
experiments 
 To verify the proper dilution range of the unpurified C-terminal p20Bap31 antibody for 
western blot analysis, this antibody was first tested in HeLa cells overexpressing Bap31 and 
caspase-8.  HeLa cells were transfected with Bap31 and caspase 8 prior to being harvested, 
then harvested 24 hours post-transfection for western blot analysis. Protein lysates were 
probed with different dilutions of the antibody -1: 500, 1: 1000, 1: 3000, 1: 6000- from 2 
rabbits. GAPDH was used as an internal control. The results show that the p20Bap31 band 
was detected in overexpressed Bap31 and caspase-8 HeLa cells by the highest dilution 
(1:6000) and also the lowest dilution (1:500). In addition, the intermediate p27Bap31 
cleavage form (Bap31 was only cleaved at D238) was also detected in the western blot but 
with a lower amount compared to p20Bap31. The ratio between p20Bap31 and p27Bap31 in 
all dilutions remained the same (Figure 4-1). In addition to western blot analysis, the dilutions 
of the antibody were also used for immunofluorescence/FACS analysis. Higher 
concentrations of the antibody are normally used in such experiments compared to western 
blots. The dilutions of the C-terminus p20Bap31 antibody used for immunofluorescence prior 
to FACS analysis were 1:250, 1:500, 1:1000. In this experiment, HeLa cells were transfected 
with Bap31 and caspase-8 and harvested 24 hours post-transfection. p20Bap31 in the cells 
was determined by immunofluorescence using different dilutions of the antibody from two 
rabbits. The percentage of cells with p20Bap31 was quantified via FACS analysis. The 
results demonstrate that the antibodies in 1:250 to 1: 1000 dilutions from the two rabbits 
could detect p20Bap31 in Bap31- and caspase-8-transfected HeLa cells. Additionally, a 
background signal of p20Bap31 was also detected in Bap31-upregulated cells. This result 
indicates that the upregulation of Bap31 alone also induces a low background of a pro-
apoptotic signal caused by the generation of p20Bap31. In immunofluorescence 
experiments, the histograms of p20Bap31 generated by rabbit 1 and 2 antibodies produced 
similar patterns (Figure 4-2), while the C-terminal p20Bap31 antibody from rabbit 2 seemed 
to generate more background signal compared to rabbit 1 in the same exposure of the 
western blot experiment (Figure 4-1). Therefore, the C-terminal antibody from rabbit 1 was 
used in all further experiments.   
 To investigate the ability of this antibody to detect endogenous p20Bap31, HeLa cells 
were transfected with Fis1 and caspase 8 with and without Bap31 and harvested 24 hours 
post-transfection. Immunofluorescence using the antibody from rabbit 1 in a 1:1000 dilution 
was carried out to determine the cells with p20Bap31via FACS quantification. Histograms of 
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different samples were plotted in the same layout. The results show that there is an obvious 
shift of p20Bap31, visible in cell populations overexpressing Fis1 and caspase-8, and this is 
even more pronounced upon co-transfection with Bap31, indicating an increase in p20Bap31 
cleavage (Figure 4-3). However, the signal of endogenous p20Bap31 was not very distinct 
compared to the pre-immune serum. Thus, the C-terminal p20Bap31 antibody was purified 
by an affinity column that was coupled to the peptide (GAAVD) via its N-terminus, as the C-
terminus should remain accessible to the antibodies. The purification process was done by 
EuroGentec. 
 For the purified C-terminal antibody the proper dilution to detect endogenous 
p20Bap31 was determined. HeLa cells were transfected with Bap31 or caspase-8 either 
alone or in combination, and the cells harvested 24 hours post-transfection. 
Immunofluorescence using different dilutions of the purified C-terminal p20Bap31 antibody 
was performed for optimisation and quantified via FACS. Histograms of different dilutions 
were plotted in the same layout. The FACS results show that we can detect endogenous 
p20Bap31 in cells overexpressing caspase-8, which is known to efficiently cleave Bap31 into 
the pro-apoptotic p20Bap31 form. Endogenous p20Bap31 could be detected from 1:500 to 
1: 5000 dilutions of the antibody, but the more diluted the antibody was, the more distinct the 
peaks of non-transfected compared to cells overexpresing caspase-8 were. Additionally, the 
p20Bap31 signal from FACS was higher in Bap31 and caspase-8 overexpressing cells 
compared to caspase-8 upregulation alone (Figure 4-4A). This result indicates that the 
purified C-terminal p20Bap31 antibody can specifically detect p20Bap31 in cells since 
overexpressed Bap31 should theoretically generate Bap31 background that is converted into 
p20Bap31 when caspase-8 is upregulated. In addition, the different dilutions of this purified 
C-terminal p20Bap31 antibody were determined in western blot analysis, which probed the 
cell lysates of cells overexpressing caspase-8 alone and in combination with Bap31. This 
result shows that this antibody can also detect endogenous p20Bap31 from a 1:1000 to 
1:5000 dilution.  The intensity of the endogenous p20Bap31 band was stronger when probed 
with the 1: 1000 antibody dilution. This antibody dilution was therefore selected in all 
subsequent experiments (Figure 4-4B).  
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Figure 4-1 : Verification of the optimal dilutions of the unpurified C-terminal p20Bap31 
antibody 
(A)   HeLa cells were transfected with Bap31 and caspase-8 prior to harvesting 24 hours 
post-transfection for western blot analysis. Protein lysates were probed with different 
dilutions of antibodies from two rabbits against the C-terminal p20Bap31 antibody and also 
GAPDH (sc32233) as an internal control. (B) Schematic drawing shows the two caspase-8 
cleavage sites of Bap31 (Top). The recognition sequences of caspase substrates similar to 
the C-terminal of p20Bap31 (GAAVD) are listed (Bottom).    
 
 
 
 
 
 
Bap31-myc         +   +   - +   +   - +   +   - +   +   -
C-ter of p20Bap31 :  GAAVD G
AAAVD :  1. hnRNP1 (nucleus)
2. protein 4.1 (erythocyte)
- AVD  :    10  caspase substrates
- - VD  :  124 caspase substrates
- - - D  :  760 caspase substrates
A -VD  :      4 caspase substrates
AA -D  :      1 caspase substrate
myc
caspase-8 
cleavage site
Bap31-eYFP
D164
D238
caspase-8           +    - - +    - - +   - - +   - -
Bgal - +   +     - +  +       - +   +     - +   +
15
25
35
15
25
35
rabbit 1
rabbit 2
dilution                1:500    1:1000      1:3000    1:6000
p27Bap31
p20Bap31
p27Bap31
p20Bap31
GAPDH
(B)(A)
135 | P a g e  
 
 
 
  
 
 
Figure 4-2 : Test of the unpurified C-terminal p20Bap31 antibody dilutions 
(A) HeLa cells were transfected with Bap31 and caspase-8 prior to harvesting 24 hours post- 
transfection. Cells with a p20Bap31 signal was determined by immunofluorescence using 
different dilutions of the C-terminal p20Bap31 antibody (1:250, 1:500, 1:1000) from two 
rabbits and quantified by FACS. Histograms of different dilutions were plotted in the same 
layout. (B) Thepercentage of cells with p20Bap31 in Bap31- and caspase-8 overexpressed 
cells was determined by FACS and quantified by FlowJo software (BD Bioscience). Data are 
presented as means ± S.D. n=3. 
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Figure 4-3 : Test the ability of the unpurified C-terminal p20Bap31 antibody to detect 
endogenous and overexpressed Bap31 
HeLa cells were transfected with Fis1 and caspase-8 in the absence (A) and presence (B) of 
Bap31 and harvested 24 hours post-transfection. Cells with p20Bap31 were determined by 
immunofluorescence using the antibody against C-terminal p20Bap31 (1:1000) and 
quantified by FACS. Histograms of different samples were plotted in the same layout. 
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Figure 4-4  : Test of the dilutions of the purified C-terminal p20Bap31 antibody  
(A) HeLa cells were transfected with Bap31 and caspase-8 prior to being harvested 24 hours 
post-transfection. Cells with p20Bap31 were determined by immunofluorescence using 
different dilutions of the antibody against the C-terminal p20Bap31 and quantified by FACS. 
Histograms of different dilutions were plotted in the same layout. (B) Protein lysates were 
probed with different dilutions of the C-terminal p20Bap31 antibody and also GAPDH 
(sc32233) as an internal control.  
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4.2.2 Bcl-XL and Bcl-2 inhibit Bap31 cleavage into p20Bap31 upon ARCosome 
activation by Fis1 overexpression. 
 Results from the previous chapter have shown that Bcl-XL and Bcl-2 can inhibit cell 
death by blocking caspase-8 recruitment to the ARCosome complex and its activation. This 
chapter aims to explain the effect of Bcl-XL and Bcl-2 in inhibiting the generation of the pro-
apoptotic p20Bap31, which is a key consequence of ARCosome activation, upon cell death 
via Fis1 upregulation. HeLa cells were co-transfected with Fis1 and either Bcl-XL or Bcl-2 in a 
1:1 ratio and harvested 24 hours post-transfection. The protein profile was analysed by 
western blot with the C-terminal p20Bap31 antibody at a 1:1000 dilution in this experiment. 
GAPDH was used as an internal control. The results demonstrate that Bcl-XL and Bcl-2 
inhibit the cleavage of Bap31 into the pro-apoptotic p20Bap31 (Figure 4-5). This supports 
results from the previous chapter (Figure 3-12, 3-13), which illustrate that Bcl-XL and Bcl-2 
block caspase-8 recruitment to the ARCosome complex and inhibit its activation. These 
events, in our hypothesis, occur upstream of Bap31 cleavage into the pro-apoptotic 
p20Bap31.    
 To quantify the effect of Bcl-XL and Bcl-2 for inhibiting p20Bap31 generation upon 
both Fis1 upregulation and etoposide treatment, immunofluorescence and FACS assay 
using different dilutions of this antibody were performed. Note that this experiment was done 
at the same time with Figure 4-4, so different dilutions of the antibody were used instead of 
the optimal antibody dilution (1: 5000). Under Fis-1 upregulated conditions, HeLa cells were 
cotransfected with Fis1 and either βgal, Bcl-XL or Bcl-2 in a 1:1 ratio. Cells were harvested 
24 hours post-transfection.  HeLa cells treated with 150 μM etoposide for 24 hours were 
used as a positive control for Bap31 cleavage. The percentage of cells with endogenous 
p20Bap31 was determined by immunofluorescence using different dilutions of the antibody 
against the C-terminus of p20Bap31 and quantified via FACS. The results show the same 
trend with Figure 4-5 in that Bcl-XL and Bcl-2 can significantly inhibit p20Bap31 generation 
when overexpressed (Figure 4-6A).This was even more evident when a 1: 5000 antibody 
dilution was used.  The percentage of cells with endogenous p20Bap31, when probed with a 
1:5000 antibody dilution, was therefore plotted in the graph (Figure 4-6C). This plot shows 
that Bcl-XL and Bcl-2 can significantly inhibit Bap31 cleavage upon Fis1 upregulation. 40.8% 
of the βgal-expressed cell population contain endogenous p20Bap31, whereas only 8.3% 
and 11.6% were p20Bap31-positive when Bcl-XL and Bcl-2, were upregulated, respectively.  
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Figure 4-5 : Bcl-XL and Bcl-2 inhibit  Bap31 cleavage into p20Bap31 upon ARCosome 
activation by Fis1 overexpression. 
HeLa cells were cotransfected with Fis1 and either Bcl-XL or Bcl-2 at a 1:1 ratio. Cells were 
harvested 24 hours post-transfection and protein expression was analysed by western blot. 
Protein lysates were probed with the purified C-terminal p20Bap31, Fis1 (self-made), Bcl-XL 
(sc23958), Bcl-2 (sc7382), and GAPDH (sc32233) antibody.  
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Figure 4-6 : Bcl-XL and Bcl-2 inhibit Bap31 cleavage into p20Bap31 upon ARCosome 
activation by Fis1 upregulation. 
(A) HeLa cells were cotransfected with Fis1 and either Bcl-XL and Bcl-2 in a 1:1 ratio prior to 
harvesting 24 hours post-transfection. The cells with endogenous p20Bap31 was determined 
by immunofluorescence using different dilutions of the C-terminal p20Bap31 antibody and 
quantified via FACS. (B) HeLa cells were treated with 150 μM etoposide for 24 hours as a 
positive control. The cells with p20Bap31 was determined by immunofluorescence using the 
C-terminal p20Bap31 antibody and quantified by FACS as a positive control. (C) The 
percentage of cells with endogenous p20Bap31 as determined with the 1:5000 antibody 
dilution in (A) and (B) was plotted in the graph. Data are presented as means ± S.D. n=3 *** 
p<0.001 (student‟s t-test). 
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4.2.3  Inducers for p20Bap31 cleavage   
 Although the cleavage of Bap31 into the pro-apoptotic p20Bap31 has been 
presumed to be induced via ER stress, the question whether the induction of Bap31 
cleavage is also induced by other cell death-inducing drugs has not been fully understood.  
In this experiment, HeLa cells were therefore treated with a range of drugs to investigate 
whether they could activate the ARCosome and induce Bap31cleavage. HeLa cells were 
treated with different drugs namely tunicamycin (TM, 4 µg/ml), thapsigargin (TG, 6 µM), 
brefedin A (bref A, 0.1 µM), doxorubicin (doxo, 2.5 µM), cisplatin (cisp, 60 µM), 
arsenictrioxide (As2O3, 10 µM), etoposide (etop, 200 µM), actinomycin D (actD, 150 nM) and 
harvested 30 hours following the start of treatment. Note that the concentration of drugs, 
which can induce about 50-60% cell death, was used in this experiment as determined in 
prior titration experiments. Cells were harvested and stained with DiOC6 and PI prior to 
FACS for cell death analysis. The FACS results were used to determine the percentage of 
dead cells with DiOC6-negative and PI-positive cells within each sample. Protein lysates of 
the same cell population used for cell death analysis were probed with a Bap31 antibody, 
courtesy of Gordon Shore, to investigate p20Bap31 generation. The results show that all 
drugs could induce Bap31 cleavage but to different extents (Figure 4-7).  The top five drugs 
for Bap31 cleavage, namely tunicamycin (TM, 4 µg/ml), thapsigargin (TG, 6 µM), doxorubicin 
(doxo, 2.5 µM), etoposide (etop, 200 µM), and and actinomycin D (actD, 150 nM), were used 
in further experiments to investigate the rescue effect when components of the ARCosome 
were knocked down. For this, HeLa cells were transfected with siRNA constructs, 
scrambled, Fis1, Bap31, caspase-8, and components of the ARCosome 72 hours prior to 
drug treatment for 30 hours. Cells were harvested and stained with DiOC6 and PI for cell 
death and further analysis via FACS. The FACS results were used to determine the 
percentage of dead cells with DiOC6-negative and PI-positive stains within each sample. The 
results revealed that more HeLa cells survived when the ARCosome components were 
knocked down compared to cells with scrambled, the negative control (Figure 4-8). 
Additionally, the scrambled-transfected HeLa cells treated with the same concentration of 
drugs in Figure 4-8 were determined for endogenous p20Bap31 generation by 
immunofluorescence analysis using the antibody against the C-terminus of p20Bap31 
(1:10000) and Alexa Fluor® 488 Goat Anti-Rabbit IgG (1:500). The percentage of cells with 
p20Bap31 was measured by FACS and quantified via the FlowJo software (BD Bioscience). 
The histograms and graphs show that Bap31 was cleaved into the pro-apoptotic p20Bap31 
to an extent comparable with the percentage of dead cells in every condition quantified by 
FACS in Figure 4-8, when the cells were treated with these drugs (Figure 4-9). This result 
suggests that the ARCosome is involved in cell death induced by this group of drugs.   
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Figure 4-7 : Inducers for Bap31 cleavage into p20Bap31 
HeLa cells were untreated (UT) or treated with different drugs namely tunicamycin (TM,        
4 µg/ml), thapsigargin (TG, 6 µM), brefedin A (brefA, 0.1 µM), doxorubicin (doxo, 2.5 µM), 
cisplatin (cisp, 60 µM), arsenictrioxide (As2O3,10 µM), etoposide (etop, 200 µM), actinomycin 
D (actD, 150 nM) and harvested following 30 hours of treatment. Cells were stained with 
DiOC6 and PI for cell death. The FACS results were used to determine the percentage of 
dead cells (DiOC6-negative and PI-positive) within each sample. The 11.2 ± 2.05% cell 
death of untreated samples was subtracted from such of treated samples. Data are 
presented as means ± S.D. n=3 *** p<0.001 (student‟s t-test). Protein lysates were probed 
with an anti-Bap31 antibody (courtesy from Gordon Shore) and one against GAPDH 
(sc32233). 
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Figure 4-8 : ARCosome components are involved in drug-induced cell death  
HeLa cells were transfected with scrambled, Fis1, Bap31, casp8 siRNA for 72 hours prior to 
treatment with 4 μg/ml tunicamycin, 6 μM thapsigargin, 1.8 μM doxorubicin, 250 μM 
etoposide, 100 nMactinomycin D for 30 hours. Cells were harvested and stained with DiOC6 
and PI for cell death quantification. The FACS results were used to determine the 
percentage of dead cells (DiOC6-negative and PI-positive) within each sample. Data are 
presented as means ± S.D. n=3 *** p<0.001 (student‟s t-test).The expression level of 
proteins was also investigated 72 hours post-siRNA transfection by western blot using 
specific antibodies: Fis1 (self-made), Bap31 (Protein Tech, 11200-1-AP) and caspase-8 
(Cell Signaling 9746).  
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Figure 4-9 : The ARCosome is activated in drugs-induced cell death.  
HeLa cells were non-treated (NT) or treated with 4 μg/ml tunicamycin, 6 μM thapsigargin, 1.8 
μM doxorubicin, 250 μM etoposide, or 100 nM actinomycin D for 30 hours. Cells with 
p20Bap31 were determined by immunofluorescence using the C-terminal p20Bap31 
antibody (1:10000) and Alexa Fluor® 488 Goat Anti-Rabbit IgG (1:500). Histograms of 
different conditions were plotted in the same layout. The percentage of cells with p20Bap31 
was determined by FACS and quantified by FlowJo software (BD Bioscience). Data are 
presented as means ± S.D. n=3 *** p<0.001 (student‟st-test). 
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4.2.4 Bap31 is cleaved early in ER stress-mediated cell death before mitochondrial   
OM permeabilisation. 
 Bap31 was shown to be cleaved and to cause cell death upon a variety of drug 
treatments in Figure 4-8 and 4-9. It was therefore worth to investigate further whether Bap31 
cleavage happens early in cell death. Tunicamycin, an ER-stressor, was used in this 
experiment since ER-stress has been shown as a major cause for Bap31 cleavage (Maatta 
et al, 2000; Zuppini et al, 2002). HeLa cells transiently transfected with eYFP fused to the C-
terminus of Bap31allowed for the quantification of Bap31 cleavage. If Bap31-eYFP (55 KDa) 
was cleaved by activated caspase-8 into p20Bap31, we would detect two forms of the 
protein using a GFP antibody, namely the p27Bap31-by-product (only D238 was cleaved) 
fused to GFP (27KDa) and the p20Bap31-by-product (only D164 was cleaved) fused to GFP 
(55KDa). HeLa cells were transfected with the Bap-eYFP fusion construct and treated with 
tunicamycin (TM, 1 µg/ml). 20 hours post-transfection they were further harvested at the 
indicated time points. The protein profile was analysed by western blot and probed with YFP-
HRP, CHOP and GAPDH antibodies as an internal control. Using FACS analysis the 
percentage of dead cells (DiOC6-negative and PI-positive) within each sample was 
determined. The results show that 51% of ectopic Bap31 was cleaved following 24 hours of 
treatment (analysed by ImageJ software) (Figure 4-10B), while only 20% of cell death was 
quantified by FACS (Figure 4-10C) at this time point. In addition, the cleavage of Bap31 was 
not much increased compared between 24 and 30 hours of treatment (51% and 65%, 
respectively) but the percentage of cell death was significantly increased (22.1% and 50.7% 
at 24 and 30 hours, respectively) (Figure 4-10B).  Note that ER-stress was induced from 4 to 
30 hour treatment as shown by the upregulation of CHOP, an ER-stress marker. This result 
in combination with functional experiment (Figure 4-8) indicates that Bap31 cleavage into the 
pro-apoptotic p20Bap31 seems to be a cause for cell death under ER-stress by tunicamycin 
treatment in this case.   
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Figure 4-10 : Bap31 is cleaved during early ER stress-mediated cell death and before 
mitochondrial permeabilisation. 
(A)  eYFP was fused to the C-terminus of Bap31. Once caspase-8 is activated, Bap31-eYFP 
(55 KDa) is cleaved to generate p20Bap31, p27Bap31, and 8 amino acids of C-terminal 
Bap31 linked with YFP (27 KDa). (B) HeLa cells were transfected with the Bap-eYFP fusion 
construct. 20 hours after the transfection, cells were non-treated (NT) or treated with 
tunicamycin (TM, 1 µg/ml) and harvested at the indicated times. The total cell lysates were 
analysed by western blot and probed with antibodies against YFP, CHOP, and GAPDH.  (C) 
The FACS results were used to quantify the percentage of dead cells (DiOC6-negative and 
PI-positive) within each sample. All the histograms are presented as means ± S.D. n=3 *** 
p<0.001, ** p<0.01 (student‟s t-test). 
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4.3 Discussion 
 In this study we successfully developed a C-terminal neo-epitope p20Bap31 
antiserum to elucidate the ARCosome-induced cell death signalling pathway. This useful tool 
can recognise the cleavage form of Bap31, p20Bap31, and therefore allowed me to assess 
the activation of the ARCosome. It was applied to detect p20Bap31 both in cell extract 
analysed by western blotting and in intact cells quantified by flow cytometry. This C-terminal 
neo-epitope p20Bap31 antibody generated in our lab is therefore a very useful tool with 
distinct advantages over conventional antibodies. This antibody will allow quantifying the 
amount of p20Bap31 in fixed cells without cell lysis procedure. This will overcome the low 
sensitivity of western blots to detect the p20Bap31 band compared to FACS analysis, which 
might not detect the small amount of p20Bap31 in cell lysates. This problem might be 
encountered especially at early time points or in drug treatment with a low concentration, 
which induces only a small amount of Bap31 cleavage products but still leads to cell death. 
Although the non-purified antibody could be applied to detect the cleavage of overexpressed 
Bap31, it was quite limited in its sensitivity to detect the generation of endogenous 
p20Bap31. Therefore, the purification procedure of this C-terminal p20Bap31 antibody was 
required. As expected, the purified antibody provided a much better tool compared to the 
non-purified antibody in terms of generating a specific signal and background ratio. This 
purified C-terminal p20Bap31 antibody could therefore be used to detect endogenous 
p20Bap31. Furthermore, although we detected protein background bands in western blots 
with this antibody, the intensity of the background bands was shown to be equal between 
non-transfected cells (as a negative control) and caspase-8-transfected cells (as a positive 
control). This background noise did not interfere with FACS or western blot results. 
According to the western blot data (Figure 4-4), it seems that the purified C-terminal 
p20Bp31 antibody can, in addition to fully cleaved p20Bap31, also detect the intermediate 
p27Bap31. However, it is difficult to draw any quantitative conclusions about the prevalence 
of these Bap31 species as the sensitivity of this antibody to detect p27Bap31 and p20Bap31 
might be different since the fifth amino acid from the C-terminal end of these two cleavage 
forms is different. p20Bap31 features the GAAVD amino acid sequence at the C-terminus, 
whereas QAAVD are the last five amino acids of p27Bap31. As shown in Robert J. Edwards 
et al's study the fifth amino acid from the C-terminal end of a protein can affect the sensitivity 
of the detection by antibodies (Robert J. Edwards et al, 2007). It is therefore difficult to solely 
rely on this tool to illustrate how much Bap31 protein is cleaved into intermediate p27Bap31 
and p20Bap31.  
 According to the results shown in chapter 3 (Figure 3-12, 3-13) the association of 
Bcl-XL and Bcl-2 with the ARCosome complex seems to blockcaspase-8 recruitment to the 
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complex and activation. In this chapter, the results additionally show that upon ARCosome 
activation by Fis1 upregulation Bcl-XL and Bcl-2 inhibit Bap31 cleavage into p20Bap31, 
which is generated by active caspase-8. This is supported by previous findings that 
overexpressed Bcl-2 is able to inhibit both procaspase-8 processing and Bap31 cleavage 
(Ng et al, 1997; Ng & Shore, 1998). Anti-apoptotic Bcl-XL was also shown in a yeast study to 
repress the apoptosis caused by Fis1 (Fannjiang et al, 2004). Furthermore, the protective 
effects of Bcl-2 were also demonstrated for cell death initiated by p20Bap31 at the ER 
(Heath-Engel et al, 2012).  
 Although this result provides information about the role of Bcl-XL and Bcl-2 within the 
ARCosome complex as shown in chapter 3, there are other possible explanations for their 
inhibitory effect in Bap31 cleavage per se.  Bcl-XL and Bcl-2 might possibly also play a role 
to inhibit Bap31 cleavage into the pro-apoptotic p20Bap31 through different pathways at the 
ER. These anti-apoptotic Bcl-2 proteins might, for example, also regulate Ca2+ signalling at 
the ER in addition to inhibition of caspase-8 activation at the ARCosome complex. This 
possibility was supported by evidence indicating that Ca2+ signalling at the ER during 
apoptosis is dampened by the anti-apoptotic Bcl-XL and Bcl-2 (Pinton et al, 2001). Bcl-XL and 
Bcl-2 were also shown to interact with the IP3R and play a role in IP3R phosphorylation state, 
which was demonstrated to regulate Ca2+signalling at the ER (Chen et al, 2004; Hanson et 
al, 2008; Rong et al, 2008; White et al, 2005). Bcl-XL and Bcl-2 also modulate ER Ca
2+ 
uptake through SERCA inactivation, as well as alter IP3R/SERCA expression levels (Kuo et 
al, 1998; Li et al, 2002). Furthermore, Bcl-XL and Bcl-2 might play a role in BH3-only protein 
pathways and/or Bak/Bak sequestration at the ER. The BH3-only proteins Bik, Bim and 
Puma have been shown to localise at the ER and to induce Ca2+ release from the ER 
(Heath-Engel et al, 2008; Mathai et al, 2005). ER-localised Bak, in the absence of 
endogenous Bax/Bak, was found to be required for apoptosis induced by ER-targeted Bim or 
Puma (Klee et al, 2009).ER Ca2+ release was also shown to depend on Bax/Bak 
oligomerisation at the ER (Klee et al, 2009). Importantly, inhibition of cell death by ER-
restricted Bcl-2 was also shown in Bik-initiated cell death, presumably due to sequestration 
of either Bik and/or Bax/Bak (Mathai et al, 2005).   
 The survival effect of Bcl-XL and Bcl-2 might be accomplished not only at the ER but 
also at the mitochondria. The ARCosome is presumed to act as a sensitiser to amplify the 
signal from the ER to the mitochondria or vice versa (Iwasawa et al, 2011). Bcl-XL and Bcl-2 
might therefore play a role to inhibit p20Bap31 generation via the feedback signal from the 
mitochondria. As described in the introduction, the pro-apoptotic multi-BH proteins, Bax and 
Bak, are directly involved in MOMP. Upon apoptotic stimuli, Bax/Bak undergo conformational 
changes, membrane integration, oligomerisation and ultimately pore formation for releasing 
mitochondrial molecules into the cytoplasm. It was shown that Bcl-XL and Bcl-2 can inhibit 
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pore formation by acting as antagonists of Bax/Bak activation (Chipuk et al, 2010; Dewson & 
Kluck, 2009; Leber et al, 2010). Furthermore, MOMP was hypothesised to be achieved 
independently of Bax/Bak but through the activation of the mitochondrial permeability 
transition (MPT), which relies on the opening of the permeability transition pore 
(PTP)(Kumarswamy & Chandna, 2009; Zhivotovsky et al, 2009). In fact pro and anti-
apoptotic Bcl-2 family members have been shown to interact with regulators of the PTP and 
to regulate MPT (Heath-Engel & Shore, 2006; Juhaszova et al, 2008; Smith et al, 2008; 
Tsujimoto et al, 2006). Hence, it is possible that Bcl-XL and Bcl-2 might inhibit Bap31 
cleavage also through this feedback loop from the mitochondria, for example through Ca2+ 
signalling and/or effector caspase activation, to the ER. However, whether Bap31 cleavage 
is influenced by other activities of Bcl-2 family members is debatable 
 Although it has been presumed that ER-stress is an inducer for ARCosome activation 
(Maatta et al, 2000; Zuppini et al, 2002), the ability to induce Bap31 cleavage of other cell 
death inducers has only poorly been determined. My result shows that all cell death inducers 
bring about Bap31 cleavage but to a different extent when compared with the percentage of 
dead cells quantified by FACS. According to the result Figure 4-7, it was shown that the 
strongest inducers leading to p20Bap31 generation are ER-stressors and DNA damage 
agents. The first ER-stressor that induces Bap31 cleavage is tunicamycin, which is an N-
glycosylation inhibitor. Thapsigargin, a SERCA inhibitor, is another ER-stressor that exerted 
this effect in this experiment. Furthermore, DNA damage agents, including doxorubicin, 
etoposide and actinomycin D, induce Bap31 cleavage (Figure 4-7). Theseinducers were also 
verified for p20Bap31 generationin fixed cells using the C-terminal p20Bap31 antibody and 
quantified by FACS (Figure 4-9). To determine whether the cells specificly died from the 
ARCosome activation, the ARCosome components, Fis1, Bap31 and caspase-8, were 
downregulated with siRNA in HeLa cells and then treated with the drugs. In order to observe 
a distinct survival effect upon drug treatments and exclude side effect, transient siRNA was 
used in this experiment rather than stable knockdown cells since Bap31 was described to 
also have additional functions in the cell such as mediating the transport of proteins to the 
plasma membrane(Stojanovic et al, 2005). Moreover, Bap31 is normally highly expressed in 
cells and was more prominently downregulated when siRNA was applied. Additionally, the 
downregulated cell population was more uniform as the overgrowth effect of the Bap31-
targeted cells was omitted. The result demonstrates that HeLa cells died less when the 
ARCosome components were downregulated. This result is consistent with results that cells 
become resistant to actinomycin D and etoposide treatment when Fis1 was abated (Lee et 
al, 2004). Although a significant rescue effect was observed in the ARCosome components-
knockdown cells for all drug treatments, the survival effect mediated by each protein 
component upon its knockdown varied among the drugs. This result raises the possibility 
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that the ARCosome complex might be responsible for cell death in different signalling 
pathways. For example, it might play a more direct and important role in ER stress- rather 
than DNA damage-mediated cell death. As mentioned in the introduction, JNK1/2 
phosphorylation was reported to be involved in ER stress-induced apoptosis (Rosati et al, 
2010). This also activates pro-apoptotic protein Bim (Lei & Davis, 2003; Luciano et al, 2003; 
Putcha et al, 2003) and inhibits the anti-apoptotic protein Bcl-2 (Yamamoto et al, 1999). This 
might be a possible explanation why Bcl-2 inhibits ER stress-induced cell death through the 
ARCosome. Recently it has been manifested that multiple pathways are engaged in concert 
in ER stress-mediated cell death (Kim et al, 2008). The preferential engagement of a 
particular signalling pathway over another is likely dependent on the type, strength and 
duration of the ER stress signal and cell type. Up to now, no single component has yet been 
identified to completely abrogate cell death in ER stress conditions. Furthermore, DNA 
damage agents likely also activate complex cell death signalling pathways in addition to cell 
cycle arrest and mitochondria alterations. For example, doxorubicin was shown to induce 
mitochondrial depolarisation, elevated matrix calcium levels and mitochondrial ROS 
production (Kuznetsov et al, 2011). Therefore, this drug – and also the others - might 
activate mitochondria cell death signalling and this signal could then be transmitted back to 
the ER in a feedback loop signalling. Importantly, the results also show that the cleavage of 
Bap31 happens early and before mitochondria permeabilisation for cell death in HeLa 
cells.This points out that the cleavage of Bap31 at the ER is a cause for cell death and 
upstream of mitochondria permeabilisation at the mitochondria. In this chapter, the role of 
BclXL and Bcl-2 to inhibit Bap31 cleavage at those early time point was demonstrated using 
the C-terminal p20Bap31 antibody, which was generated in our lab. More information on 
ARCosome signalling will hopefully discovered for other disease-relevant treatments leading 
to novel therapeutic target design in the future.    
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Chapter 5  
The downstream signalling upon ARCosome activation  
 
5.1  Introduction 
5.1.1  ARCosome Discovery 
 
 Bap31 was first identified to be part of a complex including Bcl-XL/Bcl-2 and pro-
caspase-8L (pro-FLICE) when Bcl-XL, Bcl-2 and Bap31 were overexpressed in HEk293T 
cells (Ng et al, 1997). Bap31 plays both an anti-apoptotic role in its full-length form, 
presumably through Bcl-2 interaction (Nguyen et al, 2000), and a pro-apoptotic role when it 
is cleaved into p20Bap31 at the two caspase cleavage sites. Ectopic expression of 
p20Bap31 initiates mobilisation of ER Ca2+ stores and mitochondria Ca2+ uptake, which 
leads to cytochrome c release from mitochondria (Granville et al, 1998; Ng et al, 1997; 
Nguyen et al, 2000). The p20Bap31-induced cell death signalling pathway was first shown to 
proceed through Ca2+ signalling from the ER to the mitochondria. However, the question 
whether an apoptosis signal from the mitochondria is first transmitted to the ER remained 
unanswered until Iwasawa et al showed this in a study in 2011 from our lab. In this 
publication, fission protein Fission 1 homologue (Fis1), which was isolated from our genetic 
screening for apoptosis inducers (Albayrak & Grimm, 2003), was investigated for its 
interaction with Bap31 and its ability to act as an ER-mitochondria platform for apoptosis. 
The ARCosome complex, composing of Bap31 and Fis1, was indeed shown to form a 
platform between the ER and the mitochondria for caspase-8 recruitment and activation. 
Caspase-8 could then further cleave Bap31 into the pro-apoptotic p20Bap31, which induces 
Ca2+ release from the ER, its mitochondrial uptake and eventually apoptosis (Iwasawa et al, 
2011). 
 
5.1.2  Bap31 cleavage in the extrinsic / intrinsic apoptosis pathway  
 Bap31 was found to be cleaved into p20Bap31 in response to a variety of apoptotic 
stimuli. Although the inducers of the extrinsic pathway, such as Fas stimulation (Nguyen et 
al, 2000)and tumour necrosis factor (Maatta et al, 2000) were first shown to induce Bap31 
cleavage (Maatta et al, 2000; Nguyen et al, 2000).  Inducers of the intrinsic pathway that 
induce Bap31 cleavage are, for example, photodynamic therapy (PDT) (Granville et al, 
1998), cycloheximide, staurosporine (Maatta et al, 2000), thapsigargin (Zuppini et al, 2002), 
etoposide (VP16) (Chandra et al, 2004), and ER stress via accumulation of bile acid (Iizaka 
et al, 2007). In our study from 2011, the ARCosome complex composed of Bap31 and Fis1 
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was discovered. Fis1-induced cell death and Bap31 cleavage into p20Bap31 was 
consistently used as an inducer and indicator, respectively, for ARCosome activation in this 
and in my own study.     
 
 
5.1.3 Ca2+ signalling in apoptosis 
 
 Ca2+ release from the ER plays an important role in apoptotic signalling pathways, 
which are initiated by oxidative stress, ER stress, oncogenic stress and lipid second 
messengers. Mobilisation of ER Ca2+ stores can result in apoptosis through either cytosolic 
or mitochondrial signalling, as well as the extrinsic and intrinsic apoptotic pathways. 
Increased cytosolic Ca2+ levels can activate Ca2+-dependent proteases, kinases, 
phosphatases thereby promoting apoptosis through, for example, calpain-mediated cleavage 
of caspases and calcineurin-mediated dephosphorylation of Bcl2 family members (Dong et 
al, 2006; Heath-Engel et al, 2008; Pinton et al, 2008; Roderick & Cook, 2008; Timmins et al, 
2009). ER-mitochondria Ca2+ transfer can lead to mobilisation of pro-apoptotic factors 
including cytochrome c within the IMS into the cytoplasm, induction of mitochondrial swelling 
and MOM rupture (Giorgi et al, 2008; Heath-Engel et al, 2008; Lemasters et al, 2009; 
Rizzuto et al, 2009). 
 Ca2+ release from the ER occurs primarily through IP3R (inositol 1,4,5-triphosphate 
receptor) and RyR (ryanodine receptor) channels, whereas Ca2+ uptake is dependent on the 
SERCA (sarco/ER Ca2+-ATPase) pump. At the mitochondria, Ca2+ import occurs through the 
unspecific MOM VDAC (voltage dependent ion channel) and the specific MIM MCU 
(mitochondrial Ca2+ uniporter), and Ca2+ export occurs through antiporters (Na+/Ca2+ or 
H+/Ca2+ exchangers) and the PTP (Giorgi et al, 2008; Rizzuto et al, 2009; Spat et al, 2008). 
The MCU is a low affinity transporter. Therefore, ER-mitochondria Ca2+ transfer requires 
high local [Ca2+] and the close physical proximity of the two organelles. Although the 
importance of ER-mitochondria tethering complexes such as mitochondria-associated 
membranes (MAMs), the complex composing of phosphofurin acidic cluster sorting protein 2 
(PACS-2) (Giorgi et al, 2008; Hayashi et al, 2009; Rizzuto et al, 2009; Simmen et al, 2005) 
and mitofusion 2 (a protein involved in mitochondrial fusion) (de Brito & Scorrano, 2008a; 
Merkwirth & Langer, 2008), has been recognised to facilitate ER-mitochondria Ca2+ transfer, 
the molecular basis of ER-mitochondria apposition is still unclear. The ARCosome complex 
was discovered as an ER-mitochondria spanning complex and the generation of p20Bap31, 
the consequence of the ARCosome activation, leads to Ca2+ release from the ER, its 
mitochondrial uptake and eventually apoptosis (Iwasawa et al, 2011). However, the question 
which receptors and channels are responsible for Ca2+ transfer in this signalling pathway 
remained unanswered.   
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5.1.4 Apoptosis signalling at the mitochondria  
 Bax and/or Bak are essential for mitochondrial apoptosis in response to a variety       
of stimuli. The role of Bax/Bak in MOMP is thought to involve pore formation;      
nevertheless, the precise role of Bax/Bak in this event is still unknown. They might form a 
pore on their own, or in association with other proteins and/or lipids, alternatively they    
might modulate existing ion channels in MOMP. The correct model still remains to be 
identified.  
 MOMP, however, can be achieved in a Bax/Bak independent manner, through the 
induction of the mitochondrial permeability transition (MPT) (Garrido et al, 2006; Giorgi et al, 
2008; Murgia et al, 2009). MPT results from the sustained opening of the permeability 
transition pore (PTP), a nonselective MIM channel. This can be induced by a variety of 
stimuli, such as Ca2+, oxidative stress, and leads to an influx of solutes and water       
resulting in a distorted balance of osmotic pressure, loss of mitochondrial membrane 
potential (ΔΨ), and swelling of the mitochondrial matrix(Kroemer & Reed, 2000; Susin et al, 
1998). The matrix swelling induces the swelling of IMM, the rupture of OMM, and the  
release of IMS proteins resulting in the loss of mitochondrial structure and function       
(Green & Kroemer, 2004; Zamzami & Kroemer, 2001). Adenine nucleotide translocase 
(ANT), VDAC and the matrix peptidyl-propyl cis-trans isomerase (PPIase) cyclophilin D 
(CypD) have been identified as essential regulators of the PTP. CypD exhibits both           
pro- and anti-apoptotic effects depending on the experimental settings and inducers for 
mitochondrial PT (Li et al, 2004; Lin & Lechleiter, 2002; Schubert & Grimm, 2004) 
 Additionally, complex II of the respiratory chain is also a pro-apoptotic sensor. The 
inhibition of complex II leads to apoptotic cell death through reactive oxygen species (ROS) 
production and loss of mitochondrial membrane potential (ΔΨ) (Ricci et al, 2003). In 
eukaryotic cells, complex II is comprised of two MIM transmembrane proteins, SDHC and 
SDHD, as well as two mitochondrial matrix proteins, SDHA and SDHB (Sun et al, 2005). 
Membrane-anchoring SDHC and SDHD are associated with SDHB, which forms the 
hydrophilic head with SDHA protruding into the mitochondrial matrix. The catalytic core of 
the complex in the matrix, SDHA and SDHB, can oxidise succinate to fumarate in the TCA 
cycle and this consequently generates electrons, which are then transported to the FAD 
cofactor in SDHA and the three [Fe–S] clusters in SDHB (Sun et al, 2005; Yankovskaya et 
al, 2003). These three electrons are subsequently transferred to ubiquinone that is   
converted into ubiquinol and further to complex III of the respiratory chain. During cell    
death, the sub-complex of SDHA and SDHB is released from the membrane-anchoring 
SDHC and SDHD sub-complex (Lemarie et al, 2011). Electrons from the substrate succinate 
are then instead transferred to oxygen molecules resulting in ROS production for cell death 
(Albayrak et al, 2003; Lemarie et al, 2011).        
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5.2  Results 
 
5.2.1  Bcl-XL and Bcl-2 inhibit cytosolic Ca
2+ release and its mitochondrial uptake upon 
Fis1-induced cell death. 
 The expression of Fis1, a component of the ARCosome complex, and also of 
p20Bap31, the consequence of ARCosome activation, leads to ER Ca2+ release into the 
cytoplasm (Iwasawa et al, 2011). According to the results in Figures 3-4 and 3-5, Bcl-XL and 
Bcl-2 can inhibit cell death and caspase-8 activation when upregulated together with        
Fis1 in HeLa cells. Therefore, this chapter aims to further demonstrate their role in the 
regulation of Ca2+ release between the two organelles, the ER and the mitochondria.           
In this study, the role of Bcl-XL and Bcl-2 was first investigated to determine whether they 
play a role in decreasing cytosolic [Ca2+] and whether Ca2+ transfer to the mitochondria is 
then also reduced. To investigate this hypothesis, HeLa cells were transfected with Fis1 in 
combination with either Bcl-XL or Bcl-2 in a 1:1 ratio prior to harvesting 24 hours post-
transfection. The cytosolic and mitochondrial calcium levels were determined using Fluo-
4/AM and Rhod-2/AM staining via FACS analysis, respectively. The mean fluorescence 
intensity of β-gal-transfected cells were set to 100% and the cytosolic and mitochondrial 
calcium levels were calculated as relative to 100% of β-gal-transfected cells. The result 
shows that the cytosolic Ca2+ increase by Fis1 was diminished when HeLa cells were co-
transfected with either Bcl-XL or Bcl-2: The cytosolic Ca
2+ level increased to 228% compared 
to β-gal-transfected cells when Fis1 was upregulated on its own, while it was reduced to 
126% and 141% when Bcl-XL and Bcl-2 were co-transfected, respectively (Figure 5-1A). At 
the same time, mitochondrial Ca2+ levels also decreased when Bcl-XL and Bcl-2 were 
transfected together with Fis1. Upon Fis1 transfection the mitochondrial Ca2+ level rose to 
137% compared to β-gal-transfected cells where it was reduced to 113% and 112% once 
Bcl-XL or Bcl-2 were overexpressed, respectively (Figure 5-1B).  
 Although we found that Fis1, an inducer for ARCosome activation, induced cell  
death through ER Ca2+ release into the cytoplasm (Iwasawa et al, 2011), the ER and 
mitochondrial channels responsible for Ca2+ release/uptake in this signalling pathway      
were unknown. To investigate this point, cell death was determined in Fis1-upregulated 
HeLa cells treated with ER and mitochondrial receptor inhibitors. HeLa cells were 
transfected with Fis1 5 hours prior to treatment with and without ER channel inhibitors, 
namely dantrolene (100 μM), a ryanodine receptor (RyR) inhibitor, and 2-APB (100 μM), an 
inositol 1,4,5-triphosphate receptor (IP3R) inhibitor, for 19 hours following the start of 
treatment. At the mitochondria, the question whether the mitochondrial Ca2+ uniporter (MCU) 
and the PT-pore complex play a role in Ca2+ uptake and cell death in this pathway was 
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investigated. HeLa cells were transfected with Fis1 5 hours prior to treatment with Ru360  
(10 μM), a uniporter inhibitor, as well as bongkrekic acid (50 μM), an inhibitor of ANT, a 
component of PTP, for 19 hours following the start of treatment. The FACS results were 
used to quantify the percentage of dead cells, scoring DiOC6-negative and PI-positive    
cells, within each sample.At the ER, the result shows that 75.5% of the cells died in Fis1-
transfected cells while it was slightly reduced to 66% in cells treated with the ryanodine 
receptor (RyR) inhibitor dantrolene (100 μM), but no effect was observed with 2-APB  
(Figure 5-2A). This result indicates that RyR but not IP3R partially plays a role in Ca
2+ 
transfer from the ER in this pathway. At the mitochondria, the results demonstrate that 
75.7% of the cells died in Fis1-control transfected cells, while it significantly decreased to 
54.7% and 55.6% in cells treated with Ru360 and bongkrekic acid, respectively (Figure 5-
2B). This indicates that the MCU and the PT-pore play a substantial role in Ca2+ uptake and 
in cell death induction in the ARCosome signalling pathway. 
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Figure 5-1 : Bcl-XL and Bcl-2 inhibit cytosolic Ca
2+ release and mitochondria Ca2+ 
uptake upon Fis1-induced cell death. 
(A) HeLa cells were cotransfected with Fis1 and either Bcl-XL or Bcl-2 in a 1:1 ratio. Cells 
were harvested 24 hours post-transfection and cytosolic Ca2+levels were determined      
using Fluo-4/AM staining and subsequent FACS analysis. (B)The mitochondrial calcium 
level was measured in the same experimental setting as in (A) but using Rhod-2/AM  
staining with FACS analysis. The mean fluorescence intensity of β-gal-transfected cells  
were set to 100%. Data are presented as means ± S.D. n=3 *** p<0.001 (student‟s t-test). 
 
 
 
 
 
 
(B)(A)
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Figure5-2 : Calcium signalling between the ER and the mitochondria upon Fis1-
induced cell death 
(A) HeLa cells were transfected with Fis1 in the presence or absence (untreated, UT) of 
calcium channel inhibitors namely dantrolene (100 μM), a ryanodine receptor inhibitor, and 
2-APB (100 μM), an inositol 1,4,5-triphosphate receptor inhibitor. The FACS results were 
used to quantify the percentage of dead cells with DiOC6-negative and PI-positive cells 
within each sample.  (B) HeLa cells were transfected with Fis1 in the presence or absence of 
channel inhibitors namely Ru360 (10 μM), a uniporter inhibitor, and bongkrekic acid (50 μM), 
an ANT inhibitor. The FACS results were used to quantify the percentage of dead cells 
(DiOC6-negative and PI-positive) within each sample. All the histograms are presented as 
means ± S.D. n=3 ** p<0.01,* p<0.05 (student‟s t-test). 
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5.2.2 Bax, complex II of the respiratory chain, and PTP are activated at the 
mitochondria upon p20Bap31-induced cell death. 
 Bax activation was shown in Fis1 upregulated-induced apoptosis (Iwasawa et al, 
2011).  However, it was unknown whether Bap31 is required for Bax activation induced by 
Fis1. An experiment was performed to elucidate this point. Scrambled and Bap31 stable 
knockdown HeLa cells were transfected with Fis1 prior toharvesting, 24 hours post-
transfection. The percentage of cells with activated Bax was determined by 
immunofluorescence using an antibody against activated Bax and Alexa Fluor® 488 Goat 
Anti-Rabbit IgG before quantification via FACS. p20Bap31 and Bax were used as a positive 
control for ARCosome activation and Bax overexpression in this experiment. The percentage 
of cells with activated Bax was normalised to 90.5%±1.02 GFP transfection efficiency. The 
result in Figure 5-3 shows that 35.1% of scrambled cells activated Bax whereas it 
significantly reduced to 27.9% in Bap31 stable knockdown cells when Fis1 was up-
regulated. This effect was not caused by a difference of physiological background of 
scrambled and Bap31 stable knockdown cells since they experienced the same extent of cell 
death when p20Bap31 or Bax were up-regulated. This result indicates that Bax is activated 
in ARCosome activation by Fis1 and this activation requires Bap31.  
 Complex II of the respiratory chain and the PTP at the mitochondria were further 
investigated for their role in p20Bap31-induced cell death. Prohibitin (PHB), the mammalian 
homologue of the yeast complex II assembly factor Tcm62p14, can inhibit the disintegration 
of SDHA/SDHB sub-complex from the SDHC/SDHD sub-complex of complex II and 
apoptosis induction (Hwang et al, 2014). Cyclophylin F (CypF, CypD), a protein component 
of the PT complex, has been shown to inhibit apoptosis when upregulated (Li et al, 2004). 
Therefore, to determine the role of complex II and the PT-pore complex in the ARCosome 
activation pathway, the inhibition of cell death and ROS production in HeLa cells upon 
upregulation of p20Bap31 in combination with PHB and CypF was investigated. HeLa cells 
were cotransfected with p20Bap31 and either PHB or CypF 24 hours prior to FACS analysis. 
In addition HeLa cells were co-transfected with p20Bap31 and manganese SOD (MnSOD), a 
ROS scavenger, to transform the toxic superoxide into hydrogen peroxide and 
diatomic oxygen, as a positive control for cell death inhibition. Cells were also treated with 50 
µM menadione as another positive control for mitochondrial ROS production. For all 
conditions, cells were harvested and stained with DiOC6 and PI for cell death and mitoSOX 
for mitochondrial ROS production within each sample. The FACS results quantified by 
FlowJo software (BD bioscience) were used to determine the percentage of dead cells 
(DiOC6-negative and PI-positive) and mitoSOX-positive cells in each sample. The 
histograms of mitoSOX-positive cells (FL-2) were plotted in the same graph. The result 
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shows that 66.6% of cells died upon p20Bap31-upregulation whereas it was significantly 
reduced to 46.6% and 31.2% when PHB and CypF were overexpressed, respectively 
(Figure 5-4A). Furthermore, 57.8% of cells were mitoSOX-positive, which significantly 
decreased to 41.6% and 39.4% in PHB and CypF-upregulated HeLa cells, respectively 
(Figure 5-4B,C). There was less cell death and ROS was produced at significantly lower 
levels when MnSOD was upregulated. This result demonstrates that ectopic expression of 
PHB and CypF can inhibit both cell death and ROS production in p20Bap31-upregulated 
HeLa cells. This result indicates that complex II of the respiratory chain and PTP at the 
mitochondria play a role in the ARCosome activation pathway in mitochondria.   
 To support that, complex II in cell death was turned on in p20Bap31-induced cell 
death, these cells were also treated with 3NP, an inhibitor of SDH activity in complex II. 
HeLa cells were transfected with p20Bap31 5 hours prior to 1 mM 3NP treatment. Cells were 
harvested 24 hours following the start of treatment and stained with DiOC6 and PI for cell 
death. Cells were also stained with mitoSOX for mitochondrial ROS production. The FACS 
results were used to determine the percentage of dead cells (DiOC6-negative and PI-
positive) and mitoSOX-positive cells within each sample. The percentage of dead cells and 
mitoSOX-positive cells were normalised to 70.5%±2.24 of GFP-positive and therefore 
transfected cells. The results show that 68.2% of cells died when p20Bap31 was 
overexpressed, whereas only 41.4% of death was observed when these cells were treated 
with 3NP (Figure 5-5A). In addition, 3NP was also shown to inhibit ROS production at the 
mitochondria. 57.8% of cells showed a positive signal for mitoSOX, while it significantly 
decreased to 40.3% upon 3NP treatment (Figure 5-5B). This and the previous result from 
Figure 4-4 indicate that complex II, more specifically in this case its SDH activity, is involved 
in ARCosome-induced cell death signalling.      
 
 
 
 
 
 
 
 
160 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3 : Bax activation upon Fis1-induced cell death requires Bap31. 
(A) Scrambled- and Bap31- knockdown HeLa cells were transfected with Fis1 and harvested 
24 hours post-transfection. The percentage of cells with activated Bax was determined by 
immunofluorescence using an antibody against activated Bax (556467, BD Pharmingen) and 
Alexa Fluor® 488 Goat Anti-Rabbit IgG (Invitrogen) prior to quantifying by FACS. The 
knockdown level of Bap31 was determined by western blot analysis. (B) Scrambled- and 
Bap31- knockdown HeLa cells were transfected with p20Bap31 and Bax as a positive 
control and harvested 24 hours post-transfection. The percentages of cells with activated 
Bax were determined by immunofluorescence using antibody against activated Bax and 
Alexa Fluor® 488 Goat Anti-Rabbit IgG prior to quantifiying by FACS. The percentage of 
cells with activated Bax was normalised with 90.5%±1.02 of GFP-positive and therefore 
transfected cells. Data are presented as means ± S.D. n=3, ** p<0.01 (student‟s t-test). 
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Figure 5-4 : Prohibitin (PHB) and cyclophylin F (CypF) inhibition of p20Bap31-induced 
cell death and mitochondrial ROS production 
(A) HeLa cells were cotransfected with p20Bap31 and either prohibitin (PHB) or cyclophylin 
F (CypF) 24 hours prior to FACS analysis. The percentage of stained cells was quantified by 
FlowJo software (BD bioscience). HeLa cells were cotransfected with p20Bap31 and 
Manganese SOD (MnSOD) as a positive control of mitochondria-related cell death inhibition 
via ROS squelching. Cells were harvested and stained with DiOC6 and PI for cell death.The 
FACS results were used to determine the percentage of dead cells (DiOC6-negative and PI-
positive) within each sample. (B) Cells were stained with mitoSOX for mitochondrial ROS 
production. The FACS results were used to quantify the percentage of mitoSOX-positive 
cells for each sample. Data are presented as means ± S.D. n=3, *** p<0.001 (student‟s t-
test). (C) The histogram of mitoSOX-stained cells (FL-2) was plotted in the same graph. 
Cells were treated with 50 µM menadione as a positive control for mitochondrial ROS 
production.  
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Figure5-5 : 3NP inhibition of p20Bap31-induced cell death and mitochondrial ROS 
production 
(A) HeLa cells were transfected with p20Bap31 5 hours prior to 1 mM 3NP treatment for 24 
hours. Cells were harvested and stained with DiOC6 and PI for cell death. The FACS results 
were used to determine the percentage of dead cells (DiOC6-negative and PI-positive) within 
each sample. (B) Cells were stained with mitoSOX for mitochondrial ROS production. The 
FACS results were used to quantify the percentage of mitoSOX-positive cells within each 
sample. The percentage of dead cells and mitoSOX-positive cells were normalised 
to70.5%±2.24 of GFP-positive and therefore transfected cells. Data are presented as means 
± S.D. n=6 *** p<0.001 (student‟s t-test). 
 
 
 
 
 
 
 
(B)(A)
163 | P a g e  
 
5.2.3  p20Bap31 induces the dissociation of complex II as determined by FRET. 
 
 Complex II of the respiratory chain is a sensor of apoptosis signalling at the 
mitochondria. When complex II is activated in apoptotic cells, the sub-complex comprising 
SDHA and SDHB is released from the membrane-anchoring SDHC/SDHD sub-complex.  It 
was discovered that Ca2+ ions pass into mitochondria and bind to cardiolipin. Upon this 
binding, it clusters and dissociates from complex II. This results in the disintegration of the 
SDHA/SDHB sub-complex from the SDHC/SDHD sub-complex leading to ROS generation 
for PT-pore activation and cell death as shown in the model in Figure 5-6A.In our lab, Hwang 
et al developed a novel tool by measuring the FRET efficiency ratio between the CFP-SDHD 
donor and the YFP-SDHB acceptor to investigate the dissociation of these two complex II 
subunits (Hwang et al, 2014). The CFP-SDHD donor and YFP-SDHB acceptor FRET 
constructs used in this experiment are shown in Figure 5-6B. The 3D protein structure of the 
SDHA/SDHB sub-complex and SDHC/SDHD sub-complex is presented in Figure 5-6C. 
HeLa cells stably expressing the CFP-SDHD donor and the YFP-SDHB acceptor were 
generated by infection with lentiviral particles, which produce the fusion proteins (Hwang et 
al, 2014). The protein expression and localisations of the CFP-SDHD donor and the YFP-
SDHB acceptor in combination with mitochondrial staining by TMRE were investigated using 
confocal microscopy (Leica TCS SP5) (Hwang et al, 2014). The results show that both, CFP-
SDHD donor and YFP-SDHB acceptor, are localised to the mitochondria as revealed by 
TMRE staining (Hwang et al, 2014)(Figure 5-6D). FRET was monitored using the CFP-
SDHD donor and YFP-SDHB acceptor fusion proteins with the Leica TCS SP5 Confocal and 
its FRET Sensitised Emission (SE) Wizard. The FRET efficiency was calculated using the 
Leica protocol with a specific equation (see Material and Method).  
 According to Hwang et al‟s results, a strong reduction in FRET efficiency was 
observed upon As2O3 treatment (Hwang et al, 2014), which is known to induce Ca
2+ influx 
into mitochondria (Keinan et al, 2013). These results indicate that SDHB and SDHD 
disintegrate under this condition. Furthermore, prohibitin (PHB), the mammalian homologue 
of the yeast complex II assembly factor Tcm62p14, efficiently reduced the disintegration of 
SDHB and SDHD by As2O3 (Hwang et al, 2014) (Figure 4-7A). The release of the sub-
complex SDHA/SDHB also led to ROS accumulation as measured by MitoSOX, which emits 
a red fluorescent signal upon oxidation by superoxide. The ROS production and the 
dissipation of the mitochondrial membrane potential (ΔΨ) can also be inhibited by the up-
regulation of PHB (Hwang et al, 2014) (Figure 5-7B, 5-7C). Additionally, As2O3 treatment, 
resulting in ROS production, was supported by the observation that MnSOD can inhibit cell 
death under these conditions (Hwang et al, 2014)(Figure 5-7D).   
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 Based on Hwang et al, this FRET tool was used in my study to investigate whether 
the activation of complex II leading to the production of ROS is also a downstream 
consequence for cell death at the mitochondria when the ARCosome is activated. The 
p20Bap31 expression plasmid was transfected into a HeLa clone stably expressing the 
FRET acceptor (YFP-SDHB) and the FRET donor (CFP-SDHD). The start and end 
calculation for FRET efficiency was made in triplicates 4 and 20 hours post-transfection, 
respectively. The percent decrease in FRET efficiency ratio was calculated from two sets of 
measurements and normalised to fixed cells as a negative control. The results show that 
ectopic expression of p20Bap31resulted in the decrease in FRET efficiency between the 
acceptor (YFP-SDHB) and the FRET donor (CFP-SDHD). The percent decrease of FRET 
efficiency ratio was 8.1% in β-gal transfected cells, but significantly increased to 60.1% when 
p20Bap31 was up-regulated (Figure 5-8). This result indicates that p20Bap31, a 
consequence of ARCosome activation, induces the disintegration of complex II, in this case 
assessed by the association between SDHB and SDHD. Additionally, as PHB was shown to 
inhibit the disintegration of complex II, mitochondrial ROS production and cell death in Figure 
4-7 (Hwang et al, 2014), the inhibitory role of PHB in p20Bap31-induced cell death was 
further investigated. p20Bap31 and either pcDNA3 or the PHB expression plasmid were co-
transfected into a HeLa clone pool stably expressing the FRET acceptor (YFP-SDHB) and 
the FRET donor (CFP-SDHD) prior to investigating FRET efficiency. The initial and the end 
calculations for FRET efficiency were made 4 and 20 hours following the co-transfections, 
respectively. The results show that PHB can efficiently inhibit the disintegration of complex II 
(SDHB from SDHD). The percent decrease of FRET efficiency ratio was reduced from 
48.9% in p20Bap31-transfected cells to 3.6% when PHB was co-transfected with p20Bap31.  
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Figure 5-6 : Complex II of respiratory chain in cell death  
(A) The role of complex II in apoptosis outlined in a model. In apoptotic cells, the influx of 
Ca2+ into the matrix of mitochondria (left panel) leads to the dissociation of enzymatically 
active SDHA/SDHB sub-complex from the membrane-anchoring SDHC/SDHD sub-complex. 
As a result ROS are generated resulting in PT-pore activation for cell death (right panel)     
(B) The MT sequence represents the N-terminal mitochondrial-targeting sequence that is 
cleaved off upon the protein‟s import into mitochondria. The FRET donor construct is 
composed of CFP fused to the N-terminus of SDHD. In addition, a sequence of the mature 
SDHD sequence was duplicated on the N-terminus of CFP following the MT sequence to 
ensure efficient cleavage site recognition. The FRET acceptor construct consists of YFP 
fused to the C-terminus of SDHB via a linker sequence. (C) The predicted location of FRET 
fusions are highlighted in the crystal structure of complex II. The distance between the N-
terminus of SDHD (left circle) and the C-terminus of SDHB (right circle) is approximately 
eight Ångströms. Adapted from (Sun et al, 2005). (D) Images of HeLa cells taken using a 
Leica SP5 confocal microscope following the transient co-transfection of both FRET YFP 
acceptor and CPF donor constructs in combination with mitochondria staining with TMRE.  
Figure (C,D) were reprinted from (Hwang et al, 2014). 
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Figure 5-7 :  FRET between SDHB and SDHD fusion proteins, a novel tool to 
investigate Complex II disintegration by As2O3  
(A) HeLa stable clones expressing the FRET acceptor (YFP-SDHB fusion protein) and the 
FRET donor (CFP-SDHD fusion protein) were transfected with pcDNA3 and prohibitin (PHB) 
24 hours prior to treatment with As2O3. Cells were treated with DMSO, the carrier alone, or 
with 10 μM As2O3 for 15 hours. Complex II dissociation measured by FRET efficiency was 
determined in triplicates at 0 hour and 15 hours after treatment started.  The two sets of 
measurements were used to calculate the percent decrease in FRET efficiency ratio with a 
positive value representing a decrease and a negative value representing an increase. (B) 
The cells which were transfected and treated as same as the conditions in A were 
determined mitochondrial ROS production using MitoSOX staining prior to FACS analysis 
with FL-2 channel. (C) The role of PHB for cell death inhibition upon 10 μM As2O3 treatment 
for 25 hours was determined by DiOC6 and PI staining prior to FACS analysis. (D) HeLa 
cells were transfected with pcDNA3 as a control or MnSOD 24 hours prior to treatment with 
10 μM As2O3 for 25 hours and harvested for FACS analysis to determine the percent cell 
death present within each sample.Data are presented as means ± S.D. n=3 *** p<0.001,** 
p<0.01  (student‟s t-test). 
Figure was reprinted from (Hwang et al, 2014). 
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Figure 5-8 : The dissociation of complex II upon upregulation of p20Bap31 measured 
via FRET efficiency.  
HeLa clones stably expressing the FRET acceptor (YFP-SDHB fusion protein) and the FRET 
donor (CFP-SDHD fusion protein) were transfected with pcDNA3 empty vector and 
compared with those transfected with p20Bap31. An initial calculation for FRET efficiency 
was made in triplicate for both sets 4 hours following transfection and an end calculation for 
FRET efficiency was made in triplicate for both sets 20 hours post transfection. The two sets 
of measurements were used to calculate the percent decrease in FRET efficiency ratio, 
normalised to a fixed control, with a positive value representing the percent decrease and a 
negative value representing the percent increase. Data are presented as means ± S.D. n=3, 
*** p<0.001 (student‟s t-test). 
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Figure 5-9 :  Prohibitin (PHB) inhibits the dissociation of complex II induced by 
p20Bap31 upregulation measured via FRET efficiency.  
HeLa cells were co-transfected with p20Bap31 and either pcDNA3 or PHB to observe for the 
consequences of inhibition. An initial calculation for FRET efficiency was made in triplicate 
for all four sets 4 hours following the co-transfections and an end calculation for FRET 
efficiency was made in triplicate for all four sets 20 hours post co-transfections. The two sets 
of measurements were used to calculate the percent decrease in FRET efficiency ratio with 
a positive value representing a percent decrease and a negative value representing a 
percent increase. Data are presented as means ± S.D., n=3 *** p<0.001 (student‟s t-test). 
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5.3  Discussion 
 
The reduced Ca2+-dependent apoptotic signalling at the ER is associated with an 
impaired release of Ca2+ from this organelle and/or a decreased ER Ca2+ storage. Bcl-2 
family members are one of the most important proteins to regulate ER Ca2+ store and/or 
signalling leading to apoptosis. Although Bcl-XL and Bcl-2 proteins have been shown to 
inhibit Ca2+ signalling during apoptosis (Chen et al, 2004; Pinton & Rizzuto, 2006; Rong & 
Distelhorst, 2008; Szegezdi et al, 2009; White et al, 2005; Xu et al, 2007), their exact roles at 
the ER are only incompletely known. In Chapter 3, the inhibitory role of Bcl-XL and Bcl-2 
were shown in Fis1- and etoposide treatment-induced cell death. In this chapter, the role of 
Bcl-XL and Bcl-2 in Ca
2+ signalling related to the ARCosome activation pathway was 
examined. It was previously discovered in our group by Iwasawa et al that Fis1, an inducer 
of ARCosome activation, and also the pro-apoptotic p20Bap31, which is generated upon 
ARCosome activation, bring about ER Ca2+ release into the cytoplasm (Iwasawa et al, 
2011). In my study the result in Figure 5-1A corresponds to his finding. Importantly, in my 
study, both Bcl-XL and Bcl-2 were shown to significantly diminish the cytosolic Ca
2+ upon 
Fis1 upregulation. The effect of Bcl-XL and Bcl-2 to reduce the cytosolic Ca
2+ is possibly 
caused by a decreased ER Ca2+ storage or the inhibition of Ca2+ release from the ER. The 
first possibility is supported by evidence showing that Bcl-XL and Bcl-2 regulate ER Ca
2+ 
uptake through inhibiting SERCA, the Ca2+ ATPase for transferring Ca2+ from the cytosol to 
the ER (Dremina et al, 2004; Dremina et al, 2006)and the alteration of the IP3R/SERCA 
expression level (Kuo et al, 1998; Li et al, 2002; Vanden Abeele et al, 2002). This question is 
an interesting point to be addressed in future experiments. In line with this observation, in 
Figure 5-1B, a higher amount of Ca2+ was also taken up by the mitochondria upon Fis1-
induced cell death. In the same way this could be inhibited in cells co-transfected with either 
Bcl-XL or Bcl-2. This result points out that the diminished cytosolic Ca
2+ was also less 
efficiently taken up by the mitochondria. This finding is in line with studies showing that the 
overexpression of wild-type or ER-restricted Bcl-XL/ Bcl-2 decrease both ER Ca
2+ release as 
well as Ca2+uptake by the mitochondria (Pinton & Rizzuto, 2006; Rong & Distelhorst, 2008; 
Szegezdi et al, 2009). These results further support my model that Bcl-XL and Bcl-2 regulate 
ARCosome activation through inhibiting caspase-8 recruitment at the ER, which are events 
upstream of the mitochondria activation for cell death.  
 The ER and mitochondria channels responsible for Ca2+ release and uptake in the 
ARCosome signalling pathway were attempted to be determined in this chapter. The results 
in Figures 5-2A and 5-2B show that based on specific inhibitors RyR but not IP3R partially 
play a role in releasing Ca2+ from the ER to the cytoplasm. Additionally the MCU and the 
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ANT seem to play a role in this pathway. These results were obtained in experiments in 
which Fis1-transfected cells were treated with particular inhibitors of these channels. The 
inhibition effect might be stronger when these channels would be specifically down-regulated 
using genetic tools, so this experiment should be confirmed in a future study. However, the 
role of IP3R in this signalling pathway should not be overlooked as IP3R regulates ER Ca
2+ 
signalling and/or IP3R phosphorylation depending on the interaction with Bcl-XL or Bcl-2 
(Chen et al, 2004; Hanson et al, 2008; Rong et al, 2009; White et al, 2005). The MCU is a 
low affinity transporter; therefore, high local [Ca2+] is required for mitochondrial Ca2+ uptake. 
The complexes tethering the ER and the mitochondria possibly facilitate this. For example, 
within mitochondria-associated membranes (MAMs) the close proximity of MCU and ER 
Ca2+ release channels promotes efficient Ca2+ transfer from the ER to the mitochondria. The 
importance of MAMs has been addressed by a number of researchers. The complete protein 
components of MAMs, however, have not been identified yet (Giorgi et al, 2009; Hayashi et 
al, 2009; Rizzuto et al, 2009). The ARCosome on its own might play a role in Ca2+ transfer 
from the ER to the mitochondria or it possibly performs this role through being a part of the 
MAMs. Furthermore, Ca2+ transfer between these two organelles, which is a consequence of 
the ARCosome activation, might depend on the putative ER ion channel A4 since it was 
identified as a Bap31 binding partner: The apoptosis protective effect of a caspase resistant 
form of Bap31 (crBap31) following Fas stimulation, such as the inhibition of cytoplasmic 
membrane blebbling and fragmentation, loss of membrane integrity and cytochrome c 
release, relies on the presence of this putative ion channel A4 (Wang et al, 2003).  
MOMP for apoptosis can be achieved through Bax and/or Bak activation and the 
induction of the mitochondrial permeability transition (MPT) as mentioned before. Bax is 
activated in Fis1 upregulated-induced apoptosis (Iwasawa et al, 2011), while the question 
whether Bap31 is necessary for Bax activation in this pathway remained unanswered. Here 
my results show that Bap31 is required for Bax activation upon ARCosome activation by  
Fis1. Furthermore, the activation of complex II of the respiratory chain and PTP at the 
mitochondria in this pathway was investigated. The hypothesis that complex II might be 
activated in the ARCosome activation pathway came from the finding, discovered in our 
group, that complex II disintegration results from high Ca2+ concentration and massive 
mitochondrial Ca2+ influx (Hwang et al, 2014). Ca2+ transmission to the mitochondria was 
therefore assumed to be possibly facilitated by the ARCosome complex, which physically 
bridges the ER and the mitochondria. In addition, prohibitin (PHB) was used as an inhibitor 
for complex II activation since the disintegration of SDHA/SDHB sub-complex from the 
SDHC/SDHD sub-complex leading to cell death can be blocked by PHB (Hwang et al, 2014). 
In addition, 3NP, a pharmacological SDHA (a complex II component) inhibitor, was also 
used as an additional proof to investigate this point. CypF, a protein component of the PT 
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complex, was used to determine the activation of the PTP as it can inhibit this complex and 
apoptosis when upregulated (Li et al, 2004). The results demonstrate that cell death and 
mitochondrial ROS production induced by pro-apoptotic p20Bap31, the cleavage form of 
Bap31, can be inhibited by Prohibitin (PHB) and 3NP as well as Cyclophilin F (CypF, 
CypD)(Figure 5-4, 5-5). These results show that complex II and PTP at the mitochondria are 
activated in the ARCosome activation pathway. However, the multi-target inhibitory role of 
Bcl-2 family members cannot be overlooked since Bcl-2 family members have been 
demonstrated to interact with regulators of PTP and to control the PTP (Juhaszova et al, 
2008; Smith et al, 2008; Tsujimoto et al, 2006).  
In addition to inhibition experiments for complex II investigation, Hwang et al 
developed a novel tool, FRET, in our lab to determine the dissociation of the two sub-
complexes of complex II, namely the releasing of the SDHA/SDHB sub-complex from the 
membrane-anchoring SDHC/SDHD sub-complex. This disintegration results in electron 
transfer from the substrate succinate to oxygen molecules that leads to ROS production for 
cell death (Albayrak et al, 2003; Lemarie et al, 2011). Relying on this mechanism, FRET 
efficiency ratio between the CFP-SDHD donor and the YFP-SDHB acceptor was monitored 
to investigate the dissociation of these two complex II sub-complexes. The position of SDHD 
and SDHB was predicted from the crystal structure of complex II reported by Sun et al (Sun 
et al, 2005)to assume that these two proteins are in close physical juxtaposition to be 
detected with the FRET technique. The predicted 3D structure showed that the N-terminus 
of SDHD (FRET Donor Construct) was approximately eight Ångströms apart from the C-
terminus of SDHB (FRET Acceptor Construct). CFP and YFP were therefore fused with the 
SDHD donor and the SDHB acceptor, respectively, according to the predicted positions. 
According to the results, it was shown that both CFP-SDHD donor and YFP-SDHB acceptor 
localise to the mitochondria as expected since they were fused with the N-terminal 
mitochondrial-targeting sequence (MT) as wild-type proteins (Hwang et al, 2014). Hwang et 
al successfully validated this tool to show that the dissociation of complex II sub-complexes 
was observed in HeLa cells treated with As2O3 (Hwang et al, 2014). Additionally, this 
disintegration of complex II, in line with cell death and mitochondrial ROS production, can be 
inhibited by PHB.  
 In my study, ectopic expression of p20Bap31 induces SDHD and SDHB dissociation 
as measured by the decrease of FRET efficiency ratio. This dissociation in these cells was 
inhibited by the overexpression of PHB. These data support the previous results that 
complex II is activated in the ARCosome signalling pathway. This finding highlights the 
connection of ARCosome activation at the ER leading to Ca2+ transmission from this 
organelle to the mitochondria. As a consequence of this activation, complex II and PTP are 
activated as part of the downstream signalling pathway at mitochondria. 
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Chapter 6    
ARCosome activation in necroptosis as an alternative cell 
death scenario  
 
6.1 Introduction      
6.1.1  Necroptosis 
Cell death is a process to eliminate non-essential or damaged cells during cellular 
development, homeostasis and pathogenesis. In the early 1970s, the term “apoptosis” was 
coined to explain a regulated cell death process (Kerr et al, 1972). Apoptosis is 
characterised by morphological and chemical changes, including cell shrinkage, membrane 
blebbling, chromatin condensation and non-random DNA fragmentation as well as caspase 
activation. Another form of cell death, which displays a „balloon-like‟ morphology without 
nuclear disintegration was most recently identified in 1988 (Laster et al, 1988). While 
apoptosis was considered as a form of programmed cell death, necrosis was regarded as an 
unregulated and uncontrollable process. The main features that distinguish necrosis from 
apoptosis are summarised in Table 6-1.  
The regulation of necrosis is governed by Bcl-2 family members. Necrotic cell death, 
in some cases, can be activated by pro-apoptotic and inhibited by anti-apoptotic Bcl-2 family 
members (Amarante-Mendes et al, 1998; Burton & Gibson, 2009; Fukuda & Yamamoto, 
1999; Moubarak et al, 2007; Quinsay et al, 2010; Tsujimoto et al, 1997). These effective and 
protective effects of Bcl-2 family proteins in necrosis may result from their roles in MPT, 
Bax/Bak dependent MOMP and/or ER-mitochondria Ca2+ transfer. The disruption of 
mitochondrial integrity is probably involved in both apoptotic and necrotic cell death (Pradelli 
et al, 2010; Tait & Green, 2008).  
 Accumulating evidence reveals that necrosis can also be regulated. The term 
“necroptosis” has emerged to describe this phenomenon of “programmed necrosis”. 
Necroptosis requires the kinase activity of receptor-interacting protein 1 and 3 (RIP1 and 
RIP3) (Cho et al, 2009; He et al, 2009; Holler et al, 2000; Hsu et al, 1996a). The 
physiological role of necroptosis has been largely underestimated due to limited biochemical 
markers. This restriction has now been partially addressed since an allosteric RIP1 inhibitor, 
necrostatin-1 (nec-1), was identified (Degterev et al, 2008; Vandenabeele et al, 2008). This 
kind of cell death can be initiated by a variety of cell death inducers, such as tumour necrosis 
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factor (TNF), DNA damage, ischemia/reperfusion (I/R) and DR ligation(Declercq et al, 2009; 
Duprez et al, 2009; Galluzzi & Kroemer, 2008). 
  Unregulated necroptosis is involved in diseases, such as neurogenesis, ischaemic 
injury and viral infection (Cho et al, 2010; Duprez et al, 2009; Tait & Green, 2008; 
Zhivotovsky & Orrenius, 2010). Additionally, necroptosis has also been observed in 
chemotherapy-induced cell death in cancerous cells. Hence, molecules and processes in 
this pathway are attractive targets for drug design in such diseases.  
Table 6-1 : The different phenomenon between apoptosis and necroptosis (adapted 
from (Han et al, 2011)) 
apoptosis necroptosis 
affects single cells affects groups of neighbouring cells 
no inflammatory response significant inflammatory response 
cell shrinkage  cell swelling  
membrane blebbling but integrity maintained lost membrane integrity 
Initially increased mitochondria membrane 
potential 
organelle swelling and lysosomal leakage  
chromatin condensation and non-random   
DNA fragmentation 
random degradation of DNA  
apoptotic bodies ingested by neighbouring 
cells 
lysed cells ingested by macrophages 
 
6.1.2 IFNγ-induced necroptosis 
The interferons (IFNs) are a family of cytokines classified into two major groups 
depending on their cell surface receptors, stimuli and cells that produce them. Type I 
interferons (predominantly α/β) are produced by most cell types in response to virus 
infections. In contrast, type II interferon (IFN-γ) is made primarily by T cells and NK cells and 
is not virus inducible (Stark et al, 1998). Based on its antiproliferative and 
immunomodulatory properties, IFN-γ has widely been applied as antitumour agents. 
However, the antitumour efficacy of IFN-γ is still controversial in term of its toxicity and short 
half-life in serum (Balachandran & Adams, 2013). Antibody-cytokine fusions have been 
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developed to enhance the stability and the half life of IFN-γ in the circulation (Ghetie & Ward, 
2002). IFN-γ was found to induce RIP1-dependent necroptosis, which can be inhibited by 
nec-1 in NF-B–deficient cells. IFN-γ induces the accumulation of ROS and eventual loss of 
mitochondrial membrane potential in these cells (Thapa et al, 2011). Hence, to investigate 
whether ARCosome activation plays a role in necroptosis, IFN-γ was used as an inducer of 
this pathway in my study.   
 
6.1.3  Alzheimer’s disease (AD) 
 Lower fertility and mortality of the world population are major causes of demographic 
transition in demographics. This transition has been rapid and shifted the mean age 
distribution from children and working-age to the elderly in the world population, especially in 
developed countries. In addition, this trend has been projected to considerably increase in 
the next few decades. The number of persons aged over 60 years is projected to grow to 
nearly 2 billion by 2050, which is estimated to be 22% of the whole population. By that date, 
11% of the population will be aged 80 or older (United Nations. Department of Economic and 
Social Affairs. Population Division., 2000). This demographic transition brings about a 
considerable increase in the number of elderly people. It is inevitable that cancer and heart 
disease will be the leading causes of death in future decades. Interestingly, according to 
statistics, the percentage of people that died with Alzheimer‟s disease increased by 68% in 
2000-2010, whereas the number who died from cancer and heart disease was slightly 
reduced(Anderson, 2002; y Sherry L. Murphy, 2013). This trend possibly stems from this 
demographic transition.    
 Alzheimer‟s disease (AD) is the most common irreversible neurodegenerative 
disorder, which is characterised by progressive neuronal loss. The accumulation of 
intracellular neurofibrillary tangles and extracellular plaques is presumed to be the main 
cause of AD. Amyloid-β (Aβ), which is a small peptide derived from processing of the 
amyloid-β precursor protein (APP) and the prominent component of plaque, is most 
prominently associated with AD (Goedert & Spillantini, 2006). AD is often characterised as a 
late-onset neurodegenerative disorder since it is often diagnosed in people aged over 
65 years. However, less than 1% of patients have also diagnosed as early-onset AD, which 
is inherited in autosomal-dominant manner in younger people (Harvey et al, 2003). The main 
factors of early-onset AD are mutation in one of three proteins: the above mentioned APP, 
presenilin 1 (PS1) and/or presinilin 2 (PS2). PS1 and PS2 are components of -secretase, 
which can cleave APP at several positions to generate various lengths of Aβ fragments. Aβ 
that is 42 amino acids long (Aβ42) is more likely to form plaques in the brain than other 
versions. The mutation of APP, PS1 and/or PS2 results in the increase of Aβ42 compared to 
other forms (Citron et al, 1997; Jayadev et al, 2010). This accumulation of Aβ42 leading to 
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plaque formation in early-onset AD possibly cause a higher rate of cell death in the brain and 
consequently mortality in younger people.      
 
6.1.4  Cell death in Alzheimer’s disease 
Cell death and tissue loss throughout the brain are presumably a major cause for AD. 
The symptoms of AD correlate with the destruction of particular regions of brain, which 
control different functions. The most common symptom in AD starts with the loss of the 
ability to remember new information, which is a consequence of the hippocampus damage. 
The following are common symptoms in AD: short-memory loss, time and space confusion, 
speaking and writing problems, visual images and spatial relationship difficulty, poor 
judgment and mobility deterioration in late stage of AD. Current evidence has suggested that 
Aβ may play a key role for neuronal apoptosis involving a mitochondria-dependent pathway. 
Aβ treatment in differentiated SK-N-BE neurons leads to cytochrome c release, PARP 
cleavage and the caspase-3 activation. The prevention of Aβ-induced apoptosis is 
demonstrated by a specific p53 inhibitor (Tamagno et al, 2003). This piece of information 
shows that p53 also plays a role in Aβ-mediated cell death pathway in AD. The precise 
mechanism(s) how Aβ induces apoptosis in neurons, however, remain unanswered.        
Accumulating evidence suggests that oxidative stress generated in brain tissue might be a 
cause for this disease. Reactive oxygen species, generated in neuronal cells, seem to cause 
protein oxidation, lipid peroxidation and peroxynitrite formation, which have been detected in 
human brain samples or in experimental models (Pratico, 2002). Interestingly, it was shown 
for the first time in Lu et al‟s study in 2014 that apoptosis inhibition of neurons has a clinical 
benefit for AD (Lu et al, 2014). In this study, repressor element 1-silencing transcription 
factor (REST) was identified as important for mild cognitive impairment and AD. REST 
protects neuronal cell death from oxidative stress and Aβ toxicity (Lu et al, 2014). It works 
through the suppression of cell-death promoting genes and the promotion of anti-apoptosis 
genes (Lu et al, 2014). However, all protein targets of REST have not yet identified. 
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6.2  Results 
 
6.2.1  IFNγ-induced necroptosis is caspase independent. 
 In healthy cells, phosphotidylserine (PS) is normally found on the intracellular leaflet 
of the cell membrane. On the other hand, PS translocates to the external leaflet during early 
apoptosis resulting in the loss of membrane asymmetry. According to this property, 
Fluorochrome-labeled Annexin V therefore can be used to identify apoptotic cells. 
Additionally, PI was used to determinemembrane permeability. In necroptotic cells, no PS 
translocates to the external leaflet and the positive signal of membrane permeability (FITC-
conjugated Annexin V negative and PI positive) should be detected. To set up a suitable 
condition to study the signalling pathway of IFNγ-mediated cell death, the concentrations of 
IFNγ and the treatment periods were determined in HeLa cells this could induce 
approximately 40-50% necroptosis in the cell population. In this experiment, the percentage 
of necroptotic cells after 12.5, 25, and 50 ng/ml IFNγ treatment in combination with different 
time points (72, 96, 120 hours) was determined. To distinguish necroptotic cells from 
apoptotic cells, 200 μM etoposide and 0.5 μM actinomycin D for drug-induced apoptosis, 
were applied as a control for apoptosis. According to the plots in Figure 6-1A, 29.3 and 
29.5% of the population treated with 25 and 50 ng/ml IFNγ for 120 hours were necroptotic 
cells (FL-1 (Annexin V) negative and FL-3 (PI) positive). The gating was adjusted based on 
the plot of cells treated with etoposide and actinomycin D shown in Figure 5-1B.  Hence, the 
treatment with 25 ng/ml IFNγ for 120 hours was applied in all further experiments. 
Additionally, the minimum concentration of zVAD, a pan-caspase inhibitior, which can inhibit 
apoptosis was determined for further study. The zVAD activity was tested in cells treated 
with TNF and cyclohexamide (CHX), known to induce apoptosis. Different concentrations of 
zVAD were monitored in cells treated with 50 ng/ml TNF and 3 μg/ml (CHX). The results 
show that the lowest concentration at which zVAD can significantly inhibit apoptosis was 
12.5 μM and the inhibitory effect was stronger when concentrations of zVAD were increased. 
Upon TNF and CHX treatment, 46.6% of the population died (DiOC6 negative and/or PI 
positive), whereas a significant reduction to 28.1% was observed when these cells were 
treated with 12.5 μM zVAD. Hence, this concentration of zVAD was used in further 
experiments (Figure 6-2).   
 To investigate which type of cell death, apoptosis or necroptosis, IFNγ induces, cell 
death inhibition by zVAD and necrostatin-1 (nec-1), the necroptosis inhibitor, was 
determined in cells treated with IFNγ for 120 hours. HeLa cells were treated with 25ng/ml 
IFNγ in the presence of 12.5 μM zVAD or 100 µM nec-1.  The percentage of dead cells was 
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quantified using Annexin V-FITC and PI staining and analysed by FACS. The result shows 
that nec-1 but not zVAD could significantly inhibit cell death upon IFNγ treatment. 55.1% of 
cells died when treated with IFNγ alone, while it was significantly reduced to 19.2% when 
nec-1 was added in this treatment. Cell death was partially inhibited by zVAD; that is, it was 
reduced from 55.1% in treatments without zVAD to 45.2% when zVAD was added (Figure 6-
3A). In addition to Annexin V-FITC, PI staining, and FACS analysis, the number and 
morphology of dead cells under the microscope also corresponded to the FACS results 
(Figure 6-3B). These results indicate that IFNγ induces necroptosis and to a lesser extent 
apoptosis in HeLa cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-1 : Determination of the concentrations of IFNγ to induce necroptosis           
(A) HeLa cells were untreated (UT) or treated with 12.5, 25, and 50 ng/ml IFNγ prior to 
harvesting at 72, 96, and 120 hours following the start of treatment. Cells were then stained 
with FITC-conjugated Annexin V and PI. The percentage of necroptotic cells (FL-1 (Annexin 
V) negative and FL-3 (PI) positive) was quantified by FACS. Data are presented as means ± 
S.D., n=3. (B) Cells were treated with etoposide (200 μM, etop) and actinomycin D (0.5 μM, 
actD) as a control for apoptosis. 
 
 
(B) (A) 
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Figure 6-2 : Determination of the concentrations of zVAD to inhibit apoptosis  
HeLa cells were treated with 50 ng/ml TNF and 3μg/ml cycloheximide (CHX) in combination 
with 12.5, 25, 50, and 100 μM zVAD for 24 hours. Cells were harvested and analysed by 
FACS. The FACS results were used to quantify the percentage of dead cells (DiOC6-
negative and PI-positive) within each sample. Data are presented as means ± S.D. n=3,     
*** p<0.001 (student‟s t-test). 
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Figure 6-3 : IFNγ-induced necroptosis is largely caspase independent. 
(A) HeLa cells were treated with 25ng/ml IFNγ combination with either 100 µM necrostatin-1 
(nec-1) or 12.5 µM z-VAD for 120 hours. The percentage of cell death was quantified using 
Annexin V-FITC and PI staining. The percentage of cell death (PI-positive) was quantified by 
FACS. Data are presented as means ± S.D. n=3, *** p<0.001, ** p<0.01,* p<0.05 (student‟s 
t-test). (B) The number and morphology of cells treated with the conditions corresponding to 
(A) were analysed under the microscope.  
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6.2.2  The cleavage of Bap31 is an early event in IFNγ-induced necroptosis. 
 
 Based on results from previous chapters and other studies, Bap31 has been shown 
to play an important role in apoptosis or general cell death, but has not been identified as 
necroptosis or necrosis (Iwasawa et al, 2011; Ng et al, 1997; Ng & Shore, 1998). This 
therefore raises the interesting question whether Bap31 is also involved in necroptotic 
signalling for cell death apart from apoptosis. An experiment was set up to address this 
question. HeLa cells, treated with 25 ng/ml IFNγ, were harvested at 0, 72, 96, and 120 hours 
for analysis of their protein profile. The cleavage of Bap31 into the pro-apoptotic p20Bap31, 
a consequence of the ARCosome activation, was determined by probing with a Bap31 
antibody. The results show that Bap31 was gradually cleaved over time from 72 to 120 hours 
following treatment (Figure 6-4B). Interestingly, at 72 hours of treatment, approximately 40% 
of Bap31 cleavage was observed, whereas only 14.8% of cells were dead according to 
FITC-conjugated Annexin V, PI staining, and FACS results (Figure 6-4A, B). These results 
point out that Bap31 cleavage is an early event in IFNγ-mediated necroptosis. In addition to 
this finding, the role of the ARCosome in the IFNγ-mediated necroptosis pathway was 
determined. The survival effect was tested in cells where components of the complex were 
down-regulated. 25ng/ml IFNγ was applied for 72 hours to cells transfected with scrambled, 
Fis1, Bap31 or caspase-8 siRNA for 6 hours prior to treatment. Cells were harvested for 
staining with FITC-conjugated Annexin V, PI, and FACS analysis. The results show that cell 
death was significantly reduced when the ARCosome components were down-regulated. 
The percentage of dead cells was reduced to 2.1%, 13.2% and 14.7% when Fis1, Bap31 
and caspase-8 were knocked down respectively, whereas 36.9% of cells died in the 
scrambled control (Figure 6-5). These results indicate that the ARCosome plays an 
important role in cell death induced by IFNγ.  
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Figure 6-4 :  p20Bap31 cleavage is an early event in IFNγ-induced necroptosis. 
(A) HeLa cells were treated with 25ng/ml IFNγand harvested at 0, 72, 96, and 120 
hoursfollowing the start of treatment and stained with FITC-conjugated Annexin V and PI. 
The percentage of cell death was quantified via FACS analysis. (B) Protein lysates of cells at 
0, 72, 96, 120 hours treatment were probed with a Bap31 antibody (courtesy from Gordon 
Shore), one against GAPDH.  
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Figure 6-5 : The ARCosome components Bap31, Fis1, caspase-8 are involved in IFNγ-
induced cell death. 
HeLa cells were transfected with scrambled, Fis1, Bap31 or caspase-8 siRNA for 6 hours 
prior to 25ng/ml IFNγ treatment. Cells were harvested 72 hours following the start of 
treatment and stained with FITC-conjugated Annexin V and PI. The percentage of cell death 
was quantified via FACS analysis and normalised to the transfection efficiency of 
72.5±2.05%. Data are presented as means ± S.D. n=3, *** p<0.001 (student‟s t-test). 
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6.2.3 Bap31 and PARP but not other caspase substrates are cleaved upon IFNγ-
induced necroptosis. 
 Cell death signalling pathways are regulated and orchestrated by the cooperative 
network of caspases and the cleavage products of their substrates. Caspase-8, a prominent 
initiator caspase, and its substrates play a pivotal role in ARCosome-mediated apoptosis 
(Iwasawa et al, 2011). As shown in previous results, the ARCosome plays a role in the IFNγ-
mediated necroptosis signalling pathway (Figure 6-5). The question whether Bap31 is the 
only substrate cleaved by caspase-8 during this condition was a challenge to be answered. 
The caspase-8 substrates Flip, Bid, RIP and Bap31 as well as PARP, a caspase-3/7 
substrate, were investigated in this experiment. HeLa cells were treated with IFNγ in 
combination with nec-1, the necroptosis inhibitor, or zVAD, a pan-caspase inhibitor, using 
the same experimental settings as in Figure 6-3 for 120 hours. In addition, cells treated with 
etoposide and transfected with caspase-8 were used as positive controls for Bap31 cleavage 
into p20Bap31. Protein profiles of different conditions were analysed with western blot by 
probing with antibodies specific to the caspase substrates mentioned above. The results 
show that, upon 120 hours of 25ng/ml IFNγ treatment, procaspase-8 (56 KDa) was cleaved 
to active caspase-8 (19KDa) and both nec-1 and zVAD could inhibit this cleavage (Figure 6-
6). These results indicate that caspase-8 is activated in the IFNγ-induced necroptosis 
signalling pathway. In parallel with this finding, it was shown that IFNγ induced Bap31 
cleavage into the pro-apoptotic p20Bap31 and this cleavage could be inhibited by nec-1 but 
not by zVAD. Furthermore, in the caspase substrate list above, only PARP was cleaved and 
nec-1 could not inhibit this cleavage. These results therefore point out that Bap31 is the only 
caspase-8 substrate that was cleaved in this pathway.  
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Figure6-6 :Bap31 and PARP are cleaved during IFNγ-induced necroptosis 
HeLa cells were treated with 25ng/ml IFNγin combination with either 100 µM necrostatin-1 
(nec-1) or 12.5 µM z-VAD for 120 hours. Cells treated with 250 μM etoposide (etop) for 30 
hours or transfected with caspase-8 for 30 hours were used as a positive control for 
p20Bap31 cleavage. Protein lysates were probed with caspase-substrate antibodies namely 
Bap31, PARP, Flip, BID, RIP, caspase-8, and GAPDH.   
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6.2.4  Bcl-XL and Bcl-2 inhibit IFNγ-induced necroptosis. 
 As shown in Chapter 3 Bcl-XL and Bcl-2 inhibit ARCosome activation, induced by 
Fis-1upregulation or etoposide treatment, by blocking caspase-8 recruitment to the complex. 
In this chapter, the question, whether necroptosis-induced by IFNγ can be inhibited by these 
Bcl-2 family members, was addressed. Bcl-XL and Bcl-2 were upregulated in HeLa cells prior 
to treatment with 25 ng/ml IFNγ for 96, 120, and 144 hours. Cells were harvested for protein 
profile analysis using western blot. At the same time point, the percentage of dead cells 
under these particular conditions was also determined using FITC-conjugated Annexin V, PI 
staining, and FACS analysis. The results show that both Bcl-XL and Bcl-2 can significantly 
inhibit IFNγ-mediated cell death, (necroptosis), at all three time points. The percentage of 
surviving cells was observed to be higher under conditions where Bcl-XL was up-regulated 
compared to Bcl-2. In parallel, it was observed that the generation of p20Bap31 upon IFNγ 
treatment could be inhibited when Bcl-XL and Bcl-2 were ectopically expressed (Figure 6-7).    
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Figure 6-7 : Bcl-XL and Bcl-2 inhibit IFNγ-induced cell death.  
(A) HeLa cells were transfected with β-gal, Bcl-XL and Bcl-2 prior to treatment with 25ng/ml 
IFNγ 6 hours following transfection. Cells were harvested at 96, 120, and 144 hours after 
treatment and stained with FITC-conjugated Annexin V and PI. The percentage of cell death 
was quantified by FACS analysis. Data are presented as means ± S.D., *** p<0.001,             
** p<0.01,* p<0.05 (student‟s t-test). (B) Protein lysates were probed with an antibody 
against a C-terminal p20Bap31, Bcl-XL, Bcl-2and GAPDH.  
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6.2.5  Amyloid β-induced cell death depends on Bap31. 
 Activation of the ARCosome leading to cell death induction was investigated in 
neuronal cells, SHSY-5Y in this case. The correlation between Bap31 cleavage, a 
consequence of ARCosome activation, and cell death-induced by amyloid-β was 
determined. To determine the proper range of amyloid-β concentrations and time points for 
further study, a titration curve of amyloid-β treatment was tested. According to my data,48 
hours of treatment with 20 μM amyloid-β (1-42) led to approximately 50% cell death when 
cells were treated with the aggregated form of amyloid-β, whereas cell death was reduced to 
about 15% by non-aggregated forms (data not shown). Hence, the aggregated amyloid-β at 
this concentration was applied in subsequent experiments. Cells were harvested following 
48 hours of treatment for western blot analysis. In the same samples, cell death was 
determined using annexin V-FITC, PI staining, and FACS analysis. The results show that 
53.2% of cells died under these conditions (PI-positive cells). Interestingly, the generation of 
p20Bap31 was observed upon treatment (Figure 6-8A) and correlated with the percentage of 
dead cells (Figure 6-8B). In addition to p20Bap31, the intermediate p27Bap31 was also 
detected (Figure 6-8A). These results indicate that the ARCosome is also activated in 
neuronal cells treated with the aggregated amyloid-β (1-42).  
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Figure 6-8 :  p20Bap31 is cleaved upon amyloid-β treatment. 
(A) SHSY-5Y cells were treated with 20 μM of aggregated amyloid-β (1-42) for 48 hours. 
Protein lysates were probed with a Bap31 antibody (courtesy from Gordon Shore) or an 
antibody against GAPDH. (B) Treated cells were double stained with annexinV- FITC and PI 
and analysed by FACS. The percentage of dead cells was quantified by FlowJo software 
(BD bioscience). Data are presented as means ± S.D. n=3 *** p<0.001 (student‟s t-test). 
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6.2.6  Amyloid-β (1-42) induces both necrosis and apoptosis in SHSY-5Y cells. 
 The finding from Figure 6-8 raised the question what kinds of cell death -
apoptosis, necroptosis- are activated by amyloid-β. To answer this question, the plots of 
cells stained with annexin V- FITC and PI were determined at 0, 24, 36 and 48 hours of 20 
μM aggregated amyloid-β (1-42) treatment. The data demonstrate that cells gradually died 
over time. Although, at 48 hours, the percentage of cells with PI-positive signal was 52.2% 
over background (at 0 hour), the distinct groups of annexin V-positive or –negative were 
difficult to classify (Figure 6-9). This was further scrutinised through nec-1 and zVAD 
inhibition experiments. The inhibitory activity of nec-1 (100 μM) and zVAD (12.5 μM) were 
tested in SHSY-5Y cells treated with 20 μM amyloid-β (1-42) for 48 hours. FITC-conjugated 
Annexin V and PI were used to stain the cells prior to FACS analysis. The results show that 
both nec-1 and zVAD could inhibit cell death induced by amyloid-β. The percentage of dead 
cells was reduced from 31.9% to 20.0% and 21.8% when nec-1 and zVAD were added into 
the treatment, respectively. Additionally, under the microscope the number of live cells was 
higher in the amyloid-β treatment with nec-1 and zVAD compared to amyloid-β alone (Figure 
6-10). This data indicates that amyloid-β induces cell death via both the necroptotic and 
apoptotic pathways.   
 
 
 
 
 
 
 
 
 
Figure 6-9 :  Amyloid β-induced necroptosis at different time points  
SHSY-5Y cells were treated with 20 μM aggregated amyloid-β (1-42) for 0, 24, 36 and 
48hours. Treated cells were double stained with annexin V- FITC and PI and analysed by 
FACS.  The percentage of dead cells was quantified by FlowJo software (BD bioscience).  
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Figure 6-10 : Amyloid-β (1-42) induces both necroptosis and apoptosis in SHSY-5Y 
cells. 
SHSY5Y cells were treated with 20 μM amyloid-β (1-42) in combination with either 
necrostatin-1 (nec-1, 100 μM) or zVAD-FMK (12.5 μM) and harvested 48 hours following the 
start of treatment. The percentage of cell death was quantified using FITC-conjugated 
Annexin V, PI staining, and FACS analysis. Data are presented as means ± S.D. n=3 ** 
p<0.01 (student‟s t-test). 
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6.2.7  The  ARCosome components, Bap31, Fis1, caspase-8, are involved in amyloid 
β-induced cell death. 
 It was previously shown that Bap31 is cleaved during amyloid-β (1-42) treatment and 
its cleavage is correlated with the number of dead cells (Figure 6-8). An experiment was set 
up to investigate the role of the ARCosome in this signalling pathway. The question whether 
Bap31 and other ARCosome components, namely Fis1 and caspase-8, play a role in cell 
death induced by amyloid-β (1-42) was addressed. Bap31, Fis1, and caspase-8 were 
transiently down-regulated with shRNA transfection 20 hours prior to amyloid-β (1-42) 
treatment. After 48 hours, cell death was determined with FITC-conjugated Annexin V, PI 
staining, and FACS analysis. The results show that the percentage of dead cells treated with 
amyloid-β (1-42) was significantly diminished when Fis1, Bap31, and caspase-8 were down-
regulated in SHSY-5Y cells. Upon treatment, the percentage of dead cells was reduced from 
40.2% in scrambled cells to 14.8%, 25.1% and 11.7% in Fis1, Bap31 and caspase-8 
knockdown cells, respectively. This highlights the necessity of the ARCosome for cell death 
induced by amyloid-β (1-42). It is not only Bap31, technically through pro-apoptotic 
p20Bap31, but also Fis1 and caspase-8 that are indispensable for amyloid-β  (1-42)-induced 
cell death.   
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Figure 6-11 : ARCosome components, Bap31, Fis1, caspase-8, are involved in amyloid 
β-induced cell Death. 
SHSY-5Y cells were transfected with Fis1 shRNA (A), Bap31 shRNA (B) and caspase-8 
shRNA (C) for 24 hours prior to20 μM amyloid-β (1-42) treatment. Cells were harvested at 
48 hoursfollowing the start of treatment and stained with FITC-conjugated Annexin V and PI. 
The percentage of cell death was quantified using FACS analysis and normalised with 
63.9% of GFP-positive transfected cells. Data are presented as means ± S.D. n=3 *** 
p<0.001 (student‟s t-test). 
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6.2.8  Pro-apoptotic p20Bap31 is generated in Alzheimer patients. 
Based on my results (from Figure 6-8 to 6-11), not only was Bap31 cleavage 
observed when SHSY-5Y cells were treated with amyloid-β(1-42), but also the ARCosome 
was required for cell death induced by amyloid-β. To further scrutinise this finding in 
Alzheimer‟s disease, the expression level of p20BBap31 in Alzheimer patients compared 
with normal individuals was tested. Brain tissue samples of the frontal cortex and the 
hippocampus were obtained from the London Neurodegenerative Diseases Brain Bank and 
Brains for Dementia Research through the cooperation of Dr. Magdalena Sastre, Imperial 
College. Their details in age, sex and post-mortem delay (PMD, hours) were shown in Figure 
6-12D. Protein lysates of Alzheimer‟s and normal brain tissue (extracted by the courtesy of 
Dr. Magdalena Sastre, Imperial College) were analysed by probing with the C-terminal 
p20Bap31 antibody. Age is accepted as a key factor in neuronal cell death leading to 
Alzheimer‟s disease. p20Bap31 expression levels and the individuals‟ age were plotted in 
the graph to explore the correlation between these two factors. (Figure 6-12B,C). The graphs 
were separated into two graphs depending on age; that is, people under 75 and over 75 
years old were plotted in Figure 6-12A and 6-12B, respectively. The graphs show that, in the 
group under 75 years old, most of the Alzheimer‟s patients obtain a higher expression level 
of p20Bap31 compared to normal people (indicated with blue circle, Figure 6-12B). In the 
group over 75 years old, the relationship between p20Bap31 generation and age was not 
clear (Figure 6-12C). These results raise the possibility that higher expression levels of pro-
apoptotic p20Bap31 might be a lethal cause in younger patients with Alzheimer‟s disease. 
However, this is a hypothesis raised by referring to only 21 samples of brain tissue. To 
confirm this finding, more samples of both Alzheimer‟s and normal brain tissue would be 
required.  
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(D)  
Case Code Age Sex PMD Path. Diagnosis 
1 A323/11 85 F 40 
Alzheimer‟s disease HP-tau (Brakk) stage 5 
with marked amyloid angiopathy 
2 A204/11 92 F 11 
Alzheimer‟s disease HP-tau Brakk/BNE 
stage 5 
3 A028/11 95 F 51 
Alzheimer‟s disease pathology (BNE stage 5 
with skipping) with focal amyloid angiopathy 
and limbic TDP-43 pathology (amygdala) 
4 A282/10 68 M 25 
Alzheimer‟s disease HP-tau stage 6 with mild 
to moderate amyloid angiopathy 
5 A099/10 73 M 35 Alzheimer‟s disease Brakk 6 BNE 5 
11 A012/10 70 M 60 Alzheimer‟s disease Brakk/BNE 6 
12 A008/10 98 M 25 Alzheimer‟s disease HP-tau stage 6 
13 A318/09 72 M 5 
Alzheimer‟s disease Brakk 6 with marked 
amyloid angiopathy 
14 A224/08 47 M 12 
Familial Alzheimer‟s disease HP-tau stage 6  
with amyloid angiopathy 
15 A029/98 42 M 6 Familial Alzheimer‟s disease PS1 (DELTA 4) 
16 A148/99 65 M 22 Familial Alzheimer‟s disease PS1 (E280G) 
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(D) (continued) 
 
Case Code Age Sex PMD Path. Diagnosis 
6 A053/11 77 M 10 normal control 
7 A033/11 82 M 47 
control case (very early Alzheimer‟s disease 
pathology - BNE stage 1) with focal amyloid 
angiopathy 
8 A144/10 92 F 23 amyloid angiopathy. Suitable as control.  
9 A011/06 82 F 43 normal brain 
10 A265/08 79 M 47 
Early tau pathology Brakk 2, no nuritic 
plaques 
17 A358/08 55 F 47 
minimal tau pathology consistent with HP-tau 
stage 1 
18 A292/09 43 F 43 normal 
19 A150/01 40 M 40 normal adult brain  
20 A042/01 52 F 44 normal adult brain 
21 A170/00 68 F 9 normal adult brain 
 
 
 
 
Figure 6-12 : Bap31 cleavage in Alzheimer’s disease patients 
(A) The generation of pro-apoptotic p20Bap31 in Alzheimer and normal brain tissue samples 
was analysed by western blot with the C-terminal p20Bap31 antibody. (B) The relative 
expression level of p20Bap31 was plotted against age of people under 75 years old. (C) The 
graph of relative p20Bap31 generation plotted against age of people over 75 was 
demonstrated. (D) The details of brain tissues taken from the frontal cortex and 
hippocampus were listed, including age, sex (F : female, M : mail) and post-mortem delay 
(PMD, hours). The tissue samples were obtained from the London Neurodegenerative 
Diseases Brain Bank and Brains for Dementia Research through the cooperation of            
Dr. Magdalena Sastre, Imperial College. 
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6.2.9  p20Bap31 cleavage is independent of  presenilin 1 (PS1). 
The accumulation of amyloid-β in the early-onset of Alzheimer‟s disease results from 
mutations in one of three proteins: amyloid precursor protein APP, presenilin 1 (PS1) and/or 
presinilin 2 (PS2). This leads to the increase of Aβ42, which might be a cause of death in 
younger Alzheimer patients (Citron et al, 1997; Jayadev et al, 2010). To investigate whether 
the cleavage of Bap31 is dependent on PS1, the generation of p20Bap31 upon Aβ42 
treatment was determined in presenilin 1 (PS1) over-expressed, and PS1 dominant/ 
negative (PS1 dom/neg) 293T cells. In addition, etoposide (etop) treatment and caspase-8 
transfection were used as a positive control for p20Bap31 cleavage. These results show that 
Bap31 cleavage is not directly dependent on PS1 expression level (Figure 6-13). It 
presumably suggests by this experiment, not our model, that PS1 does not directly cleave 
Bap31 and that the Bap31-mediated cell death signalling pathway in AD is independent of 
PS1.   
 
 
 
 
 
 
 
 
 
Figure 6-13 :  p20Bap31 cleavage is independent of  presenilin 1 (PS1)  
The protein expressions of wild type (WT), presinilin 1 (PS1) over-expressing, and PS1 
dominant/ negative (PS1 dom/neg) expressing 293T cells were analysed by western blot 
using a Bap31 antibody (courtesy from Gordon Shore), one against GAPDH (sc32233, 
Santa Cruz).  293T cells treated with 250 μM etoposide (etop) for 30 hours and 293T cells 
transfected with caspase-8 for 30 hours were used as positive controls for p20Bap31 
cleavage.     
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6.3  Discussion            
 
p20Bap31, the cleavage product of Bap31, was first identified as a pro-apoptotic 
protein, which induces apoptotic cell death through ER Ca2+ mobilisation and mitochondria 
Ca2+ uptake, leading to cytochrome c release (Granville et al, 1998; Ng et al, 1997; Nguyen 
et al, 2000). As the Bap31 protein sequence contains two caspase cleavage sites, most 
studies focus on the role of Bap31 in apoptosis, a caspase-dependent pathway. Bap31 has 
been shown to be cleaved at two caspase recognition sites by caspase-8, caspase-3 and 
caspase-10 (Fischer et al, 2006). Additionally, many studies showed that p20Bap31 is 
generated when cells are treated with drug-induced intrinsic apoptosis, such as 
cycloheximide, staurosporine (Maatta et al, 2000), thapsigargin (Zuppini et al, 2002), 
etoposide (VP16) (Chandra et al, 2004),  photodynamic therapy (PDT) (Granville et al, 
1998), as well as the extrinsic apoptosis inducers, such as Fas stimulation (Nguyen et al, 
2000) and tumour necrosis factor (Maatta et al, 2000). Hence, the challenging hypothesis 
was whether ARCosome activation is also involved in necroptosis, another form of cell 
death. Referring to the results from Thapa et al which show that IFNγ is a necroptosis 
inducer (Thapa et al, 2011), this cytokine was used to induce necroptotic cell death. As 
shown in Figure 6-3, IFNγ-mediated necroptotic cell death can be significantly inhibited by 
nec-1, an allosteric RIP1 inhibitor, but not by zVAD, a pan-caspase inhibitor, which 
corroborates the finding mentioned above (Thapa et al, 2011). However, the percentage of 
dead cells upon IFNγ treatment was also slightly reduced when zVAD was added compared 
to IFNγ alone. This raises the possibility that caspases may play a partial role in this 
signalling pathway, which is possibly an upstream or a feedback loop downstream of the 
ARCosome activation. The downstream signal of ARCosome activation might be caspase-
3/7 activation, which is implied by the PARP cleavage (Figure 6-6) as well as Ca2+ signalling.  
The results in this chapter show that Bap31 is also cleaved under necroptosis 
conditions, such as IFNγ treatment in HeLa cells in this case (Figure 6-4). Bap31 was shown 
to be cleaved in early event of this pathway. Therefore, this data indicates that p20Bap31 
generated at an early time point (72 hours) seem to induce necroptotic cell death at a later 
time point (120 hours). In addition, the ARCosome components also play a necessary role in 
the IFNγ-induced necroptosis pathway: The survival rate upon IFNγ treatment is higher 
when the components of ARCosome were down-regulated by siRNA (Figure 6-5). The 
percentage of surviving cells when Fis1 was down-regulated was higher compared to Bap31 
knockdown. This is possibly caused as the knockdown level and/or Fis1 might be a key 
component to form the bridging structure for caspase-8 activation at the ARCosome 
complex. As shown in Figure 6-6, Bap31 cleavage was partially inhibited by zVAD and this 
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inhibition was not as strong as for Nec-1. This information supports the result in Figure 6-3 
that zVAD can inhibit cell death induced by IFNγ.  
According to the results from Figure 6-5, PARP and Bap31, but not other caspase-8 
substrates (Flip, Bid, RIP) were cleaved upon IFNγ treatment. This result suggests that 
Bap31 is the only one or one of few substrates cleaved by active caspase-8 in necroptosis, 
at least in this case induced by IFNγ. PARP was possibly cleaved by effector caspase-3/7, 
which is a downstream signalling event of caspase-8 activation at the ER. This result 
supports the model of RIP1 and RIP3 in apoptosis and necroptosis pathway. In the 
apoptosis pathway, in addition to the role of caspase-8 to induce apoptosis through the 
activation of caspase cascade, caspase-8 also cleaves and inactivates RIP1 and RIP3. In 
necroptotic cells, caspase-8 might be mostly inactivated leading to RIP1 and RIP3 
phosphorylation and hence necroptosis activation. According to the results in Figure 6-5, it 
was shown that procaspase-8 (56KDa) is cleaved into the active form of caspase-8 (18KDa). 
However, this cleavage cannot directly result in a fully active caspase-8. It is, on the other 
hand, possible that the uncleaved caspase-8 form is active. This hypothesis is supported by 
Boatright et al and Donepudi et al, which demonstrate that the caspase-8 dimerisation rather 
than interchain proteolysis is the critical event for caspase-8 activation. The autoprocessing 
of caspase-8 is suggested to merely stabilise the caspase-8 dimer (Boatright et al, 2003; 
Donepudi et al, 2003). Alternatively, caspase-8 activity might be suppressed by an inhibitor 
to switch between apoptosis and necroptosis pathway. 
Bcl-XL and Bcl-2 were shown to inhibit the necroptotic cell death upon IFNγ treatment 
(Figure 6-7).  Bcl-XL seems to play a necroptotic inhibitory role that is stronger than Bcl-2. 
This raises the possibility that Bcl-XL and Bcl-2 might be involved in necroptosis inhibition 
through similar but not identical mechanisms. Although IFNγ has been widely used in 
antitumour chemotherapy, it was suggested that the efficacy of IFNγ-induced cell death 
might be counteracted by some survival mechanisms (Balachandran & Adams, 2013). It is 
possible that Bcl-XL and Bcl-2 might play a role in a survival pathway in cancer cells treated 
with IFNγ. In future work, it would be worth to investigate whether cancerous cells are more 
vulnerable when Bcl-XL and Bcl-2 are down-regulated. If this is confirmed, the treatment of 
IFNγ combined with Bcl-XL and Bcl-2 inhibitors could provide a higher efficacy to execute 
tumour cells. Furthermore, the BH3-only protein Bmf was identified as a component of the 
DR-associated necroptotic machinery (Hitomi et al, 2008). Hence, Bmf may abate the rescue 
effect of anti-apoptotic Bcl-2 family proteins, possibly through MPT. 
 ARCosome activation was shown to be associated with different forms of cell death, 
including apoptosis and necroptosis. Bap31 was also shown to be cleaved into the pro-
apoptotic p20Bap31 when cells were treated with a variety of cell death inducers. In this 
chapter, the connection of the ARCosome activation with Alzheimer‟s disease, the most 
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common irreversible neurodegenerative disorder, was investigated. Amyloid--β (Aβ), which 
is a small peptide derived from processing of the amyloid precursor protein (APP) and a 
prominent component of plaque, is associated with AD (Goedert & Spillantini, 2006). Hence, 
in this chapter, Aβ was tested whether it can cause Bap31 cleavage in neuronal SH-SY5Y 
cells. The results show that cells treated with 20 μM aggregated Aβ(1-42) for 48 hours 
underwent cell death and at the same time p20Bap31, the consequence of Bap31 cleavage, 
was generated (Figure 6-8). The ARCosome components were also shown to be required 
for Aβ(1-42)-mediated cell death (Figure 6-11): The down-regulation of all ARCosome 
components, instead of only one component, needs to be tested to prove that the inhibition 
effect do not results from the artefact of other Fis1-, Bap31- or caspase-8-related pathways.  
In this experiment, the knockdown levels of Fis1, Bap31 and capase-8 by shRNA over time 
were primarily verified to assure that their protein expression levels were kept low throughout 
amyloid-β (1-42) treatment. Additionally, the results also shows that 20 μM aggregated Aβ(1-
42) leads to both two forms of cell death, necroptosis and apoptosis (Figure 6-10). Apoptosis 
cell death has been studied as a cause of neuronal cell death leading to Alzheimer‟s 
disease. Although, TNF-α was found to promote necroptosis of hippocampal neurons in 
CYLD-RIP1-RIP3-MLKL dependent manner which bypasses Ca2+ influx and ROS 
accumulation (Sudan He, 2014), the proteins playing a role in necroptosis signalling pathway 
has rarely been addressed. Hence, at least my study reveals that the ARCosome activation 
plays a role in this pathway.     
Current evidence shows that oxidative stress is one of the key factors for neuronal 
cell death in AD (Pratico, 2002).  As shown in chapter 5 ROS production at the mitochondria 
is also a downstream consequence of ARCosome activation through the activation of 
complex II of the respiratory chain. This piece of information raises the possibility that 
ARCosome activation-mediated cell death may also be an essential upstream signalling, that 
occurs at the ER for neuron destruction in AD. Interestingly, current evidence demonstrates 
that mild cognitive impairment and AD is related to the loss of repressor element 1-silencing 
transcription factor (REST) (Lu et al, 2014).  In addition to the role of REST to suppress cell-
death promoting genes, it also promotes expression of anti-apoptosis gene Bcl-2, antioxidant 
catalase SOD1 and transcription factor FOXO1. Additionally, REST seems to protect 
neurons from oxidative stress and Aβ toxicity. The progression of dementia cannot develop 
in individuals who show significant AD pathology in terms of Aβ aggregation if neuronal 
REST levels are maintained high (Lu et al, 2014). This raises the possibility that not only the 
accumulation of plaque and neurofibrillary tangles, but also the cooperative among proteins 
in a molecular network are required for neuronal cell death progression and the clinical 
effects in AD. Hence, the failure of a stress response to deal with this pathological 
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circumstance may also be a cause in this disease. According to this study, Bcl-2 family 
members possibly play a protective role from cell death in AD. Bcl-2 might play a role in 
multiple targets in cell death leading to AD. My proposed ARCosome model that Bcl-2 blocks 
caspase-8 recruitment for its activation for cell death might be one of them. However, 
according to our results in previous chapter, ARCosome activation-mediated cell death 
occurs upstream of signalling pathway. Hence, if firm evidence is revealed that ARCosome 
is another cell death inducer in AD, Bcl-2 may also be applied as a target for AD prevention 
or treatment. The more essential proteins in this pathway are discovered, the more hope 
there is for therapeutic intervention and drug target design.  
 The protein profiles, in this case the generation of p20Bap31, in AD patients and 
normal people were investigated. The result from Figure 6-12 shows that most of the 
Alzheimer‟s patients under 75 years old obtain a higher expression level of p20Bap31 
compared to normal people (Figure 6-12). These results raise the possibility that the higher 
expression level of pro-apoptotic p20Bap31 might be a lethal cause in younger AD patients. 
In the group over 75 years old, the relationship between p20Bap31 expression levels and 
ages was not clear. However, in this experiment only 21 samples were analysed. To confirm 
this finding, more samples of both Alzheimer‟s and normal brain tissue would be required. 
The protein profile, in this case the generation of p20Bap31, in the elderly over 75 year-old 
might be affected by their medical treatments.  More details of medical background, such as 
patients‟ disease background and their medical treatment history, would be useful for 
analysis. For example, the cancer patients who were treated with chemotherapy and/or 
radiation therapy might contain more p20Bap31 expression background compared to healthy 
individuals. In future experiment, the inhibition of neuronal cell death leading to memory lost 
in Alzheimer‟s disease would be investigated in Bap31 knock-in mouse. Alzheimer disease 
(AD) is associated with the accumulation of extracellular plaques, including amyloid-β(Aβ) 
and intracellular neurofibrillary tangles in neuron cells. At the aggregated site, neuronal cell 
death was observed. However, the cause and molecular signalling of this disease are not 
well understood. The generation of Aβ from the amyloid precursor protein (APP) relies on 
the activity of presenilin-1 (PS1), presenilin-2 (PS2), and γ-secretase, which are also located 
at the ER. The mitochondria-associated ER membranes (MAM) function and ER-
mitochondria connectivity are significantly increased in AD(Schon & Area-Gomez, 2013). 
Hence, it has been proposed that a disrupted ER–mitochondrial communication might be a 
cause for AD (Schon & Area-Gomez, 2013). My study possibly supports this hypothesis 
since the ARCosome is an ER-mitochondria tethering complex and also plays a role in cell 
death control. Additionally, another possibility is that neuronal cell death in AD may result 
from the cooperation of ARCosome with the MAM complex for cells death.    
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Chapter 7   
General discussion  
 
7.1  Bcl-XL/ Bcl-2 dissociate from ARCosome complex for cell death induction. 
 The endoplasmic reticulum (ER) and the mitochondria are organelles with essential 
roles in cell death control, especially through intracellular calcium homeostasis. Due to the 
ability of the ER to release sequestered calcium through ion channels and to activate second 
messengers in the mitochondria, a close physical and functional interaction between these 
two organelles has been established. While it was long known that a physical interaction 
between these two organelles existed as detected by electron microscopy and cell 
fractionation studies (Csordas et al, 2006; Csordas et al, 2010; Meier et al, 1981; Shore & 
Tata, 1977), only few factors have been shown to facilitate this or to act as inter-organelle 
apoptosis mediators. For example, mitochondria-associated ER membranes (MAMs) were 
discovered to facilitate the physical association between these two organelles (Hayashi et al, 
2009). Importantly, the interaction of these two organelles is increased under stress 
conditions, such as tunicamycin and serum deprivation as determined by electron 
tomography (Csordas et al, 2006). In the same study, the close proximity of ER and the 
mitochondria was shown to be important for Ca2+ signalling to the mitochondria for apoptosis 
(Csordas et al, 2006).   
My research focuses on the ARCosome, a novel protein complex that spans the 
interface between the ER and the mitochondria. This complex was discovered in our lab and 
shown to play a role in cell-death regulation. The ARCosome is composed of Fission 1 
homologue (Fis1), a fission protein, and Bap31, an integral ER membrane protein. It acts as 
a platform for procaspase-8 recruitment and activation. Caspase-8 activation brings about 
Bap31 cleavage into the pro-apoptotic p20Bap31. This signalling pathway causes Ca2+ 
release from the ER and its uptake by the mitochondria for apoptosis (Iwasawa et al, 2011). 
This is supported by fractionation studies showing that upon etoposide treatment MDA-
MB231 breast cancer cells active caspase-8 as detected in the membrane fraction 
containing both ER and mitochondria. In addition, procaspase 8 and active caspase 8 
colocalise with mitochondria as investigated by immunofluorescence (Chandra et al, 2004).  
However, how this complex is controlled in healthy and dead cells was unknown. To 
answer this question, we searched for promising candidates to investigate their association 
with or dissociation from the complex for cell death regulation. According to Ng et al‟s study 
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Bap31 was first identified as a Bcl-2 and pro-caspasas-8L (pro-FLICE) interacting partner 
(Ng et al, 1997). As anti-apoptotic Bcl-2 proteins are accepted as broad survival proteins for 
many targets in mammals (Cory & Adams, 2002; Cory et al, 2003; Cotter, 2009; Ni 
Chonghaile & Letai, 2008), they therefore are the most promising candidates in the 
ARCosome regulatory pathway to investigate in this study.  Hence, my hypothesis was that 
anti-apoptotic Bcl-2 family members, such as Bcl-XL and Bcl-2, might interact with the 
ARCosome complex in healthy cells and their dissociation is leading to complex activation 
as well as cell death induction.   
 To investigate whether Bcl-XL and Bcl-2 are key regulatory proteins in the ARCosome 
which can turn on and turn off the complex for cell death, firstly their rescue effects were 
tested in HeLa cells transfected with Fis1, an inducer of ARCosome activation. Bcl-XL / Bcl-2 
could strongly inhibit cell death-induced by Fis1 up-regulation in dose-dependent manner 
(Figure 3-4). In line with this study Fis1-induce apoptosis can also be inhibited by anti-
apoptotic Bcl-XL in a yeast study (Fannjiang et al, 2004). Although Bcl-XL / Bcl-2 survival 
effects were shown, the specific target was not investigated in this experiment. If my 
hypothesis that Bcl-XL/Bcl-2 inhibit the recruitment of procaspase-8 to the complex for its 
activation is correct, caspase-8 activation should be also inhibited when Bcl-XL / Bcl-2 are 
up-regulated in the cells upon Fis1 up-regulation. The results in Figure 3-5 showed that 
caspase-8 activation was indeed inhibited upon Bcl-XL/ Bcl-2 up-regulation. However, the 
specificity of the rescue effect by Bcl-XL / Bcl-2 for ARCosome activation could be 
questioned since they are broad anti-apoptotic proteins, which can target many apoptosis 
regulators in the cell. The survival of knockdown cells, either of Bcl-XL or Bcl-2 with the 
various ARCosome components (Bap31, Fis1 and caspase-8) down-regulation, was 
determined. The result showed that they survived more when ARCosome protein 
components were also down-regulated (Figure 3-7). This data points out that the role of Bcl-
XL or Bcl-2 is specific to the ARCosome by keeping it inactive. In future work the colony 
formation assay should be performed in this kind of experiments to affirm their ability to 
survive and to grow into a colony. Hence since apoptosis and mitochondrial fragmentation 
induced by Fis1 occur separately in apoptosis signalling (Iwasawa et al, 2011), my model of 
Bcl-2 at the ARCosome is in line with a study showing that Bcl-XL inhibits Fis1-induced 
apoptosis but not mitochondria fragmentation (James et al, 2003).  
 To be more specific, Bcl-XL / Bcl-2 were also shown to be a part of the ARCosome 
complex as determined by an immunoprecipitation (IP) experiment. In this experiment,      
Bcl-XL / Bcl-2 were found to interact with both endogenous Bap31 and Fis1, components of 
ARCosome, in healthy cells (Figure 3-9). Although Bap31 was first identified to be part of the 
complex including Bcl-XL/Bcl-2 and pro-caspase-8L (pro-FLICE) in Hek293T cells in Ng et 
al‟s study in 1997, all proteins in this study were overexpressed and hence the role of        
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Bcl-XL/Bcl-2 at this complex was not clarified(Ng et al, 1997). This point is important since 
Bcl-XL/Bcl-2 and procaspase-8 themselves play a role in cell death control. The 
overexpression of these proteins may create an artifact, which can interfere with the 
physiological conditions in cells. Therefore, in my study it was demonstrated, for the first 
time, that endogenous Bcl-XL/Bcl-2 are part of the ARCosome complex. Since there is no 
report on the direct interaction of Fis1 and Bcl-2 proteins, the interaction of these two 
proteins observed in Figure 3-9 could be mediated through Bap31 or Drp1 (Iwasawa et al, 
2011; Li et al, 2008; Yoon et al, 2003). 
 Additionally, to address the question whether the ARCosome is kept inactive in healthy 
cells based on the association or dissociation of Bcl-XL/Bcl-2 at the complex, an IP experiment 
was performed to study the different protein-protein interactions between Bcl-XL and Bap31 as 
well as Bcl-2 and Bap31 in healthy cells compared to cells treated with etoposide, an inducer 
of ARCosome activation. Importantly, their interaction in Figure 3-11 was decreased when 
cells were treated with 100 µM etoposide as well as upon Fis1 up-regulation (Figure 3-12). 
Note that in all IP experiments, the concentration of etoposide and the amount of Fis1 
plasmids induced 15-20% cell death at the time of cell harvest to assure that this regulatory 
signalling at the ARCosome is an early event and a cause of cell death. The data indicate that 
the dissociation of Bcl-XL/Bcl-2 from the complex is a turn-on switch of this complex and 
happens early and upstream in the signalling pathway. To scrutinise the mechanism in more 
detail, referring to our model that Bcl-XL/Bcl-2 could inhibit the procaspase-8 recruitment to the 
complex, the interaction of Bap31 or Fis1 with procaspase-8 was determined in cells with and 
without Bcl-XL/Bcl-2 up-regulation in combination with either etoposide treatment or Fis1 
overexpression. As expected, ectopic expression of Bcl-XL and Bcl-2 could inhibit caspase-8 
recruitment to Bap31 and Fis1 in both these conditions (Figure 3-13, 3-14).  
 According to Iwasawa et al‟s study, Bap31 and Fis1 act as an ER-mitochondria 
architectural platform for caspase-8 activation (Iwasawa et al, 2011). However, the question 
whether the regulatory role of Bcl-XL/Bcl-2 affects the Bap31-Fis1 platform remained unknown. 
Hence, this point was elucidated in Figure 3-15. The interaction of these two main components 
of ARCosome, Bap31 and Fis1, was not altered in response to Bcl-XL/Bcl-2 up-regulation. 
Additionally, the domain of Bap31, which is required for Bcl-XL/Bcl-2 interaction was 
investigated. The result of the mapping experiment (Figure 3-16) showed that the vDED 
domain and the coil-coil domain of Bap31 are dispensable for Bcl-XL and Bcl-2 binding. This 
result is in line with Far-western blotting experiment showing the interaction of recombinant 
Bap31 that possess only the three transmembrane domains (TMD) with Bcl-2 (Ng et al, 1997). 
These results support our model and it seems that Bcl-XL/Bcl-2 shield the vDED domain of 
Bap31, which is required for caspase-8 recruitment (Iwasawa et al, 2011), rather than by direct 
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interaction of Bcl-2 proteins with vDED domain of Bap31. This result led us to consider the 
possibility that transfected and over expressed Bap31 can possibly interact with endogenous 
Bap31. Therefore, this may be the indirect interaction of recombinant Bap31 and Bcl-XL/Bcl-2 
via endogenous Bap31. It should not be overlooked that Bcl-XL and Bcl-2 interacting with 
Bap31 may be ER-localised and their interaction may occur within the ER membrane since 
Bap31 containing only transmembrane domains is still be capable to interact with Bcl-XL/Bcl-2 
(Figure 3-16). This possibility is supported by the experiment in which ER-restricted Bcl-2 can 
stronger inhibit cell death compared to mitochondria-localised Bcl-2 in response to Fis1-
upregulation (Figure 3-6).  However, the inhibitory role of mitochondria-targeted Bcl-2 cannot 
be overlooked since it also can inhibit cell death when co-transfected with Fis1 (Figure 3-6). 
Since Bcl-2 is present at both organelles, they can possibly block the recruitment of caspase-8 
to the ARCosome complex from both cellular locales.  
 All together it is likely that the ARCosome regulation for cell death is similar to the 
ced4/ced-9 system in C.elegans. Comparing the ARCosome in mammals to the ced4/ced-9 
in C.elegans, Bap31 might be a ced-4 functional homolog in terms of its regulatory 
mechanism. Our model is that Bcl-XL and Bcl-2 bind Bap31 to inhibit procaspase-8 
recruitment to the ARCosome complex in healthy cells. Under cell death conditions, BH3-
only proteins, such as Bik and Bad, titrate BclXL/ Bcl-2 from the complex, which facilitates 
procaspase-8 recruitment and activation for cell death (Figure 7-1). Although Bap31 does 
not contain a CARD domain, which is necessary for ced-4 and Apaf-1 oligomerisation (Yuan 
& Akey, 2013), Bap31 instead possess a vDED domain for procaspase-8 recruitment and 
activation (Iwasawa et al, 2011). Although apoptosome has been reported to be important in 
the intrinsic signalling for apoptosis, there are some studies showing that it is not required for 
cell death in some cases. Apaf-1 knock out ES cells still undergo cell death upon treatment 
with staurosporine (STS), ultraviolet (UV) B irradiation and etoposide (Haraguchi et al, 
2000). In another independent study staurosporine resulted in caspase-dependent apoptosis 
in Apaf-1-/- cells (Imao & Nagata, 2013). This suggests that in mammals the activation 
complexes of initiator caspases has evolved in response to diverse environments (Yuan & 
Akey, 2013). Up to date, several protein platforms have been reported to activate initiator 
caspases, for example the apoptosome for procaspases-9(Acehan et al, 2002; Li et al, 1997; 
Stennicke et al, 1999); the PIDDosome for procaspases-2(Tinel & Tschopp, 2004); and the 
DISC (Boldin et al, 1995; Chinnaiyan et al, 1995), the Hip-1/Hippi complex (Gervais et al, 
2002) and ARCosome (Iwasawa et al, 2011) for procaspase-8 activation. Here in this study, 
for the first time, Bcl-XL andBcl-2 were demonstrated to act as key regulators of the 
ARCosome, another complex for initiator caspase-8 activation.   
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Figure 7-1 : Model of Bap31 as a potential CED-4 homolog 
In healthy cells, CED-4 is sequestered by CED-9 (a mammalian Bcl-2 homolog). In dying 
cells, EGL-1 (a mammalian BH3-only protein analogue) binds to CED-9 and this leads to 
CED-4 release from the complex. CED-4 recruits CED-3 to the complex and this activates 
the protease activity of CED-3. We propose a similar model for the ARCosome in which 
Bap31 is functioning as a CED-4 homolog. Bcl-XL and Bcl-2 bind to Bap31 to inhibit 
procaspase-8 recruitment to the ARCosome complex in healthy cells. Under cell death 
conditions, BH3-only proteins, such as Bik and Bad, titrate BclXL/ Bcl-2 from the complex, 
which facilitates procaspase-8 recruitment and caspase-8 activation for cell death.             
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7.2  The  upstream signalling activates the ARCosome complex. 
Bap31, a major ARCosome component, is a caspase substrate, which can be 
cleaved at two caspase cleavage sites, D164 and D238, at its C-terminus. In my study, the 
cleavage of Bap31 into pro-apoptotic p20Bap31 was used to investigate the ARCosome 
activation mechanism. Since among the commercial Bap31 antibodies on the market, no 
antibody can recognise only p20Bap31, the cleavage form of Bap31, a novel antiserum 
specific to p20Bap31 was generated.  As the fifth amino acid at the C-terminal of proteins 
was shown to be necessary for antibody specificity in Robert J. Edwards et al's study 
(Robert J. Edwards et al, 2007), a peptide of the five amino acids (GAAVD) at the C-
terminus of p20Bap31 was used to raise a C-terminal neo-epitope p20Bap31-specific 
antiserum in rabbits.  To assure the specificity of this antibody, these five amino acids were 
blasted with other caspase substrates in a caspase substrate database 
(http://bioinf.gen.tcd.ie/casbah/). This sequence was found to be unique among other 
caspase substrates when they are cleaved. Although there are some caspase substrates 
containing similar sequences to that of p20Bap31 (Figure 4-1), they are not localised at the 
ER and their protein sizes are not close to that of p20Bap31. For example, hnRNP1 (57 
KDa) is localised to the nucleus and protein 4.1 (80 KDa) is an erythrocyte protein which 
both contain AAAVD at their C-terminus. Therefore, they should not interfere with the 
p20Bap31 signal analysed by western blot. According to results in chapter 4 (Figure 4-1 to 4-
3), the C-terminal neo-epitope p20Bap31 antibody could successfully detect p20Bap31 in 
both western blot and flow cytometry analysis but only when Bap31 was overexpressed. To 
tackle this problem, the antiserum was purified to improve its specificity. After purification it 
was more specific and could detect endogenous p20Bap31 (Figure 4-4). Hence, this 
antibody is a very useful tool to detect p20Bap31, the cleavage form of Bap31. Relying on 
these results, this antibody production strategy based on five amino acids at the C-terminus 
of caspase substrates can be applied to develop antisera specific to other caspase 
substrates whose cleavage forms are difficult to detect.  
In the mechanistic study in chapter 3, it was hypothesised that Bcl-XL/Bcl-2 block 
procaspase-8 recruitment to the complex and its activation. Therefore, the generation of 
p20Bap31, which is a consequence of Bap31 cleavage by caspase-8, was also expected to 
be inhibited if Bcl-XL and Bcl-2 play this role at the ARCosome. In addition to the results 
supporting this hypothesis in chapter 3, in chapter 4 using the C-terminal neo-epitope 
p20Bap31 antibody as a tool it was demonstrated that Bcl-XL/Bcl-2 can also inhibit 
p20Bap31 generation in response to Fis1 up-regulation (Figure 4-5 and 4-6).  
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Bap31 is localised at the ER and it has been shown to be cleaved upon ER-stress, 
such as tunicamycin, thapsigargin (Maatta et al, 2000; Zuppini et al, 2002), so it has been 
presumed that ER-stress is an inducer for ARCosome activation. However, Bap31 cleavage 
induced by the other cell death inducers has poorly been investigated. In my study, the cell 
death inducers involved in ER-stress, DNA damage and/or protein production were tested 
for Bap31 cleavage. According to the result in Figure 4-7 and 4-9, Bap31 was cleaved by all 
cell death inducers but to a different extent. The strongest inducers are ER stressors 
(thapsigargin and tunicamycin) as well as DNA damage agents (doxorubicin, etoposide) and 
the translation inhibitor actinomycin D. In addition, Fis1-, Bap31- and caspase-8- depleted 
HeLa cells by siRNA knockdown were significantly rescued upon treatment with these drugs 
(Figure 4-8). This result is consistent with the result showing that cells are more resistant to 
actinomycin D and etoposide treatment when Fis1 was down-regulated (Lee et al, 2004). 
This data indicates that ARCosome is responsible for cell death mediated by a broad range 
of inducers but it is possible that some kinds of inducer are more specific to induce 
ARCosome activation than others. ARCosome activation may connect, in some points, to 
ER stress-mediated apoptosis activated by JNK1/2 phosphorylation since JNK1/2 
phosphorylation also activates pro-apoptotic protein Bim (Lei & Davis, 2003; Luciano et al, 
2003; Putcha et al, 2003) and inhibits the anti-apoptotic protein Bcl-2 (Yamamoto et al, 
1999) which would fit with my model.     
 
7.3  The downstream signalling of the ARCosome  
Ca2+ release from the ER to the mitochondria is a key cell death signalling event 
downstream of p20Bap31 generation (Iwasawa et al, 2011). My study also showed that    
Bcl-XL and Bcl-2 can significantly reduce both the cytosolic and mitochondrial Ca
2+ response 
to Fis1 upregulation (Figure 5-1). This finding is in line with studies showing that ER Ca2+ 
release to the cytosol can be inhibited by ectopic expression of both wild-type and ER-
restricted Bcl-XL/ Bcl-2 (Pinton & Rizzuto, 2006; Rong & Distelhorst, 2008; Szegezdi et al, 
2009). In addition to their role at the ARCosome, it is possible that Bcl-XL and Bcl-2 may play 
a role in ER Ca2+through the alteration ofIP3R/SERCA expression levels (Kuo et al, 1998; Li 
et al, 2002; Vanden Abeele et al, 2002) and/or SERCA activity (Dremina et al, 2004; 
Dremina et al, 2006).  
My study also reveals that complex II of the respiratory chain is a downstream sensor 
of ARCosome activation at the mitochondria as determined by the FRET technique (Figure 
5-8 and 5-9).  FRET was developed in our lab to quantify the dissociation of the two sub-
complexes of complex II, namely SDHA/SDHB sub-complex and the membrane-anchoring 
SDHC/SDHD sub-complex (Hwang et al, 2014). The complex II was shown to be activated, 
as determined by the dissociation of complex II sub-complexes, in response to mitochondrial 
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Ca2+ influx and the binding of Ca2+ ion to cardiolipin (Hwang et al, 2014). ROS production 
and PT-pore activation are the consequences of complex II activation (Hwang et al, 2014; 
Lemarie et al, 2011). According to my data, it is in line with results from this study that 
p20Bap31 induced ROS production and PT-pore activation (Figure 5-4). The signalling 
cascade model in this study from the ARCosome at the ER to the cell death-related 
complexes at the mitochondria is shown in Figure 7-2.      
 
 
 
Figure 7-2 :  Model of the ARCosome - complex II signalling cascade 
Anti-apoptotic Bcl-2 proteins protect the ARCosome complex against procaspase-8 
recruitment to the complex (left). Upon activation, the dissociation of Bcl-2 from the complex 
allows procaspase-8 recruitment and its activation (middle). The activated caspase-8 further 
cleaves Bap31 into the pro-apoptotic p20Bap31 (right). This causes Ca2+ release from the 
ER and its uptake into mitochondria. The Ca2+ ion then binds to cardiolipin (CL) and upon 
this binding it clusters and dissociates from complex II. This results in the disintegration of 
the SDHA/SDHB sub-complex from the SDHC/SDHD sub-complex leading to ROS 
generation for PT-pore activation and cell death.  
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7.4  ARCosome activation in alternative cell death scenarios  
There is growing number of studies showing that Bap31 can be cleaved in response 
to a variety of apoptotic inducers, such as cycloheximide, staurosporine (Maatta et al, 2000), 
thapsigargin (Zuppini et al, 2002), etoposide (VP16) (Chandra et al, 2004),  photodynamic 
therapy (PDT) (Granville et al, 1998), Fas stimulation (Nguyen et al, 2000), tumour necrosis 
factor (Maatta et al, 2000) as well as ER-stressors and DNA damage agents as shown in my 
study (Figure 4-7 to 4-9). In chapter 6 in my study, it was shown that ARCosome activation 
also plays a role in necroptosis induced by IFNγ. This was supported by data revealing that 
the generation of p20Bap31 can be inhibited by nec-1, the necroptosis inhibitor, when HeLa 
cells were subjected to IFNγ treatment (Figure 6-6). Additionally, the ARCosome 
components, Bap31, Fis1 and capsase-8, seem to be required for this pathway (figure 6-5).  
zVAD can slightly inhibit cell death in response to IFNγ although it is not as strong as nec-1 
(Figure 6-3). This led us to postulate that caspase activation may play at least a partial role 
in the IFNγ-cell death signalling pathway. It is likely that caspase-3/7 activation is 
downstream of ARCosome activation, cleaved by caspase-8 activated at the complex. This 
possibility is supported by the results in Figure 6-6 showing that PARP, the substrate of 
caspase-3/7, was cleaved.  Of note, Bap31 is the only caspase-8 substrate cleaved, as other 
caspase-8 substrates (Flip, Bid, RIP) remained uncleaved in the treatment with IFNγ (Figure 
6-6). It raises the possibility that Bap31 may be the only one of one of few caspase-8 
substrates that can be cleaved by the active caspase-8 in dimerisation form without 
proteolysis. This is supported by findings demonstrating that caspase-8 activation can be 
brought about by their dimerisation without interchain proteolysis (Boatright et al, 2003; 
Donepudi et al, 2003). 
My interest is to connect the molecular signalling of the ARCosome as determined by 
my experiments to relevant diseases. Since neuronal cell death is a major cause for 
Alzheimer‟s disease (AD), chapter 6 was set up to investigate whether ARCosome activation 
is one of the cell death pathways leading to this disease. Since AD is associated with the 
accumulation of the small peptide amyloid-β (Aβ) as plaques in the brain (Goedert & 
Spillantini, 2006), it was used as an inducer to investigate the role of the ARCosome in 
neuronal SH-SY5Y cells. Upon treatment with aggregated Aβ(1-42), p20Bap31 was 
generated (Figure 6-8) and Bap31, Fis1, caspase-8 were found to be required for Aβ-
induced cell death (Figure 6-11). This indicates that the ARCosome is activated in this 
pathway. Additionally, aggregated Aβ(1-42) leads to both forms of cell death, necroptosis 
and apoptosis (Figure 6-10).TNF-α was also found to promote necroptosis of hippocampal 
neurons through CYLD-RIP1-RIP3-MLKL signalling pathway, which bypasses Ca2+ influx 
and ROS accumulation (Sudan He, 2014). In addition to this paper, in my study ROS 
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generation downstream of complex II of respiratory chain was detected as a consequence of 
ARCosome activation at mitochondria (Figure 5-4, 5-5, 5-8, 5-9). Therefore, ROS may be 
another cause for neuronal cell death in AD (Pratico, 2002).  In 2014, repressor element 1-
silencing transcription factor (REST) was identified as important for mild cognitive 
impairment and AD; it suppresses cell-death promoting genes and promotes anti-apoptosis 
genes. Moreover, REST protects neuronal cell death from oxidative stress and Aβ toxicity 
(Lu et al, 2014). It is interesting that aging individuals with AD pathology do not seem to 
progress to dementia in case neuronal REST levels are high (Lu et al, 2014). This illustrates 
the importance of the molecular control over death and survival of neurons in addition to the 
plaque formation itself in the brain for the development of AD. However, all protein targets of 
REST have not yet identified. It is possible that the ARCosome is a target for REST in cell 
death regulation. If this point is proven, ARCosome subunits, especially anti-apoptotic Bcl-2 
proteins, may be applied as a target for neuronal cell death prevention prior to the 
emergence of clinical AD symptoms. This point is supported by my results showing that 
Bap31 cleavage was detected in AD patients aged lower 75 years old but not in the group 
over 75 years old (Figure 6-12). This data raises the possibility that p20Bap31 is generated 
in the early steps of AD or early onset familial AD, may be as a cause for neuronal cell death 
at younger age. As AD is known to be an irreversible degenerative disease, the prevention 
for neuronal cell death is a key strategy to prevent AD. Hence, the ARCosome may be a 
promising target to forestall AD and/or to design novel drug targets.           
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7.5  Future directions 
The association and dissociation of Bcl-XL/ Bcl-2 in the ARCosome seem to be           
a critical step to control this complex for cell death induction since their role at this complex 
is upstream of the signalling pathway. However, the exact mechanism of how Bcl-XL and 
Bcl-2 leave the ARCosome complex upon cell death induction has yet to be answered, it is 
possibly triggered by the titration of Bcl-XL and Bcl-2 from the ARCosome by BH3-only 
proteins since anti-apoptotic Bcl-2 proteins have been shown to be inhibited by BH3-only 
proteins at the ER (Elangovan & Chinnadurai, 1997; Morishima et al, 2004; Shibue et al, 
2006). The BH-3 only proteins interacting partners of Bcl-XL/Bcl-2 analysed by the STRING 
database (http://string-db.org/) (Figure 3-16), Bik, Bad and Bid, were used as candidates to 
investigate this point. The results show that the interaction of Bcl-XL/Bcl-2 with Bik or Bad 
was increased in response to etoposide treatment (Figure 3-17). This supports the 
hypothesis that BH3-only proteins, such as Bik and Bad, possibly sequester Bcl-XL/Bcl-2 
from the ARCosome complex for its activation. Hence, in future experiments the dissociation 
of Bcl-XL/Bcl-2 from the ARCosome should be further investigated in BH3-only protein 
knockdown/knockout cells. My data raise the possibility that in healthy cells Bap31 and Fis1 
normally form a bridge between the ER and the mitochondria with the cooperation of Bcl-
XL/Bcl-2 to shield the vDED domain of Bap31. Upon ARCosome activation, BH3-only 
proteins may titrate Bcl-XL/Bcl-2 out from the complex and this sets the vDED domain in 
Bap31 free for procaspase-8 recruitment for its activation. Alternatively, Bcl-XL/Bcl-2 may 
dissociate from ARCosome complex through Bax binding since Bax was shown to disrupt 
the Bap31/ Bcl-2 interaction, even though Bax does not interact with Bap31 at the complex 
(Ng et al, 1997). If this is correct, in Bax-depleted cells the ARCosome should be kept 
inactive and caspase-8 activation as well as cell death should be diminished. This point 
should be also addressed in future work. However, it is possible that the role of Bcl-XL and 
Bcl-2 in the ARCosome complex might be similar but not identical. The question whether 
one can do its job in case the other is absent should be addressed.  
Altogether, however, it is possible that Bcl-XL/ Bcl-2 play an inhibitory role at multiple 
targets in the cells, such as at the ARCosome itself, Ca2+ signalling, Bax/Bak, PT-pore, as 
well as complex II activation of respiratory chain. The supportive evidence for this hypothesis 
is that wild-type and ER localised-Bcl-2 can inhibit p20Bap31-induced cell death (this study), 
Ca2+ mobilisation as well as Ca2+uptake into mitochondria (Breckenridge et al, 2003). If Bcl-2 
only plays a role at the ARCosome complex to shield vDED domain of Bap31 to prevent 
procaspase-8 recruitment, Bcl-2 should not be able to rescue cells in response to ectopic 
p20Bap31 expression, which is does (Breckenridge et al, 2003). Furthermore, etoposide-
mediated apoptosis can be inhibited by mitochondrial Bcl-2 (Kim et al, 2004). Alternatively, it 
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is possible that the downstream consequences of p20Bap31-induced cell death, for example 
Ca2+ release from the ER and/or ROS generation, are part of a feedback loop back to the 
ARCosome from the ER. This point is rather difficult to investigate but important as the 
molecular signalling of ARCosome activation leading to cell death is very complex and many 
proteins are involved. In future works, the investigation of anti-apoptotic Bcl-2 proteins at 
individual steps in this signalling pathway should be addressed, at least its role at the ER or 
mitochondria. This point is important and worth elucidating since as mentioned in chapter 4 
(see more detail in section Introduction 4.4) ER-stress, an inducer of ARCosome activation, 
is associated with many diseases, such as autoimmune disease, cancers and 
neurodegenerative disorders. ROS generation related to protein oxidation, lipid peroxidation 
and peronitrite formation in brain samples was suggested being a cause for Alzheimer‟s 
disease (Pratico, 2002). In addition, unregulated necroptotic cell death is associated with 
neurogenesis, ischaemic injury and viral infection (Cho et al, 2010; Duprez et al, 2009; Tait & 
Green, 2008; Zhivotovsky & Orrenius, 2010). MOMP is associated with long-term 
degenerative diseases, such as Alzheimer disease, Parkinson disease, multiple sclerosis, 
and muscular dystrophy, as well as acute cellular loss following myocardial infarction and 
stroke (Baines et al, 2005; Du et al, 2008; Forte et al, 2007; Millay et al, 2008; Schinzel et al, 
2005). Additionally, apoptosis and necrosis is a cause for heart failure (Kang & Izumo, 2000; 
Nakayama et al, 2007). Cardiomyocyte necrosis is a mediator of heart failure and depends 
on Ca2+ and mitochondria signalling (Nakayama et al, 2007). As shown here, in terms of a 
potential diagnostic application, it will be a challenge to show how individual steps of 
apoptosis signalling induced by the ARCosome are correlated to relevant diseases. Studies 
on diseases mentioned above in which the individual steps of the ARCosome signalling 
cascade are deleted in vivo, for example a caspase-resistant Bap31 (crBap31) knock-in 
mouse model, are a challenge for future works.  
 According to the results in the mapping experiment (Figure 3-15), it was showed that 
Bcl-XL and Bcl-2 binding does not require the vDED domain and the coil-coil domain of 
Bap31. This interaction may be based on the indirect interaction of recombinant Bap31 and 
Bcl-XL/Bcl-2 via endogenous Bap31. To prove this possibility, this experiment should be 
investigated in Bap31- knockdown/knockout cell lines. However, this piece of information did 
not inform whether the binding of Bcl-XL/Bcl-2 to the Bap31 mutant (Bap31ΔvDED, 
Bap31ΔCCΔ/vDED) is still functional to inhibit caspase-8 recruitment or not. In future 
experiments, the caspase-8 recruitment to the complex under such conditions should be 
investigated. 
Bap31, Fis1, caspase,8 and Bcl-XL/ Bcl-2 have been identified as the main proteins 
of the ARCosome complex; however, other protein members could be part of the complex, 
which play a role in cell death control and should be elucidated in future work. As mentioned 
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above, MAMs are one of the most prominent ER-mitochondria tethering membrane regions. 
MAMs were shown to play a role in phospholipid exchange, Ca2+ signalling, lipid transport 
between two organelles (Hayashi et al, 2009). Although many proteins were reported to be 
part of MAMs, such as IP3R, Ca
2+–ATPase, VDAC and the uniporter for Ca2+ transport, 
chaperone proteins (BiP, calnexin, calreticulin, ERp44, ERp57, FKBP12, Grp75, hsp60), 
phospho-acidic cluster sorting protein 2 (PACS-2) as well as electron transport chain 
proteins (Hayashi et al, 2009), possible not all protein members at MAMs have been 
identified. This point raises the possibility that Bap31 is supposed to be part of MAMs or their 
interaction is possibly associated with cell death signalling. Additionally, CDIP1, a p53 target 
gene, which is a Bap31 binding partner, is likely part of ARCosome complex and plays a role 
in cell death activation. Upon ER stress, the association of CDIP1 with Bap31 was found to 
be enhanced and this binding is required for Bap31 cleavage, Bap31-caspase8 as well as 
Bap31-Bcl2 association (Namba et al, 2013). In the same study, according to in vivo results, 
knockout of CDIP1 in mice results in impaired response to ER-stress-activated apoptosis 
andCDIP1 expression is dramatically upregulated upon ER stress(Namba et al, 2013). 
Moreover, BAR protein, which contains a pseudo-DED similar to HIP1, Hippi and Bap31 was 
found to interact with these three proteins but no interaction was detected for DED-
containing proteins FADD and PEA15, or for non-DED proteins such as XIAP and Bid (Roth 
et al, 2003). Overexpression of BAR can protect neuronal cells from a broad range of cell 
death stimuli, including TNF and ER-stress. Conversely, the downregulation of BAR 
sensitises neuronal cells for apoptosis (Roth et al, 2003). The role of BAR for cell death 
inhibition is also supported by study in mice which showed that the overexpression of non-
degradable form of BAR prevents apoptosis and injury following ischaemia/reperfusion (I/R) 
and attenuates doxorubicin (DOX)-induced cardiotoxicity(Chua et al, 2009).It was suggested 
that the antiapoptotic properties of BAR may depend on the interaction of BAR with Bcl-XL or 
Bcl-2 via SAM domain(Zhang et al, 2000).Hence, the bifunctional apoptosis regulator (BAR), 
another Bap31 binding protein, may cooperately work with Bcl-XL/Bcl-2 for apoptosis 
inhibition through ARCosome inactivation. 
Moreover, the question which protein is responsible for Ca2+ release from the ER 
following ARCosome activation should be addressed. It may depend on the putative ER ion 
channel A4 as it was identified as a Bap31 binding partner and the presence of this protein 
was shown to be necessary for apoptotic changes, such as membrane blebbling and 
fragmentation, loss of membrane integrity and cytochrome c release (Wang et al, 2003). To 
identify more proteins at this complex and their requirement for cell death induction, mass 
spectrometry following immunoprecipitation in healthy cells and upon treatment with 
ARCosome inducers should be conducted.   
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